Access the full text.
Sign up today, get DeepDyve free for 14 days.
(BorceaAGreavesMWMethotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reactionBr J Dermatol2000520320410886169)
BorceaAGreavesMWMethotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reactionBr J Dermatol2000520320410886169BorceaAGreavesMWMethotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reactionBr J Dermatol2000520320410886169, BorceaAGreavesMWMethotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reactionBr J Dermatol2000520320410886169
(BrzozaZBadura-BrzozaKMłynekAMagerlMBaiardiniIAdaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL)J Dermatol Sci20115364121333502)
BrzozaZBadura-BrzozaKMłynekAMagerlMBaiardiniIAdaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL)J Dermatol Sci20115364121333502BrzozaZBadura-BrzozaKMłynekAMagerlMBaiardiniIAdaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL)J Dermatol Sci20115364121333502, BrzozaZBadura-BrzozaKMłynekAMagerlMBaiardiniIAdaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL)J Dermatol Sci20115364121333502
M Schatz, D Petitti (1997)
Antihistamines and pregnancyAnn Allergy Asthma Immunol, 78
(ShakouoriACompalatiELangDMKhanDAEffectiveness of Helicobacter pylori eradication in chronic Urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation systemCurr Opin Allergy Clin Immunol2010536236920610979)
ShakouoriACompalatiELangDMKhanDAEffectiveness of Helicobacter pylori eradication in chronic Urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation systemCurr Opin Allergy Clin Immunol2010536236920610979ShakouoriACompalatiELangDMKhanDAEffectiveness of Helicobacter pylori eradication in chronic Urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation systemCurr Opin Allergy Clin Immunol2010536236920610979, ShakouoriACompalatiELangDMKhanDAEffectiveness of Helicobacter pylori eradication in chronic Urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation systemCurr Opin Allergy Clin Immunol2010536236920610979
(KrauseKArdeleanEKesslerBMagerlMMetzMAntihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapyAllergy201051494149510.1111/j.1398-9995.2010.02409.x20560911)
KrauseKArdeleanEKesslerBMagerlMMetzMAntihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapyAllergy201051494149510.1111/j.1398-9995.2010.02409.x20560911KrauseKArdeleanEKesslerBMagerlMMetzMAntihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapyAllergy201051494149510.1111/j.1398-9995.2010.02409.x20560911, KrauseKArdeleanEKesslerBMagerlMMetzMAntihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapyAllergy201051494149510.1111/j.1398-9995.2010.02409.x20560911
(WolvertonSERemlingerKSuggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugsDermatol Clin19975195205)
WolvertonSERemlingerKSuggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugsDermatol Clin19975195205WolvertonSERemlingerKSuggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugsDermatol Clin19975195205, WolvertonSERemlingerKSuggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugsDermatol Clin19975195205
(GrundmannSAKieferSLugerTABrehlerRDelayed pressure urticarial--dapsone heading for first-line therapy?J Dtsch Dermatol Ges2011 in press doi:10.1111/j.1610-0387.2011.07749.x [epub ahead of print])
GrundmannSAKieferSLugerTABrehlerRDelayed pressure urticarial--dapsone heading for first-line therapy?J Dtsch Dermatol Ges2011 in press doi:10.1111/j.1610-0387.2011.07749.x [epub ahead of print]GrundmannSAKieferSLugerTABrehlerRDelayed pressure urticarial--dapsone heading for first-line therapy?J Dtsch Dermatol Ges2011 in press doi:10.1111/j.1610-0387.2011.07749.x [epub ahead of print], GrundmannSAKieferSLugerTABrehlerRDelayed pressure urticarial--dapsone heading for first-line therapy?J Dtsch Dermatol Ges2011 in press doi:10.1111/j.1610-0387.2011.07749.x [epub ahead of print]
AB Zimmerman, EM Berger, SB Elmariah, NA Soter (2011)
J Am Acad Dermatol
(GreavesMWChronic urticaria in childhoodAllergy2000530932010.1034/j.1398-9995.2000.00116.x10782515)
GreavesMWChronic urticaria in childhoodAllergy2000530932010.1034/j.1398-9995.2000.00116.x10782515GreavesMWChronic urticaria in childhoodAllergy2000530932010.1034/j.1398-9995.2000.00116.x10782515, GreavesMWChronic urticaria in childhoodAllergy2000530932010.1034/j.1398-9995.2000.00116.x10782515
(2011)
Delayed pressure urticariaddapsone heading for first-line therapy
(CassanoND'ArgentoVFiloticoRVenaGALow-dose dapsone in chronic idiopathic urticaria: preliminary results of an open studyActa Derm Venereol2005525425516040414)
CassanoND'ArgentoVFiloticoRVenaGALow-dose dapsone in chronic idiopathic urticaria: preliminary results of an open studyActa Derm Venereol2005525425516040414CassanoND'ArgentoVFiloticoRVenaGALow-dose dapsone in chronic idiopathic urticaria: preliminary results of an open studyActa Derm Venereol2005525425516040414, CassanoND'ArgentoVFiloticoRVenaGALow-dose dapsone in chronic idiopathic urticaria: preliminary results of an open studyActa Derm Venereol2005525425516040414
C. Saçkesen, B. Sekerel, F. Orhan, C. Kocabaş, A. Tuncer, G. Adalıoglu (2004)
The Etiology of Different Forms of Urticaria in ChildhoodPediatric Dermatology, 21
(GuyattGHOxmanADVistGEKunzRFalck-YtterYGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBr Med J2008592492610.1136/bmj.39489.470347.AD18436948)
GuyattGHOxmanADVistGEKunzRFalck-YtterYGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBr Med J2008592492610.1136/bmj.39489.470347.AD18436948GuyattGHOxmanADVistGEKunzRFalck-YtterYGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBr Med J2008592492610.1136/bmj.39489.470347.AD18436948, GuyattGHOxmanADVistGEKunzRFalck-YtterYGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBr Med J2008592492610.1136/bmj.39489.470347.AD18436948
(ParslewRPryceDAshworthJFriedmannPSWarfarin treatment of chronic idiopathic urticaria and angio-oedemaClin Exp Allergy200051161116510.1046/j.1365-2222.2000.00857.x10931124)
ParslewRPryceDAshworthJFriedmannPSWarfarin treatment of chronic idiopathic urticaria and angio-oedemaClin Exp Allergy200051161116510.1046/j.1365-2222.2000.00857.x10931124ParslewRPryceDAshworthJFriedmannPSWarfarin treatment of chronic idiopathic urticaria and angio-oedemaClin Exp Allergy200051161116510.1046/j.1365-2222.2000.00857.x10931124, ParslewRPryceDAshworthJFriedmannPSWarfarin treatment of chronic idiopathic urticaria and angio-oedemaClin Exp Allergy200051161116510.1046/j.1365-2222.2000.00857.x10931124
S. Chua, S. Gibbs (2005)
Chronic urticaria responding to subcutaneous heparin sodiumBritish Journal of Dermatology, 153
E. Orion, H. Matz, R. Wolf (2005)
The life-threatening complications of dermatologic therapies.Clinics in dermatology, 23 2
Kaiping Yang (1997)
Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids.Reviews of reproduction, 2 3
M. Greaves (2001)
Chronic Idiopathic Urticaria (CIU) and Helicobacter pyloriAllergy & Clinical Immunology International-journal of The World Allergy Organization, 13
(HarrisATwarogFJGehaRSChronic urticaria in childhood: natural course and aetiologyAnn Allergy198352 pt 11611656881605)
HarrisATwarogFJGehaRSChronic urticaria in childhood: natural course and aetiologyAnn Allergy198352 pt 11611656881605HarrisATwarogFJGehaRSChronic urticaria in childhood: natural course and aetiologyAnn Allergy198352 pt 11611656881605, HarrisATwarogFJGehaRSChronic urticaria in childhood: natural course and aetiologyAnn Allergy198352 pt 11611656881605
(Serhat InalozHOzturkSAkcaliCKirtakNTarakciogluMLow-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluationJ Dermatol2008527628210.1111/j.1346-8138.2008.00466.x18477227)
Serhat InalozHOzturkSAkcaliCKirtakNTarakciogluMLow-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluationJ Dermatol2008527628210.1111/j.1346-8138.2008.00466.x18477227Serhat InalozHOzturkSAkcaliCKirtakNTarakciogluMLow-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluationJ Dermatol2008527628210.1111/j.1346-8138.2008.00466.x18477227, Serhat InalozHOzturkSAkcaliCKirtakNTarakciogluMLow-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluationJ Dermatol2008527628210.1111/j.1346-8138.2008.00466.x18477227
(BeltraniVSUrticaria and angioedemaDermatol Clin199651711988821171)
BeltraniVSUrticaria and angioedemaDermatol Clin199651711988821171BeltraniVSUrticaria and angioedemaDermatol Clin199651711988821171, BeltraniVSUrticaria and angioedemaDermatol Clin199651711988821171
G. Clough, P. Boutsiouki, M. Church (2001)
Comparison of the effects of levocetirizine and loratadine on histamine‐induced wheal, flare, and itch in human skinAllergy, 56
M. Hide, D. Francis, C. Grattan, J. Hakimi, J. Kochan, M. Greaves (1993)
Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.The New England journal of medicine, 328 22
(MłynekAZalewska-JanowskaAMartusPStaubachPZuberbierTMaurerMHow to assess disease activity in patients with chronic urticaria?Allergy2008577778010.1111/j.1398-9995.2008.01726.x18445192)
MłynekAZalewska-JanowskaAMartusPStaubachPZuberbierTMaurerMHow to assess disease activity in patients with chronic urticaria?Allergy2008577778010.1111/j.1398-9995.2008.01726.x18445192MłynekAZalewska-JanowskaAMartusPStaubachPZuberbierTMaurerMHow to assess disease activity in patients with chronic urticaria?Allergy2008577778010.1111/j.1398-9995.2008.01726.x18445192, MłynekAZalewska-JanowskaAMartusPStaubachPZuberbierTMaurerMHow to assess disease activity in patients with chronic urticaria?Allergy2008577778010.1111/j.1398-9995.2008.01726.x18445192
M. Gioacchino, F. Stefano, E. Cavallucci, N. Verna, S. Ramondo, F. Paolini, R. Caruso, C. Schiavone, S. Masci, B. Santucci, R. Paganelli, P. Conti (2003)
Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation.Allergy and asthma proceedings, 24 4
(GaigPOlonaMMuñoz LejarazuDCaballeroMTDominguezFSEpidemiology of urticaria in SpainJ Investig Allergol Clin Immunol2004521422015552715)
GaigPOlonaMMuñoz LejarazuDCaballeroMTDominguezFSEpidemiology of urticaria in SpainJ Investig Allergol Clin Immunol2004521422015552715GaigPOlonaMMuñoz LejarazuDCaballeroMTDominguezFSEpidemiology of urticaria in SpainJ Investig Allergol Clin Immunol2004521422015552715, GaigPOlonaMMuñoz LejarazuDCaballeroMTDominguezFSEpidemiology of urticaria in SpainJ Investig Allergol Clin Immunol2004521422015552715
(CaproniMGiomiBVolpiWMelaniLSchincagliaEChronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced whealsClin Immunol2005528429210.1016/j.clim.2004.10.00715721839)
CaproniMGiomiBVolpiWMelaniLSchincagliaEChronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced whealsClin Immunol2005528429210.1016/j.clim.2004.10.00715721839CaproniMGiomiBVolpiWMelaniLSchincagliaEChronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced whealsClin Immunol2005528429210.1016/j.clim.2004.10.00715721839, CaproniMGiomiBVolpiWMelaniLSchincagliaEChronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced whealsClin Immunol2005528429210.1016/j.clim.2004.10.00715721839
R. Asero, A. Tedeschi, P. Riboldi, M. Cugno (2006)
Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum.The Journal of allergy and clinical immunology, 117 5
(JafferAMSulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticariaJ Allergy Clin Immunol1991596496510.1016/0091-6749(91)90255-M1683883)
JafferAMSulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticariaJ Allergy Clin Immunol1991596496510.1016/0091-6749(91)90255-M1683883JafferAMSulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticariaJ Allergy Clin Immunol1991596496510.1016/0091-6749(91)90255-M1683883, JafferAMSulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticariaJ Allergy Clin Immunol1991596496510.1016/0091-6749(91)90255-M1683883
Y. Kikuchi, A. Kaplan (2002)
A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria.The Journal of allergy and clinical immunology, 109 1
J. Verster, A. Weert, Saskia Bijtjes, M. Aarab, Armand Oosterwijck, E. Eijken, M. Verbaten, E. Volkerts (2003)
Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trialPsychopharmacology, 169
R. Asero, A. Tedeschi, M. Lorini (2001)
Leukotriene receptor antagonists in chronic urticariaAllergy, 56
(SackesenCSekerelBEOrhanFKocabosCNTurnerAAdalioglinGThe aetiology of different forms of urticaria in childhoodPediatr Dermatol2004510210810.1111/j.0736-8046.2004.21202.x15078346)
SackesenCSekerelBEOrhanFKocabosCNTurnerAAdalioglinGThe aetiology of different forms of urticaria in childhoodPediatr Dermatol2004510210810.1111/j.0736-8046.2004.21202.x15078346SackesenCSekerelBEOrhanFKocabosCNTurnerAAdalioglinGThe aetiology of different forms of urticaria in childhoodPediatr Dermatol2004510210810.1111/j.0736-8046.2004.21202.x15078346, SackesenCSekerelBEOrhanFKocabosCNTurnerAAdalioglinGThe aetiology of different forms of urticaria in childhoodPediatr Dermatol2004510210810.1111/j.0736-8046.2004.21202.x15078346
A. Shakouri, E. Compalati, D. Lang, D. Khan (2010)
Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation systemCurrent Opinion in Allergy and Clinical Immunology, 10
(MaurerMWellerKBindslev-JensenCGiménez-ArnauABousquetJUnmet clinical needs in chronic spontaneous urticaria. A Galen task force reportAllergy2010531733021083565)
MaurerMWellerKBindslev-JensenCGiménez-ArnauABousquetJUnmet clinical needs in chronic spontaneous urticaria. A Galen task force reportAllergy2010531733021083565MaurerMWellerKBindslev-JensenCGiménez-ArnauABousquetJUnmet clinical needs in chronic spontaneous urticaria. A Galen task force reportAllergy2010531733021083565, MaurerMWellerKBindslev-JensenCGiménez-ArnauABousquetJUnmet clinical needs in chronic spontaneous urticaria. A Galen task force reportAllergy2010531733021083565
H. Inaloz, S. Ozturk, C. Akçalı, N. Kırtak, M. Tarakçıoğlu (2008)
Low‐dose and short‐term cyclosporine treatment in patients with chronic idiopathic urticaria: A clinical and immunological evaluationThe Journal of Dermatology, 35
G. Toit, R. Prescott, P. Lawrence, A. Johar, Geraldine Brown, E. Weinberg, C. Motala, P. Potter (2006)
Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 96 2
(PacorMLDi LorenzoGCorrocherREfficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acidClin Exp Allergy200151607161410.1046/j.1365-2222.2001.01189.x11678862)
PacorMLDi LorenzoGCorrocherREfficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acidClin Exp Allergy200151607161410.1046/j.1365-2222.2001.01189.x11678862PacorMLDi LorenzoGCorrocherREfficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acidClin Exp Allergy200151607161410.1046/j.1365-2222.2001.01189.x11678862, PacorMLDi LorenzoGCorrocherREfficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acidClin Exp Allergy200151607161410.1046/j.1365-2222.2001.01189.x11678862
(SandsMFBlumeJWSchwartzSASuccessful treatment of 3 patients with recurrent idiopathic angioedema with omalizumabJ Allergy Clin Immunol2007597998110.1016/j.jaci.2007.07.04117931567)
SandsMFBlumeJWSchwartzSASuccessful treatment of 3 patients with recurrent idiopathic angioedema with omalizumabJ Allergy Clin Immunol2007597998110.1016/j.jaci.2007.07.04117931567SandsMFBlumeJWSchwartzSASuccessful treatment of 3 patients with recurrent idiopathic angioedema with omalizumabJ Allergy Clin Immunol2007597998110.1016/j.jaci.2007.07.04117931567, SandsMFBlumeJWSchwartzSASuccessful treatment of 3 patients with recurrent idiopathic angioedema with omalizumabJ Allergy Clin Immunol2007597998110.1016/j.jaci.2007.07.04117931567
M. Caproni, B. Giomi, W. Volpi, Lucilla Melani, E. Schincaglia, D. Macchia, M. Manfredi, A. D'Agata, P. Fabbri (2005)
Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals.Clinical immunology, 114 3
M. Marmor, U. Kellner, T. Lai, J. Lyons, W. Mieler (2002)
Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.Ophthalmology, 118 2
M. Magerl, Dina Pisarevskaja, R. Scheufele, T. Zuberbier, M. Maurer (2010)
Effects of a pseudoallergen‐free diet on chronic spontaneous urticaria: a prospective trialAllergy, 65
A. Eiser, Parikshit Singh, H. Shanies (1997)
Sustained Dapsone-Induced Remission of Hypocomplementemic Urticarial VasculitisAngiology, 48
(GarofaloJHauberTKaplanAPIdiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsiesN Eng J Med198151074107710.1056/NEJM198110293051808)
GarofaloJHauberTKaplanAPIdiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsiesN Eng J Med198151074107710.1056/NEJM198110293051808GarofaloJHauberTKaplanAPIdiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsiesN Eng J Med198151074107710.1056/NEJM198110293051808, GarofaloJHauberTKaplanAPIdiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsiesN Eng J Med198151074107710.1056/NEJM198110293051808
(GrattanCEBasophils in chronic urticariaJ Investig Dermatol Symp Proc2001513914010.1046/j.0022-202x.2001.00027.x11764301)
GrattanCEBasophils in chronic urticariaJ Investig Dermatol Symp Proc2001513914010.1046/j.0022-202x.2001.00027.x11764301GrattanCEBasophils in chronic urticariaJ Investig Dermatol Symp Proc2001513914010.1046/j.0022-202x.2001.00027.x11764301, GrattanCEBasophils in chronic urticariaJ Investig Dermatol Symp Proc2001513914010.1046/j.0022-202x.2001.00027.x11764301
(EckmanJHamiltonRGGoberLMSterbaPMSainiSSBasophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodiesJ Invest Dermatol200851956196318356810)
EckmanJHamiltonRGGoberLMSterbaPMSainiSSBasophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodiesJ Invest Dermatol200851956196318356810EckmanJHamiltonRGGoberLMSterbaPMSainiSSBasophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodiesJ Invest Dermatol200851956196318356810, EckmanJHamiltonRGGoberLMSterbaPMSainiSSBasophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodiesJ Invest Dermatol200851956196318356810
B Wedi, U Raap, D Wieczorek, A Kapp (2009)
Urticaria and infectionsAnn Asthma Clin Immunol, 5
SA Vaughan Jones, MM Black (1999)
Pregnancy dermatosesJ Am Acad Dermatol, 40
(SöderbergKCHagmarLSchwartzbaumJFeychtingMAllergic conditions and risk of hematological malignancies in adults: a cohort studyBMC Public Health200455110.1186/1471-2458-4-5115527506)
SöderbergKCHagmarLSchwartzbaumJFeychtingMAllergic conditions and risk of hematological malignancies in adults: a cohort studyBMC Public Health200455110.1186/1471-2458-4-5115527506SöderbergKCHagmarLSchwartzbaumJFeychtingMAllergic conditions and risk of hematological malignancies in adults: a cohort studyBMC Public Health200455110.1186/1471-2458-4-5115527506, SöderbergKCHagmarLSchwartzbaumJFeychtingMAllergic conditions and risk of hematological malignancies in adults: a cohort studyBMC Public Health200455110.1186/1471-2458-4-5115527506
M. Klote, M. Nelson, R. Engler (2005)
Autoimmune urticaria response to high-dose intravenous immunoglobulin.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 94 2
S. Saini, K. Rosen, H. Hsieh, D. Wong, E. Conner, A. Kaplan, S. Spector, M. Maurer (2011)
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.The Journal of allergy and clinical immunology, 128 3
R. Asero (2007)
Etoricoxib challenge in patients with chronic urticaria with NSAID intoleranceClinical and Experimental Dermatology, 32
Imke Ehlers, B. Niggemann, C. Binder, T. Zuberbier (1998)
Role of nonallergic hypersensitivity reactions in children with chronic urticariaAllergy, 53
A. Kapp, W. Pichler (2006)
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled, parallel, multicenter studyInternational Journal of Dermatology, 45
(HilbertJRadwanskiEAffrimeMBPerentesisGSymchowiczSZampagnoneNExcretion of loratadine in human breast milkJ Clin Pharmacol1988523423910.1002/j.1552-4604.1988.tb03138.x2966185)
HilbertJRadwanskiEAffrimeMBPerentesisGSymchowiczSZampagnoneNExcretion of loratadine in human breast milkJ Clin Pharmacol1988523423910.1002/j.1552-4604.1988.tb03138.x2966185HilbertJRadwanskiEAffrimeMBPerentesisGSymchowiczSZampagnoneNExcretion of loratadine in human breast milkJ Clin Pharmacol1988523423910.1002/j.1552-4604.1988.tb03138.x2966185, HilbertJRadwanskiEAffrimeMBPerentesisGSymchowiczSZampagnoneNExcretion of loratadine in human breast milkJ Clin Pharmacol1988523423910.1002/j.1552-4604.1988.tb03138.x2966185
S. Melboucy-Belkhir, S. Glitho, F. Caux, A. Mékinian, O. Fain (2014)
[Hypocomplementemic urticarial vasculitis syndrome].La Revue du praticien, 64 1
B. Lindelöf, B. Sigurgeirsson, C. Wahlgren, G. Eklund (1990)
Chronic urticaria and cancer: an epidemiological study of 1155 patientsBritish Journal of Dermatology, 123
(Vaughan JonesSABlackMMPregnancy dermatosesJ Am Acad Dermatol1999523324110.1016/S0190-9622(99)70194-510025751)
Vaughan JonesSABlackMMPregnancy dermatosesJ Am Acad Dermatol1999523324110.1016/S0190-9622(99)70194-510025751Vaughan JonesSABlackMMPregnancy dermatosesJ Am Acad Dermatol1999523324110.1016/S0190-9622(99)70194-510025751, Vaughan JonesSABlackMMPregnancy dermatosesJ Am Acad Dermatol1999523324110.1016/S0190-9622(99)70194-510025751
R. Asero, A. Tedeschi, P. Riboldi, S. Griffini, E. Bonanni, M. Cugno, O. Policlinico, R. Asero (2007)
Severe chronic urticaria is associated with elevated plasma levels of D‐dimerAllergy, 63
(FerreliCPinnaAAtzoriLAsteNEosinophilic cellulitis (Well's syndrome): a new case descriptionJ Eur Acad Dermatol Venereol19995414510.1111/j.1468-3083.1999.tb00842.x10565629)
FerreliCPinnaAAtzoriLAsteNEosinophilic cellulitis (Well's syndrome): a new case descriptionJ Eur Acad Dermatol Venereol19995414510.1111/j.1468-3083.1999.tb00842.x10565629FerreliCPinnaAAtzoriLAsteNEosinophilic cellulitis (Well's syndrome): a new case descriptionJ Eur Acad Dermatol Venereol19995414510.1111/j.1468-3083.1999.tb00842.x10565629, FerreliCPinnaAAtzoriLAsteNEosinophilic cellulitis (Well's syndrome): a new case descriptionJ Eur Acad Dermatol Venereol19995414510.1111/j.1468-3083.1999.tb00842.x10565629
(2008)
Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies.The Journal of investigative dermatology, 128 8
E. Monroe, S. Cohen, J. Kalbfleisch, C. Schulz (1981)
Combined H1 and H2 antihistamine therapy in chronic urticaria.Archives of dermatology, 117 7
(Lara-CorralesIBalma MenaAPopeEChronic urticaria in childrenClin Pediatr (Phila)2009535135519095629)
Lara-CorralesIBalma MenaAPopeEChronic urticaria in childrenClin Pediatr (Phila)2009535135519095629Lara-CorralesIBalma MenaAPopeEChronic urticaria in childrenClin Pediatr (Phila)2009535135519095629, Lara-CorralesIBalma MenaAPopeEChronic urticaria in childrenClin Pediatr (Phila)2009535135519095629
(EnginBUguzFYilmazEThe levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol20085364018181971)
EnginBUguzFYilmazEThe levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol20085364018181971EnginBUguzFYilmazEThe levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol20085364018181971, EnginBUguzFYilmazEThe levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol20085364018181971
W. Grotz, H. Baba, J. Becker, M. Baumgärtel (2009)
Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge.Deutsches Arzteblatt international, 106 46
Greaves (2000)
Chronic urticariaJ Allergy Clin Immunol, 105
(PopovTADumitrascuDBachvarovaABocsanCDimitrovVChurchMKA comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivoInflamm Res2006524124410.1007/s00011-006-0075-z16955243)
PopovTADumitrascuDBachvarovaABocsanCDimitrovVChurchMKA comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivoInflamm Res2006524124410.1007/s00011-006-0075-z16955243PopovTADumitrascuDBachvarovaABocsanCDimitrovVChurchMKA comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivoInflamm Res2006524124410.1007/s00011-006-0075-z16955243, PopovTADumitrascuDBachvarovaABocsanCDimitrovVChurchMKA comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivoInflamm Res2006524124410.1007/s00011-006-0075-z16955243
(MagerlMPisurevokajaDScheufeleRZuberbierTMannerMEffects of a pseudoallergen diet on chronic spontaneous urticaria: a prospective trialAllergy20105788319796222)
MagerlMPisurevokajaDScheufeleRZuberbierTMannerMEffects of a pseudoallergen diet on chronic spontaneous urticaria: a prospective trialAllergy20105788319796222MagerlMPisurevokajaDScheufeleRZuberbierTMannerMEffects of a pseudoallergen diet on chronic spontaneous urticaria: a prospective trialAllergy20105788319796222, MagerlMPisurevokajaDScheufeleRZuberbierTMannerMEffects of a pseudoallergen diet on chronic spontaneous urticaria: a prospective trialAllergy20105788319796222
(ErbagciZThe leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical studyJ Allergy Clin Immunol2002548448810.1067/mai.2002.12667612209099)
ErbagciZThe leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical studyJ Allergy Clin Immunol2002548448810.1067/mai.2002.12667612209099ErbagciZThe leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical studyJ Allergy Clin Immunol2002548448810.1067/mai.2002.12667612209099, ErbagciZThe leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical studyJ Allergy Clin Immunol2002548448810.1067/mai.2002.12667612209099
(CaminitiLPassalacquaGMagazzaGChronic urticaria and associated coeliac disease in children: a case control studyPaediatr Allergy Immunol2005542843210.1111/j.1399-3038.2005.00309.x)
CaminitiLPassalacquaGMagazzaGChronic urticaria and associated coeliac disease in children: a case control studyPaediatr Allergy Immunol2005542843210.1111/j.1399-3038.2005.00309.xCaminitiLPassalacquaGMagazzaGChronic urticaria and associated coeliac disease in children: a case control studyPaediatr Allergy Immunol2005542843210.1111/j.1399-3038.2005.00309.x, CaminitiLPassalacquaGMagazzaGChronic urticaria and associated coeliac disease in children: a case control studyPaediatr Allergy Immunol2005542843210.1111/j.1399-3038.2005.00309.x
Pierre Jacques, A. Lavoie, P. Bédard, C. Brunet, Jacques Hébert (1992)
Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission.The Journal of allergy and clinical immunology, 89 6
(WetterDADavisMDYianniasJAGibsonLEDahlMVEffectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experienceMayo Clin Proc20055414715667028)
WetterDADavisMDYianniasJAGibsonLEDahlMVEffectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experienceMayo Clin Proc20055414715667028WetterDADavisMDYianniasJAGibsonLEDahlMVEffectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experienceMayo Clin Proc20055414715667028, WetterDADavisMDYianniasJAGibsonLEDahlMVEffectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experienceMayo Clin Proc20055414715667028
T. Zuberbier, M. Greaves, L. Juhlin, H. Merk, G. Stingl, B. Henz (2001)
Management of urticaria: a consensus report.The journal of investigative dermatology. Symposium proceedings, 6 2
(SchatzMPetittiDAntihistamines and pregnancyAnn Allergy Asthma Immunol1997515715910.1016/S1081-1206(10)63382-09048523)
SchatzMPetittiDAntihistamines and pregnancyAnn Allergy Asthma Immunol1997515715910.1016/S1081-1206(10)63382-09048523SchatzMPetittiDAntihistamines and pregnancyAnn Allergy Asthma Immunol1997515715910.1016/S1081-1206(10)63382-09048523, SchatzMPetittiDAntihistamines and pregnancyAnn Allergy Asthma Immunol1997515715910.1016/S1081-1206(10)63382-09048523
(GrantJABernsteinDIBuckleyCEChuTFoxRWDouble-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticariaJ Allergy Clin Immunol19985574579)
GrantJABernsteinDIBuckleyCEChuTFoxRWDouble-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticariaJ Allergy Clin Immunol19985574579GrantJABernsteinDIBuckleyCEChuTFoxRWDouble-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticariaJ Allergy Clin Immunol19985574579, GrantJABernsteinDIBuckleyCEChuTFoxRWDouble-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticariaJ Allergy Clin Immunol19985574579
(SaloOPKauppinenKMännistöPTCimetidine increases the plasma concentration of hydroxyzineActa Derm Venereol198653493502430410)
SaloOPKauppinenKMännistöPTCimetidine increases the plasma concentration of hydroxyzineActa Derm Venereol198653493502430410SaloOPKauppinenKMännistöPTCimetidine increases the plasma concentration of hydroxyzineActa Derm Venereol198653493502430410, SaloOPKauppinenKMännistöPTCimetidine increases the plasma concentration of hydroxyzineActa Derm Venereol198653493502430410
(LaKKimJKungDChoiYLeeWRoJIncreased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria seraJ Invest Dermatol2002565866310.1046/j.1523-1747.2002.01733.x11918713)
LaKKimJKungDChoiYLeeWRoJIncreased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria seraJ Invest Dermatol2002565866310.1046/j.1523-1747.2002.01733.x11918713LaKKimJKungDChoiYLeeWRoJIncreased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria seraJ Invest Dermatol2002565866310.1046/j.1523-1747.2002.01733.x11918713, LaKKimJKungDChoiYLeeWRoJIncreased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria seraJ Invest Dermatol2002565866310.1046/j.1523-1747.2002.01733.x11918713
(EnginBOzdemirMProspective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol2008548148610.1111/j.1468-3083.2007.02510.x18081753)
EnginBOzdemirMProspective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol2008548148610.1111/j.1468-3083.2007.02510.x18081753EnginBOzdemirMProspective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol2008548148610.1111/j.1468-3083.2007.02510.x18081753, EnginBOzdemirMProspective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol2008548148610.1111/j.1468-3083.2007.02510.x18081753
S. Jain (2004)
Topical tretinoin or adapalene in acne vulgaris: an overviewJournal of Dermatological Treatment, 15
(2008)
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
(KaplanAPHorakovaZKatzSIAssessment of tissue fluid histamine level in patients with urticariaJ Allergy Clin Immunol1978535035410.1016/0091-6749(78)90113-6659726)
KaplanAPHorakovaZKatzSIAssessment of tissue fluid histamine level in patients with urticariaJ Allergy Clin Immunol1978535035410.1016/0091-6749(78)90113-6659726KaplanAPHorakovaZKatzSIAssessment of tissue fluid histamine level in patients with urticariaJ Allergy Clin Immunol1978535035410.1016/0091-6749(78)90113-6659726, KaplanAPHorakovaZKatzSIAssessment of tissue fluid histamine level in patients with urticariaJ Allergy Clin Immunol1978535035410.1016/0091-6749(78)90113-6659726
(KangMJKimHSKimHOParkYMThe impact of chronic idiopathic urticaria on quality of life in Korean patientsAnn Dermatol2009522622910.5021/ad.2009.21.3.22620523794)
KangMJKimHSKimHOParkYMThe impact of chronic idiopathic urticaria on quality of life in Korean patientsAnn Dermatol2009522622910.5021/ad.2009.21.3.22620523794KangMJKimHSKimHOParkYMThe impact of chronic idiopathic urticaria on quality of life in Korean patientsAnn Dermatol2009522622910.5021/ad.2009.21.3.22620523794, KangMJKimHSKimHOParkYMThe impact of chronic idiopathic urticaria on quality of life in Korean patientsAnn Dermatol2009522622910.5021/ad.2009.21.3.22620523794
(AseroRTedeschiAUsefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysisJ Investig Allergol Clin Immunol2010538639020945604)
AseroRTedeschiAUsefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysisJ Investig Allergol Clin Immunol2010538639020945604AseroRTedeschiAUsefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysisJ Investig Allergol Clin Immunol2010538639020945604, AseroRTedeschiAUsefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysisJ Investig Allergol Clin Immunol2010538639020945604
J Venzor, WL Lee, DP Huston (2002)
Urticarial vasculitisClin Rev Allergy Immunol, 23
(AseroRAre IVIG for chronic unremitting urticaria effective?Allergy200051099110010.1034/j.1398-9995.2000.00829.x11097330)
AseroRAre IVIG for chronic unremitting urticaria effective?Allergy200051099110010.1034/j.1398-9995.2000.00829.x11097330AseroRAre IVIG for chronic unremitting urticaria effective?Allergy200051099110010.1034/j.1398-9995.2000.00829.x11097330, AseroRAre IVIG for chronic unremitting urticaria effective?Allergy200051099110010.1034/j.1398-9995.2000.00829.x11097330
(AseroRTedeschiACoppolaRGriffiniSPaparellaPActivation of the tissue factor pathway of blood coagulation in patients with chronic urticariaJ Allergy Clin Immunol2007570571010.1016/j.jaci.2006.08.04317204316)
AseroRTedeschiACoppolaRGriffiniSPaparellaPActivation of the tissue factor pathway of blood coagulation in patients with chronic urticariaJ Allergy Clin Immunol2007570571010.1016/j.jaci.2006.08.04317204316AseroRTedeschiACoppolaRGriffiniSPaparellaPActivation of the tissue factor pathway of blood coagulation in patients with chronic urticariaJ Allergy Clin Immunol2007570571010.1016/j.jaci.2006.08.04317204316, AseroRTedeschiACoppolaRGriffiniSPaparellaPActivation of the tissue factor pathway of blood coagulation in patients with chronic urticariaJ Allergy Clin Immunol2007570571010.1016/j.jaci.2006.08.04317204316
F. Simons, G. Sussman, K. Simons (1995)
Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria.The Journal of allergy and clinical immunology, 95 3
Umberto Fagiolo, F. Kricek, C. Ruf, Andrea Peserico, Alberto Amadori, Mauro Cancian (2000)
Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria.The Journal of allergy and clinical immunology, 106 3
(Du ToitGPrescottRLawrencePJoharABrownGAutoantibodies to the high affinity IgE receptor in children with chronic urticariaAnn Allergy Asthma Immunol2006534134410.1016/S1081-1206(10)61245-816498857)
Du ToitGPrescottRLawrencePJoharABrownGAutoantibodies to the high affinity IgE receptor in children with chronic urticariaAnn Allergy Asthma Immunol2006534134410.1016/S1081-1206(10)61245-816498857Du ToitGPrescottRLawrencePJoharABrownGAutoantibodies to the high affinity IgE receptor in children with chronic urticariaAnn Allergy Asthma Immunol2006534134410.1016/S1081-1206(10)61245-816498857, Du ToitGPrescottRLawrencePJoharABrownGAutoantibodies to the high affinity IgE receptor in children with chronic urticariaAnn Allergy Asthma Immunol2006534134410.1016/S1081-1206(10)61245-816498857
(WediBKappAChronic urticaria: assessment of current treatmentExpert Rev Clin Immunol2005545947310.1586/1744666X.1.3.45920476995)
WediBKappAChronic urticaria: assessment of current treatmentExpert Rev Clin Immunol2005545947310.1586/1744666X.1.3.45920476995WediBKappAChronic urticaria: assessment of current treatmentExpert Rev Clin Immunol2005545947310.1586/1744666X.1.3.45920476995, WediBKappAChronic urticaria: assessment of current treatmentExpert Rev Clin Immunol2005545947310.1586/1744666X.1.3.45920476995
(KappAPichlerWJLevocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter studyInt J Dermatol2006546947410.1111/j.1365-4632.2005.02609.x16650180)
KappAPichlerWJLevocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter studyInt J Dermatol2006546947410.1111/j.1365-4632.2005.02609.x16650180KappAPichlerWJLevocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter studyInt J Dermatol2006546947410.1111/j.1365-4632.2005.02609.x16650180, KappAPichlerWJLevocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter studyInt J Dermatol2006546947410.1111/j.1365-4632.2005.02609.x16650180
S. Ardizzone, G. Porro (2002)
Comparative Tolerability of Therapies for Ulcerative ColitisDrug Safety, 25
C Vasconcelos, P Xavier, AP Vieira, M Martinho, J Rodrigues (2000)
Autoimmune progesterone urticariaGynecol Endocrinol, 14
(KaplanAJosephKMaykutRZeldinRTreatment of chronic autoimmune urticaria with omalizumabJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615)
KaplanAJosephKMaykutRZeldinRTreatment of chronic autoimmune urticaria with omalizumabJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615KaplanAJosephKMaykutRZeldinRTreatment of chronic autoimmune urticaria with omalizumabJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615, KaplanAJosephKMaykutRZeldinRTreatment of chronic autoimmune urticaria with omalizumabJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615
(2012)
World Allergy Organization
(2005)
Controlling acute episodes, coping with chronic cases
(LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of 40 patientsPaediatric Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x)
LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of 40 patientsPaediatric Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.xLegrainVTaiebASageTMalevilleJUrticaria in infants: a study of 40 patientsPaediatric Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x, LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of 40 patientsPaediatric Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x
E. Nettis, M. Colanardi, M. Paradiso, A. Ferrannini (2004)
Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled studyClinical & Experimental Allergy, 34
(LopezLRDavisKCKohlerPFShocketALThe hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxy-chloroquineJ Allergy CIin Immunol1984560060310.1016/0091-6749(84)90518-9)
LopezLRDavisKCKohlerPFShocketALThe hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxy-chloroquineJ Allergy CIin Immunol1984560060310.1016/0091-6749(84)90518-9LopezLRDavisKCKohlerPFShocketALThe hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxy-chloroquineJ Allergy CIin Immunol1984560060310.1016/0091-6749(84)90518-9, LopezLRDavisKCKohlerPFShocketALThe hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxy-chloroquineJ Allergy CIin Immunol1984560060310.1016/0091-6749(84)90518-9
C. Pereira, B. Tavares, I. Carrapatoso, G. Loureiro, E. Faria, D. Machado, C. Chieira (2007)
Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria.European annals of allergy and clinical immunology, 39 7
I. Boehm, R. Bauer, T. Bieber (1999)
Urticaria treated with dapsoneAllergy, 54
(DreyfusDHObservations on the mechanism of omalizumab as a steroid-spating agent in autoimmune or chronic idiopathic urticaria and angioedemaAnn Allergy Asthma Immunol2008562462510.1016/S1081-1206(10)60069-518592835)
DreyfusDHObservations on the mechanism of omalizumab as a steroid-spating agent in autoimmune or chronic idiopathic urticaria and angioedemaAnn Allergy Asthma Immunol2008562462510.1016/S1081-1206(10)60069-518592835DreyfusDHObservations on the mechanism of omalizumab as a steroid-spating agent in autoimmune or chronic idiopathic urticaria and angioedemaAnn Allergy Asthma Immunol2008562462510.1016/S1081-1206(10)60069-518592835, DreyfusDHObservations on the mechanism of omalizumab as a steroid-spating agent in autoimmune or chronic idiopathic urticaria and angioedemaAnn Allergy Asthma Immunol2008562462510.1016/S1081-1206(10)60069-518592835
(PaulEBodekerRHTreatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patientsEur J Clin Pharmacol1986527728010.1007/BF009811232878811)
PaulEBodekerRHTreatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patientsEur J Clin Pharmacol1986527728010.1007/BF009811232878811PaulEBodekerRHTreatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patientsEur J Clin Pharmacol1986527728010.1007/BF009811232878811, PaulEBodekerRHTreatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patientsEur J Clin Pharmacol1986527728010.1007/BF009811232878811
R. Asero, A. Tedeschi, M. Cugno (2010)
Heparin and Tranexamic Acid Therapy May Be Effective in Treatment-Resistant Chronic Urticaria with Elevated D-Dimer: A Pilot StudyInternational Archives of Allergy and Immunology, 152
(GrattanCEThe urticarial spectrum: recognition of clinical patterns can help managementClin Exp Dermatol2004521722110.1111/j.1365-2230.2004.01494.x15115497)
GrattanCEThe urticarial spectrum: recognition of clinical patterns can help managementClin Exp Dermatol2004521722110.1111/j.1365-2230.2004.01494.x15115497GrattanCEThe urticarial spectrum: recognition of clinical patterns can help managementClin Exp Dermatol2004521722110.1111/j.1365-2230.2004.01494.x15115497, GrattanCEThe urticarial spectrum: recognition of clinical patterns can help managementClin Exp Dermatol2004521722110.1111/j.1365-2230.2004.01494.x15115497
(Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesJAMA1995541341810.1001/jama.1995.035202900650317823388)
Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesJAMA1995541341810.1001/jama.1995.035202900650317823388Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesJAMA1995541341810.1001/jama.1995.035202900650317823388, Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesJAMA1995541341810.1001/jama.1995.035202900650317823388
(VonakisBMSainiSSNew concepts in chronic urticariaCurr Opin Immunol2008570971610.1016/j.coi.2008.09.00518832031)
VonakisBMSainiSSNew concepts in chronic urticariaCurr Opin Immunol2008570971610.1016/j.coi.2008.09.00518832031VonakisBMSainiSSNew concepts in chronic urticariaCurr Opin Immunol2008570971610.1016/j.coi.2008.09.00518832031, VonakisBMSainiSSNew concepts in chronic urticariaCurr Opin Immunol2008570971610.1016/j.coi.2008.09.00518832031
(SahinerUMCivelekETuncerAYavuzSTCarabulutESackasenCSekerelBEChronic urticaria aetiology and natural course in childrenInt Arch Allergy Immunol2011522423021597304)
SahinerUMCivelekETuncerAYavuzSTCarabulutESackasenCSekerelBEChronic urticaria aetiology and natural course in childrenInt Arch Allergy Immunol2011522423021597304SahinerUMCivelekETuncerAYavuzSTCarabulutESackasenCSekerelBEChronic urticaria aetiology and natural course in childrenInt Arch Allergy Immunol2011522423021597304, SahinerUMCivelekETuncerAYavuzSTCarabulutESackasenCSekerelBEChronic urticaria aetiology and natural course in childrenInt Arch Allergy Immunol2011522423021597304
R. Sabroe, E. Fiebiger, D. Francis, D. Maurer, P. Seed, C. Grattan, A. Black, G. Stingl, M. Greaves, R. Barr (2002)
Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.The Journal of allergy and clinical immunology, 110 3
A Tedeschi, L Airaghi, M Lorini, R Asero (2003)
Chronic urticaria. A role for newer immunomodulatory drugs?Am J Clin Dermatol, 4
D Hamel-Teillac (2003)
Chronic urticaria in childrenAnn Dermatology Venereol, 1
(ChurchMKComparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humansInflamm Res2011 in press [epub ahead of print])
ChurchMKComparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humansInflamm Res2011 in press [epub ahead of print]ChurchMKComparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humansInflamm Res2011 in press [epub ahead of print], ChurchMKComparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humansInflamm Res2011 in press [epub ahead of print]
(FerrerMGamboaPSanzMLGoicoetxeaMJCabrera-FreitaqPOmalizumab is effective in non-autoimmune urticariaJ Allergy Clin Immunol201151300130210.1016/j.jaci.2010.12.108521315432)
FerrerMGamboaPSanzMLGoicoetxeaMJCabrera-FreitaqPOmalizumab is effective in non-autoimmune urticariaJ Allergy Clin Immunol201151300130210.1016/j.jaci.2010.12.108521315432FerrerMGamboaPSanzMLGoicoetxeaMJCabrera-FreitaqPOmalizumab is effective in non-autoimmune urticariaJ Allergy Clin Immunol201151300130210.1016/j.jaci.2010.12.108521315432, FerrerMGamboaPSanzMLGoicoetxeaMJCabrera-FreitaqPOmalizumab is effective in non-autoimmune urticariaJ Allergy Clin Immunol201151300130210.1016/j.jaci.2010.12.108521315432
(O'DonnellBFBarrRMKobza BlackAFrancisDMKermaniFIntravenous immunoglobulin in autoimmune chronic urticariaBr J Dermatol1998510110610.1046/j.1365-2133.1998.02033.x9536230)
O'DonnellBFBarrRMKobza BlackAFrancisDMKermaniFIntravenous immunoglobulin in autoimmune chronic urticariaBr J Dermatol1998510110610.1046/j.1365-2133.1998.02033.x9536230O'DonnellBFBarrRMKobza BlackAFrancisDMKermaniFIntravenous immunoglobulin in autoimmune chronic urticariaBr J Dermatol1998510110610.1046/j.1365-2133.1998.02033.x9536230, O'DonnellBFBarrRMKobza BlackAFrancisDMKermaniFIntravenous immunoglobulin in autoimmune chronic urticariaBr J Dermatol1998510110610.1046/j.1365-2133.1998.02033.x9536230
J. Grob, P. Auquier, I. Dreyfus, J. Ortonne (2007)
Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double‐blind, multicentre, placebo‐controlled studyJournal of the European Academy of Dermatology and Venereology, 22
(Di GioacchinoMDi StefanoFCavallucciEVernaNRamondoSTreatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluationAllergy Asthma Proc2003528529012974197)
Di GioacchinoMDi StefanoFCavallucciEVernaNRamondoSTreatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluationAllergy Asthma Proc2003528529012974197Di GioacchinoMDi StefanoFCavallucciEVernaNRamondoSTreatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluationAllergy Asthma Proc2003528529012974197, Di GioacchinoMDi StefanoFCavallucciEVernaNRamondoSTreatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluationAllergy Asthma Proc2003528529012974197
(BossiFFrossiBRadilloOCugnoMTedeschiANast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationAllergy201151538154510.1111/j.1398-9995.2011.02704.x21906078)
BossiFFrossiBRadilloOCugnoMTedeschiANast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationAllergy201151538154510.1111/j.1398-9995.2011.02704.x21906078BossiFFrossiBRadilloOCugnoMTedeschiANast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationAllergy201151538154510.1111/j.1398-9995.2011.02704.x21906078, BossiFFrossiBRadilloOCugnoMTedeschiANast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationAllergy201151538154510.1111/j.1398-9995.2011.02704.x21906078
(RaxinEMarxGThrombin-induced degranulation of cultured bone marrow-derived mast cellsJ Immunol19845328232856208276)
RaxinEMarxGThrombin-induced degranulation of cultured bone marrow-derived mast cellsJ Immunol19845328232856208276RaxinEMarxGThrombin-induced degranulation of cultured bone marrow-derived mast cellsJ Immunol19845328232856208276, RaxinEMarxGThrombin-induced degranulation of cultured bone marrow-derived mast cellsJ Immunol19845328232856208276
(PoulosLMWatersAMPop HtlhGDCorrellPKLoblayRHMarksGBTrends in hospitalizations for anaphylaxis, angioedema and urticaria in Australia, 1993-1994 to 2004-2005J Allergy Clin Immunol2007587888410.1016/j.jaci.2007.07.04017931562)
PoulosLMWatersAMPop HtlhGDCorrellPKLoblayRHMarksGBTrends in hospitalizations for anaphylaxis, angioedema and urticaria in Australia, 1993-1994 to 2004-2005J Allergy Clin Immunol2007587888410.1016/j.jaci.2007.07.04017931562PoulosLMWatersAMPop HtlhGDCorrellPKLoblayRHMarksGBTrends in hospitalizations for anaphylaxis, angioedema and urticaria in Australia, 1993-1994 to 2004-2005J Allergy Clin Immunol2007587888410.1016/j.jaci.2007.07.04017931562, PoulosLMWatersAMPop HtlhGDCorrellPKLoblayRHMarksGBTrends in hospitalizations for anaphylaxis, angioedema and urticaria in Australia, 1993-1994 to 2004-2005J Allergy Clin Immunol2007587888410.1016/j.jaci.2007.07.04017931562
I. Hindmarch, S. Johnson, R. Meadows, T. Kirkpatrick, Z. Shamsi (2001)
The Acute and Sub-chronic Effects of Levocetirizine, Cetirizine, Loratadine, Promethazine and Placebo on Cognitive Function, Psychomotor Performance, and Weal and FlareCurrent Medical Research and Opinion, 17
E. Başkan, Ş. Tunali, T. Turker, H. Saricaoğlu (2004)
Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.The Journal of dermatological treatment, 15 3
(GreavesMChronic urticariaN Engl J Med199551767177210.1056/NEJM1995062933226087760895)
GreavesMChronic urticariaN Engl J Med199551767177210.1056/NEJM1995062933226087760895GreavesMChronic urticariaN Engl J Med199551767177210.1056/NEJM1995062933226087760895, GreavesMChronic urticariaN Engl J Med199551767177210.1056/NEJM1995062933226087760895
(MonroeEWCohenSHKalbfleischJSchulzCICombined H1 and H2 antihistamine therapy in chronic urticariaArch Dermatol1981540440710.1001/archderm.1981.016500700320186114712)
MonroeEWCohenSHKalbfleischJSchulzCICombined H1 and H2 antihistamine therapy in chronic urticariaArch Dermatol1981540440710.1001/archderm.1981.016500700320186114712MonroeEWCohenSHKalbfleischJSchulzCICombined H1 and H2 antihistamine therapy in chronic urticariaArch Dermatol1981540440710.1001/archderm.1981.016500700320186114712, MonroeEWCohenSHKalbfleischJSchulzCICombined H1 and H2 antihistamine therapy in chronic urticariaArch Dermatol1981540440710.1001/archderm.1981.016500700320186114712
C. Grattan, T. Wallington, R. Warin, C. Kennedy, J. Lbradfield (1986)
A serological mediator in chronic idiopathic urticaria—a clinical, immunological and histological evaluationBritish Journal of Dermatology, 114
E. Shahar, R. Bergman, E. Guttman‐Yassky, S. Pollack (2006)
Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroidsInternational Journal of Dermatology, 45
(TarboxJAGuttaRCRadojicicCLangDMUtility of routine laboratory testing in management of chronic urticaria/angioedemaAnn Allergy Asthma Immunol2011523924310.1016/j.anai.2011.06.00821875543)
TarboxJAGuttaRCRadojicicCLangDMUtility of routine laboratory testing in management of chronic urticaria/angioedemaAnn Allergy Asthma Immunol2011523924310.1016/j.anai.2011.06.00821875543TarboxJAGuttaRCRadojicicCLangDMUtility of routine laboratory testing in management of chronic urticaria/angioedemaAnn Allergy Asthma Immunol2011523924310.1016/j.anai.2011.06.00821875543, TarboxJAGuttaRCRadojicicCLangDMUtility of routine laboratory testing in management of chronic urticaria/angioedemaAnn Allergy Asthma Immunol2011523924310.1016/j.anai.2011.06.00821875543
A. Finlay, G. Khan (1994)
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical useClinical and Experimental Dermatology, 19
(KocatürkEWellerKMartusPAktasAKavalaMThe Turkish version of the chronic urticaria quality-of-life questionnaire: cultural adaptation, assessment of reliability and validityActa Derm Venereol2012541942510.2340/00015555-119921918791)
KocatürkEWellerKMartusPAktasAKavalaMThe Turkish version of the chronic urticaria quality-of-life questionnaire: cultural adaptation, assessment of reliability and validityActa Derm Venereol2012541942510.2340/00015555-119921918791KocatürkEWellerKMartusPAktasAKavalaMThe Turkish version of the chronic urticaria quality-of-life questionnaire: cultural adaptation, assessment of reliability and validityActa Derm Venereol2012541942510.2340/00015555-119921918791, KocatürkEWellerKMartusPAktasAKavalaMThe Turkish version of the chronic urticaria quality-of-life questionnaire: cultural adaptation, assessment of reliability and validityActa Derm Venereol2012541942510.2340/00015555-119921918791
(MonroeEWRelative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticariaClin Ther1992517211349509)
MonroeEWRelative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticariaClin Ther1992517211349509MonroeEWRelative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticariaClin Ther1992517211349509, MonroeEWRelative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticariaClin Ther1992517211349509
(EckmanJASterbaPMKellyDAlexanderVLiuMCEffects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challengeJ Allergy Clin Immunol2010588989510.1016/j.jaci.2009.09.01219962744)
EckmanJASterbaPMKellyDAlexanderVLiuMCEffects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challengeJ Allergy Clin Immunol2010588989510.1016/j.jaci.2009.09.01219962744EckmanJASterbaPMKellyDAlexanderVLiuMCEffects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challengeJ Allergy Clin Immunol2010588989510.1016/j.jaci.2009.09.01219962744, EckmanJASterbaPMKellyDAlexanderVLiuMCEffects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challengeJ Allergy Clin Immunol2010588989510.1016/j.jaci.2009.09.01219962744
(ReevesGEBoyleMJBonfieldJDobsonPLoewenthalMImpact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluationIntern Med J2004518218610.1111/j.1444-0903.2004.00532.x15086698)
ReevesGEBoyleMJBonfieldJDobsonPLoewenthalMImpact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluationIntern Med J2004518218610.1111/j.1444-0903.2004.00532.x15086698ReevesGEBoyleMJBonfieldJDobsonPLoewenthalMImpact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluationIntern Med J2004518218610.1111/j.1444-0903.2004.00532.x15086698, ReevesGEBoyleMJBonfieldJDobsonPLoewenthalMImpact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluationIntern Med J2004518218610.1111/j.1444-0903.2004.00532.x15086698
(ZimmermanABBergerEMElmariahSBSoterNAThe use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patientsJ Am Acad Dermatol2011 in press [epub ahead of print])
ZimmermanABBergerEMElmariahSBSoterNAThe use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patientsJ Am Acad Dermatol2011 in press [epub ahead of print]ZimmermanABBergerEMElmariahSBSoterNAThe use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patientsJ Am Acad Dermatol2011 in press [epub ahead of print], ZimmermanABBergerEMElmariahSBSoterNAThe use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patientsJ Am Acad Dermatol2011 in press [epub ahead of print]
(AseroRTedeschiARiboldiPGriffiniSBonanniECugnoMSevere chronic urticaria is associated with elevated plasma levels of D-dimerAllergy2007517618017961199)
AseroRTedeschiARiboldiPGriffiniSBonanniECugnoMSevere chronic urticaria is associated with elevated plasma levels of D-dimerAllergy2007517618017961199AseroRTedeschiARiboldiPGriffiniSBonanniECugnoMSevere chronic urticaria is associated with elevated plasma levels of D-dimerAllergy2007517618017961199, AseroRTedeschiARiboldiPGriffiniSBonanniECugnoMSevere chronic urticaria is associated with elevated plasma levels of D-dimerAllergy2007517618017961199
E. Razin, G. Marx (1984)
Thrombin-induced degranulation of cultured bone marrow-derived mast cells.Journal of immunology, 133 6
(LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of forty patientsPediatr Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x2359724)
LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of forty patientsPediatr Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x2359724LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of forty patientsPediatr Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x2359724, LegrainVTaiebASageTMalevilleJUrticaria in infants: a study of forty patientsPediatr Dermatol1990510110710.1111/j.1525-1470.1990.tb00663.x2359724
AR Eiser, P Singh, HM Shanies (1997)
Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case reportAngiology, 48
(LaroccaCMcEvoyJEllisCJunkins-HopkinsJKolbTSchnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulationClin Rheumatol2012516917410.1007/s10067-011-1804-421710158)
LaroccaCMcEvoyJEllisCJunkins-HopkinsJKolbTSchnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulationClin Rheumatol2012516917410.1007/s10067-011-1804-421710158LaroccaCMcEvoyJEllisCJunkins-HopkinsJKolbTSchnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulationClin Rheumatol2012516917410.1007/s10067-011-1804-421710158, LaroccaCMcEvoyJEllisCJunkins-HopkinsJKolbTSchnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulationClin Rheumatol2012516917410.1007/s10067-011-1804-421710158
(ZuberbierTBalkeMWormMEdenharterGMaurerMEpidemiology of urticaria: a representative cross-sectional population surveyClin Exp Dermatol2010586987310.1111/j.1365-2230.2010.03840.x20456386)
ZuberbierTBalkeMWormMEdenharterGMaurerMEpidemiology of urticaria: a representative cross-sectional population surveyClin Exp Dermatol2010586987310.1111/j.1365-2230.2010.03840.x20456386ZuberbierTBalkeMWormMEdenharterGMaurerMEpidemiology of urticaria: a representative cross-sectional population surveyClin Exp Dermatol2010586987310.1111/j.1365-2230.2010.03840.x20456386, ZuberbierTBalkeMWormMEdenharterGMaurerMEpidemiology of urticaria: a representative cross-sectional population surveyClin Exp Dermatol2010586987310.1111/j.1365-2230.2010.03840.x20456386
(ValeroAHerdmanMBartraJFerrerMJáureguiIAdaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL)J Investig Allergol Clin Immunol2008542643219123433)
ValeroAHerdmanMBartraJFerrerMJáureguiIAdaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL)J Investig Allergol Clin Immunol2008542643219123433ValeroAHerdmanMBartraJFerrerMJáureguiIAdaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL)J Investig Allergol Clin Immunol2008542643219123433, ValeroAHerdmanMBartraJFerrerMJáureguiIAdaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL)J Investig Allergol Clin Immunol2008542643219123433
(BaskanEBTunaliSTurkerTSaricaogluHComparison of short-and long-term cyclosporine A therapy in chronic idiopathic urticariaJ Dermatolog Treat2004516416815204149)
BaskanEBTunaliSTurkerTSaricaogluHComparison of short-and long-term cyclosporine A therapy in chronic idiopathic urticariaJ Dermatolog Treat2004516416815204149BaskanEBTunaliSTurkerTSaricaogluHComparison of short-and long-term cyclosporine A therapy in chronic idiopathic urticariaJ Dermatolog Treat2004516416815204149, BaskanEBTunaliSTurkerTSaricaogluHComparison of short-and long-term cyclosporine A therapy in chronic idiopathic urticariaJ Dermatolog Treat2004516416815204149
Ruth Sabroe (2014)
Acute urticaria.Immunology and allergy clinics of North America, 34 1
(Gimenez-ArnauAIzquierdoIMaurerMThe use of a responder analysis to identify clinically meaningful differences in chronic urticarial patients following placebo-controlled treatment with rupatadine 10 and 20 mgJ Eur Acad Dermatol Venereol200951088109110.1111/j.1468-3083.2009.03289.x19453774)
Gimenez-ArnauAIzquierdoIMaurerMThe use of a responder analysis to identify clinically meaningful differences in chronic urticarial patients following placebo-controlled treatment with rupatadine 10 and 20 mgJ Eur Acad Dermatol Venereol200951088109110.1111/j.1468-3083.2009.03289.x19453774Gimenez-ArnauAIzquierdoIMaurerMThe use of a responder analysis to identify clinically meaningful differences in chronic urticarial patients following placebo-controlled treatment with rupatadine 10 and 20 mgJ Eur Acad Dermatol Venereol200951088109110.1111/j.1468-3083.2009.03289.x19453774, Gimenez-ArnauAIzquierdoIMaurerMThe use of a responder analysis to identify clinically meaningful differences in chronic urticarial patients following placebo-controlled treatment with rupatadine 10 and 20 mgJ Eur Acad Dermatol Venereol200951088109110.1111/j.1468-3083.2009.03289.x19453774
Greaves (1995)
Chronic urticariaN Engl J Med, 332
(European Medicines Agency. Committee for medicinal products for human use (CHMP)Reflection paper on the regulatory guidance for the use of health-related quality of life (HROL) measures in the evaluation of medicinal productsEuropean Medicines Agency Web site2005Available at: http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf. Accessed August 30, 2011)
European Medicines Agency. Committee for medicinal products for human use (CHMP)Reflection paper on the regulatory guidance for the use of health-related quality of life (HROL) measures in the evaluation of medicinal productsEuropean Medicines Agency Web site2005Available at: http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf. Accessed August 30, 2011European Medicines Agency. Committee for medicinal products for human use (CHMP)Reflection paper on the regulatory guidance for the use of health-related quality of life (HROL) measures in the evaluation of medicinal productsEuropean Medicines Agency Web site2005Available at: http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf. Accessed August 30, 2011, European Medicines Agency. Committee for medicinal products for human use (CHMP)Reflection paper on the regulatory guidance for the use of health-related quality of life (HROL) measures in the evaluation of medicinal productsEuropean Medicines Agency Web site2005Available at: http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf. Accessed August 30, 2011
P. Schweitzer, M. Muehlbach, James Welsh (1994)
Sleepiness and performance during three-day administration of cetirizine or diphenhydramine.The Journal of allergy and clinical immunology, 94 4
(HideMFrancisDGrattanCHakimiJKochanJGreavesMAutoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticariaN Eng J Med199351599160410.1056/NEJM199306033282204)
HideMFrancisDGrattanCHakimiJKochanJGreavesMAutoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticariaN Eng J Med199351599160410.1056/NEJM199306033282204HideMFrancisDGrattanCHakimiJKochanJGreavesMAutoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticariaN Eng J Med199351599160410.1056/NEJM199306033282204, HideMFrancisDGrattanCHakimiJKochanJGreavesMAutoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticariaN Eng J Med199351599160410.1056/NEJM199306033282204
A. Młynek, Markus Magerl, M. Hanna, Stefan Lhachimi, I. Baiardini, G. Canonica, Z. Brzoza, Alicja Kasperska‐Zajac, Barbara Rogala, A. Zalewska-Janowska, Torsten Zuberbier, Marcus Maurer (2009)
The German version of the chronic urticaria quality‐of‐life questionnaire: factor analysis, validation, and initial clinical findingsAllergy, 64
(AseroRTedeschiALoriniMLeukotriene receptor antagonists in chronic urticariaAllergy2001545645710.1034/j.1398-9995.2001.056005456.x11350316)
AseroRTedeschiALoriniMLeukotriene receptor antagonists in chronic urticariaAllergy2001545645710.1034/j.1398-9995.2001.056005456.x11350316AseroRTedeschiALoriniMLeukotriene receptor antagonists in chronic urticariaAllergy2001545645710.1034/j.1398-9995.2001.056005456.x11350316, AseroRTedeschiALoriniMLeukotriene receptor antagonists in chronic urticariaAllergy2001545645710.1034/j.1398-9995.2001.056005456.x11350316
(GrattanCEDawnGGibbsSFrancisDMBlood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activityClin Exp Allergy2003533734110.1046/j.1365-2222.2003.01589.x12614448)
GrattanCEDawnGGibbsSFrancisDMBlood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activityClin Exp Allergy2003533734110.1046/j.1365-2222.2003.01589.x12614448GrattanCEDawnGGibbsSFrancisDMBlood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activityClin Exp Allergy2003533734110.1046/j.1365-2222.2003.01589.x12614448, GrattanCEDawnGGibbsSFrancisDMBlood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activityClin Exp Allergy2003533734110.1046/j.1365-2222.2003.01589.x12614448
(BernsteinJAGarramoneSMLowerEGSuccessful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamideAnn Allergy Asthma Immunol2002521221410.1016/S1081-1206(10)61941-212197581)
BernsteinJAGarramoneSMLowerEGSuccessful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamideAnn Allergy Asthma Immunol2002521221410.1016/S1081-1206(10)61941-212197581BernsteinJAGarramoneSMLowerEGSuccessful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamideAnn Allergy Asthma Immunol2002521221410.1016/S1081-1206(10)61941-212197581, BernsteinJAGarramoneSMLowerEGSuccessful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamideAnn Allergy Asthma Immunol2002521221410.1016/S1081-1206(10)61941-212197581
R. Asero (2005)
Oral cyclophosphamide in a case of cyclosporin and steroid‐resistant chronic urticaria showing autoreactivity on autologous serum skin testingClinical and Experimental Dermatology, 30
C Léauté-Labréze, P Mortureux, A Taieb (2000)
Urticaria and Serum Sickness
I. Baiardini, M. Pasquali, F. Braido, F. Fumagalli, L. Guerra, E. Compalati, M. Braga, C. Lombardi, O. Fassio, G. Canonica (2005)
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU‐Q2oL)Allergy, 60
(HarveyPRWegsJShocketALA controlled trial of therapy in chronic urticariaJ Allergy Clin Immunol1981526226610.1016/0091-6749(81)90149-46116728)
HarveyPRWegsJShocketALA controlled trial of therapy in chronic urticariaJ Allergy Clin Immunol1981526226610.1016/0091-6749(81)90149-46116728HarveyPRWegsJShocketALA controlled trial of therapy in chronic urticariaJ Allergy Clin Immunol1981526226610.1016/0091-6749(81)90149-46116728, HarveyPRWegsJShocketALA controlled trial of therapy in chronic urticariaJ Allergy Clin Immunol1981526226610.1016/0091-6749(81)90149-46116728
T. Zuberbier, A. Oanță, E. Bogacka, I. Medina, F. Wesel, P. Uhl, I. Antépara, I. Jáuregui, R. Valiente (2010)
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled studyAllergy, 65
(KappAWediBChronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizineJ Drugs Dermatol2004563263915624746)
KappAWediBChronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizineJ Drugs Dermatol2004563263915624746KappAWediBChronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizineJ Drugs Dermatol2004563263915624746, KappAWediBChronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizineJ Drugs Dermatol2004563263915624746
A. Kaplan (2009)
What the first 10,000 patients with chronic urticaria have taught me: a personal journey.The Journal of allergy and clinical immunology, 123 3
(KroumpouzosGCohenLMSpecific dermatoses of pregnancy: an evidence-based systematic reviewAm J Obstet Gynecol200351083109210.1067/mob.2003.12912712115)
KroumpouzosGCohenLMSpecific dermatoses of pregnancy: an evidence-based systematic reviewAm J Obstet Gynecol200351083109210.1067/mob.2003.12912712115KroumpouzosGCohenLMSpecific dermatoses of pregnancy: an evidence-based systematic reviewAm J Obstet Gynecol200351083109210.1067/mob.2003.12912712115, KroumpouzosGCohenLMSpecific dermatoses of pregnancy: an evidence-based systematic reviewAm J Obstet Gynecol200351083109210.1067/mob.2003.12912712115
J. Grob, P. Auquier, I. Dreyfus, J. Ortonne (2009)
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of lifeAllergy, 64
B. Engin, M. Özdemir (2008)
Prospective randomized non‐blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticariaJournal of the European Academy of Dermatology and Venereology, 22
H. Kjaer, E. Eller, A. Høst, K. Andersen, C. Bindslev‐Jensen (2008)
The prevalence of allergic diseases in an unselected group of 6‐year‐old children. The DARC birth cohort studyPediatric Allergy and Immunology, 19
B. Gruber, B. Gruber, M. Baeza, M. Baeza, M. Marchese, M. Marchese, V. Agnello, V. Agnello, A. Kaplan, A. Kaplan (1988)
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes.The Journal of investigative dermatology, 90 2
(CarmichaelSLShawGMMaternal corticosteroid use and risk of selected congenital anomaliesAm J Med Genet1999524224410.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U10482873)
CarmichaelSLShawGMMaternal corticosteroid use and risk of selected congenital anomaliesAm J Med Genet1999524224410.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U10482873CarmichaelSLShawGMMaternal corticosteroid use and risk of selected congenital anomaliesAm J Med Genet1999524224410.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U10482873, CarmichaelSLShawGMMaternal corticosteroid use and risk of selected congenital anomaliesAm J Med Genet1999524224410.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U10482873
(BaiardiniIBraidoFBindslev-JensenCBousquetPJBrzozaZRecommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paperAllergy2011584084410.1111/j.1398-9995.2011.02580.x21385184)
BaiardiniIBraidoFBindslev-JensenCBousquetPJBrzozaZRecommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paperAllergy2011584084410.1111/j.1398-9995.2011.02580.x21385184BaiardiniIBraidoFBindslev-JensenCBousquetPJBrzozaZRecommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paperAllergy2011584084410.1111/j.1398-9995.2011.02580.x21385184, BaiardiniIBraidoFBindslev-JensenCBousquetPJBrzozaZRecommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paperAllergy2011584084410.1111/j.1398-9995.2011.02580.x21385184
N. Weegerink, M. Schraders, J. Leijendeckers, K. Slieker, P. Huygen, L. Hoefsloot, J. Oostrik, R. Pennings, A. Simon, A. Snik, H. Kremer, H. Kunst (2011)
Audiometric characteristics of a Dutch family with Muckle-Wells syndromeHearing Research, 282
L. Brodell, L. Beck, S. Saini (2008)
Pathophysiology of chronic urticaria.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 100 4
(VersterJCde WeertAMBijtjesSIAarabMvan OosterwijckAWDriving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trialPsychopharmacology (Berl)20035849010.1007/s00213-003-1462-612721777)
VersterJCde WeertAMBijtjesSIAarabMvan OosterwijckAWDriving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trialPsychopharmacology (Berl)20035849010.1007/s00213-003-1462-612721777VersterJCde WeertAMBijtjesSIAarabMvan OosterwijckAWDriving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trialPsychopharmacology (Berl)20035849010.1007/s00213-003-1462-612721777, VersterJCde WeertAMBijtjesSIAarabMvan OosterwijckAWDriving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trialPsychopharmacology (Berl)20035849010.1007/s00213-003-1462-612721777
A. Thompson, A. Finn, W. Schoenwetter (2000)
Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.Journal of the American Academy of Dermatology, 43 1 Pt 1
J. Engstrom, J. Neher, L. Anna (2011)
What is the prognosis for patients with chronic urticaria
P. Gaig, M. Olona, D. MuñozLejarazu, Caballero Mt, D. Fj, S. Echechipía, García Jl, Gonzalo Ma, R. Lleonart, C. MartínezCócera, Alejandro Rodríguez, M. Ferrer (2004)
Epidemiology of urticaria in Spain.Journal of investigational allergology & clinical immunology, 14 3
D. Khan (2008)
Chronic urticaria: diagnosis and management.Allergy and asthma proceedings, 29 5
(LeznoffASussmanGSyndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patientsJ Allergy Clin Immunol19895667110.1016/0091-6749(89)90180-22754146)
LeznoffASussmanGSyndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patientsJ Allergy Clin Immunol19895667110.1016/0091-6749(89)90180-22754146LeznoffASussmanGSyndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patientsJ Allergy Clin Immunol19895667110.1016/0091-6749(89)90180-22754146, LeznoffASussmanGSyndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patientsJ Allergy Clin Immunol19895667110.1016/0091-6749(89)90180-22754146
E Paul, RH Bodeker (1986)
Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patientsEur J Clin Pharmacol, 31
E. Rodríguez‐Pinilla, M. Martínez‐Frías (1998)
Corticosteroids during pregnancy and oral clefts: a case-control study.Teratology, 58 1
(PereiraCTavaresBCarrapatosoILoureiroGFariaEMachadoDChieiraCLow-dose intravenous gammaglobulin in the treatment of severe autoimmune urticariaEur Ann Allergy Clin Immunol2007523724218237000)
PereiraCTavaresBCarrapatosoILoureiroGFariaEMachadoDChieiraCLow-dose intravenous gammaglobulin in the treatment of severe autoimmune urticariaEur Ann Allergy Clin Immunol2007523724218237000PereiraCTavaresBCarrapatosoILoureiroGFariaEMachadoDChieiraCLow-dose intravenous gammaglobulin in the treatment of severe autoimmune urticariaEur Ann Allergy Clin Immunol2007523724218237000, PereiraCTavaresBCarrapatosoILoureiroGFariaEMachadoDChieiraCLow-dose intravenous gammaglobulin in the treatment of severe autoimmune urticariaEur Ann Allergy Clin Immunol2007523724218237000
Salo Op, K. Kauppinen, Männistö Pt (1986)
Cimetidine increases the plasma concentration of hydroxyzine.Acta dermato-venereologica, 66 4
(YamaguchiMHiraiKNakajimaKOhtoshiTTakaishiTDexamethasone inhibits basophil migrationAllergy1994537137510.1111/j.1398-9995.1994.tb02284.x8092436)
YamaguchiMHiraiKNakajimaKOhtoshiTTakaishiTDexamethasone inhibits basophil migrationAllergy1994537137510.1111/j.1398-9995.1994.tb02284.x8092436YamaguchiMHiraiKNakajimaKOhtoshiTTakaishiTDexamethasone inhibits basophil migrationAllergy1994537137510.1111/j.1398-9995.1994.tb02284.x8092436, YamaguchiMHiraiKNakajimaKOhtoshiTTakaishiTDexamethasone inhibits basophil migrationAllergy1994537137510.1111/j.1398-9995.1994.tb02284.x8092436
(GodseKVAutologous serum skin test in childrenIndian J Dermatol20085616310.4103/0019-5154.3957619881988)
GodseKVAutologous serum skin test in childrenIndian J Dermatol20085616310.4103/0019-5154.3957619881988GodseKVAutologous serum skin test in childrenIndian J Dermatol20085616310.4103/0019-5154.3957619881988, GodseKVAutologous serum skin test in childrenIndian J Dermatol20085616310.4103/0019-5154.3957619881988
(Diav-CitrinOShechtmanSAharonovichAMoermanLArnonJWajnbergROrnovAPregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort studyJ Allergy Clin Immunol200351239124310.1067/mai.2003.149912789223)
Diav-CitrinOShechtmanSAharonovichAMoermanLArnonJWajnbergROrnovAPregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort studyJ Allergy Clin Immunol200351239124310.1067/mai.2003.149912789223Diav-CitrinOShechtmanSAharonovichAMoermanLArnonJWajnbergROrnovAPregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort studyJ Allergy Clin Immunol200351239124310.1067/mai.2003.149912789223, Diav-CitrinOShechtmanSAharonovichAMoermanLArnonJWajnbergROrnovAPregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort studyJ Allergy Clin Immunol200351239124310.1067/mai.2003.149912789223
L. Brunetti, R. Francavilla, V. Miniello, M. Platzer, D. Rizzi, M. Lospalluti, L. Poulsen, L. Armenio, P. Skov (2004)
High prevalence of autoimmune urticaria in children with chronic urticaria.The Journal of allergy and clinical immunology, 114 4
U. Sahiner, E. Civelek, A. Tuncer, S. Yavuz, E. Karabulut, C. Saçkesen, B. Sekerel (2011)
Chronic Urticaria: Etiology and Natural Course in ChildrenInternational Archives of Allergy and Immunology, 156
(OrionEMatzHWolfRThe life-threatening complications of dermatologic therapiesClin Dermatol2005518219210.1016/j.clindermatol.2004.06.01315802212)
OrionEMatzHWolfRThe life-threatening complications of dermatologic therapiesClin Dermatol2005518219210.1016/j.clindermatol.2004.06.01315802212OrionEMatzHWolfRThe life-threatening complications of dermatologic therapiesClin Dermatol2005518219210.1016/j.clindermatol.2004.06.01315802212, OrionEMatzHWolfRThe life-threatening complications of dermatologic therapiesClin Dermatol2005518219210.1016/j.clindermatol.2004.06.01315802212
G. Kroumpouzos, L. Cohen (2003)
Specific dermatoses of pregnancy: an evidence-based systematic review.American journal of obstetrics and gynecology, 188 4
J. Fortson, J. Zone, M. Hammond, G. Groggel (1986)
Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.Journal of the American Academy of Dermatology, 15 5 Pt 2
(WilesJCHansenRCLynchPJUrticarial vasculitis treated with colchicineArch Dermatol198558028080285)
WilesJCHansenRCLynchPJUrticarial vasculitis treated with colchicineArch Dermatol198558028080285WilesJCHansenRCLynchPJUrticarial vasculitis treated with colchicineArch Dermatol198558028080285, WilesJCHansenRCLynchPJUrticarial vasculitis treated with colchicineArch Dermatol198558028080285
(SimonsFEPrevention of acute urticaria in young children with atopic dermatitisJ Allergy Clin Immunol2001570370610.1067/mai.2001.11386611295661)
SimonsFEPrevention of acute urticaria in young children with atopic dermatitisJ Allergy Clin Immunol2001570370610.1067/mai.2001.11386611295661SimonsFEPrevention of acute urticaria in young children with atopic dermatitisJ Allergy Clin Immunol2001570370610.1067/mai.2001.11386611295661, SimonsFEPrevention of acute urticaria in young children with atopic dermatitisJ Allergy Clin Immunol2001570370610.1067/mai.2001.11386611295661
T. Zuberbier, J. Iffländer, C. Semmler, B. Henz (1996)
Acute urticaria: clinical aspects and therapeutic responsiveness.Acta dermato-venereologica, 76 4
R. Harvey, J. Wegs, A. Schocket (1981)
A controlled trial of therapy in chronic urticaria.The Journal of allergy and clinical immunology, 68 4
(TakedaTSakuraiYTakahagiSKatoJYoshidaKIncrease of coagulation potential in chronic spontaneous urticariaAllergy2011542843310.1111/j.1398-9995.2010.02506.x21083568)
TakedaTSakuraiYTakahagiSKatoJYoshidaKIncrease of coagulation potential in chronic spontaneous urticariaAllergy2011542843310.1111/j.1398-9995.2010.02506.x21083568TakedaTSakuraiYTakahagiSKatoJYoshidaKIncrease of coagulation potential in chronic spontaneous urticariaAllergy2011542843310.1111/j.1398-9995.2010.02506.x21083568, TakedaTSakuraiYTakahagiSKatoJYoshidaKIncrease of coagulation potential in chronic spontaneous urticariaAllergy2011542843310.1111/j.1398-9995.2010.02506.x21083568
C. Grattan, B. O'donnell, D. Francis, N. Niimi, R. Barlow, P. Seed, A. Black, M. Greaves (2000)
Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticariaBritish Journal of Dermatology, 143
G. Reeves, M. Boyle, J. Bonfield, P. Dobson, M. Loewenthal (2004)
Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluationInternal Medicine Journal, 34
M. Moretti, Daniela Caprara, C. Coutinho, B. Bar‐Oz, M. Berkovitch, A. Addis, E. Jovanovski, L. Schüler-Faccini, G. Koren (2003)
Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study.The Journal of allergy and clinical immunology, 111 3
(CzeizelAERockenbauerMPopulation-based case-control study of teratogenic potential of corticosteroidsTeratology1997533534010.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W9451758)
CzeizelAERockenbauerMPopulation-based case-control study of teratogenic potential of corticosteroidsTeratology1997533534010.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W9451758CzeizelAERockenbauerMPopulation-based case-control study of teratogenic potential of corticosteroidsTeratology1997533534010.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W9451758, CzeizelAERockenbauerMPopulation-based case-control study of teratogenic potential of corticosteroidsTeratology1997533534010.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W9451758
K. Wan (2009)
Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticariaJournal of Dermatological Treatment, 20
(YingSKikuchiYMengQKayABKaplanAPTH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reactionJ Allergy Clin Immunol2002569470010.1067/mai.2002.12323611941321)
YingSKikuchiYMengQKayABKaplanAPTH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reactionJ Allergy Clin Immunol2002569470010.1067/mai.2002.12323611941321YingSKikuchiYMengQKayABKaplanAPTH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reactionJ Allergy Clin Immunol2002569470010.1067/mai.2002.12323611941321, YingSKikuchiYMengQKayABKaplanAPTH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reactionJ Allergy Clin Immunol2002569470010.1067/mai.2002.12323611941321
M. Maurer, K. Weller, C. Bindslev‐Jensen, A. Giménez-Arnau, P. Bousquet, J. Bousquet, G. Canonica, M. Church, M. Church, K. Godse, C. Grattan, M. Greaves, M. Hide, D. Kalogeromitros, A. Kaplan, S. Saini, X. Zhu, T. Zuberbier (2011)
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1Allergy, 66
(OstLWettrellGBjörkhemIRaneAPrednisolone excretion in human milkJ Pediatr198551008101110.1016/S0022-3476(85)80259-63998938)
OstLWettrellGBjörkhemIRaneAPrednisolone excretion in human milkJ Pediatr198551008101110.1016/S0022-3476(85)80259-63998938OstLWettrellGBjörkhemIRaneAPrednisolone excretion in human milkJ Pediatr198551008101110.1016/S0022-3476(85)80259-63998938, OstLWettrellGBjörkhemIRaneAPrednisolone excretion in human milkJ Pediatr198551008101110.1016/S0022-3476(85)80259-63998938
(OzkanMOflazSBKocamanDOzsekerFGelincikAPsychiatric morbidity and quality of life in patients with chronic idiopathic urticariaAnn Allergy Asthma20075293310.1016/S1081-1206(10)60617-5)
OzkanMOflazSBKocamanDOzsekerFGelincikAPsychiatric morbidity and quality of life in patients with chronic idiopathic urticariaAnn Allergy Asthma20075293310.1016/S1081-1206(10)60617-5OzkanMOflazSBKocamanDOzsekerFGelincikAPsychiatric morbidity and quality of life in patients with chronic idiopathic urticariaAnn Allergy Asthma20075293310.1016/S1081-1206(10)60617-5, OzkanMOflazSBKocamanDOzsekerFGelincikAPsychiatric morbidity and quality of life in patients with chronic idiopathic urticariaAnn Allergy Asthma20075293310.1016/S1081-1206(10)60617-5
(Di LorenzoGD'AlcamoARizzoMLeto-BaroneMSBiancoCLLeukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic reviewJ Asthma Allergy2008591621437139)
Di LorenzoGD'AlcamoARizzoMLeto-BaroneMSBiancoCLLeukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic reviewJ Asthma Allergy2008591621437139Di LorenzoGD'AlcamoARizzoMLeto-BaroneMSBiancoCLLeukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic reviewJ Asthma Allergy2008591621437139, Di LorenzoGD'AlcamoARizzoMLeto-BaroneMSBiancoCLLeukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic reviewJ Asthma Allergy2008591621437139
(NurseDSPrurigo of pregnancyAustralas J Dermatol1968525826710.1111/j.1440-0960.1968.tb01616.x5673933)
NurseDSPrurigo of pregnancyAustralas J Dermatol1968525826710.1111/j.1440-0960.1968.tb01616.x5673933NurseDSPrurigo of pregnancyAustralas J Dermatol1968525826710.1111/j.1440-0960.1968.tb01616.x5673933, NurseDSPrurigo of pregnancyAustralas J Dermatol1968525826710.1111/j.1440-0960.1968.tb01616.x5673933
(PoonESeedPTGreavesMWKobza-BlackAThe extent and nature of disability in different urticarial conditionsBr J Dermatol1999566767110.1046/j.1365-2133.1999.02767.x10233318)
PoonESeedPTGreavesMWKobza-BlackAThe extent and nature of disability in different urticarial conditionsBr J Dermatol1999566767110.1046/j.1365-2133.1999.02767.x10233318PoonESeedPTGreavesMWKobza-BlackAThe extent and nature of disability in different urticarial conditionsBr J Dermatol1999566767110.1046/j.1365-2133.1999.02767.x10233318, PoonESeedPTGreavesMWKobza-BlackAThe extent and nature of disability in different urticarial conditionsBr J Dermatol1999566767110.1046/j.1365-2133.1999.02767.x10233318
M. Fradin, C. Ellis, M. Goldfarb, J. Voorhees (1991)
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema.Journal of the American Academy of Dermatology, 25 6 Pt 1
JM Camarasa, A Aliaga, JM Fernández-Vozmediano, E Fonseca, L Iglesias, I Tagarro (2001)
Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trialSkin Pharmacol Appl Skin Physiol, 14
(WeegerinkNSchradersMLeijendeckersJSliekerKHoygenPLAudiometric characteristics of a Dutch family with Muckle-Wells syndromeHear Res2011524325110.1016/j.heares.2011.07.00621810457)
WeegerinkNSchradersMLeijendeckersJSliekerKHoygenPLAudiometric characteristics of a Dutch family with Muckle-Wells syndromeHear Res2011524325110.1016/j.heares.2011.07.00621810457WeegerinkNSchradersMLeijendeckersJSliekerKHoygenPLAudiometric characteristics of a Dutch family with Muckle-Wells syndromeHear Res2011524325110.1016/j.heares.2011.07.00621810457, WeegerinkNSchradersMLeijendeckersJSliekerKHoygenPLAudiometric characteristics of a Dutch family with Muckle-Wells syndromeHear Res2011524325110.1016/j.heares.2011.07.00621810457
(VenzorJLeeWLHustonDPUrticarial vasculitisClin Rev Allergy Immunol2002520121610.1385/CRIAI:23:2:20112221865)
VenzorJLeeWLHustonDPUrticarial vasculitisClin Rev Allergy Immunol2002520121610.1385/CRIAI:23:2:20112221865VenzorJLeeWLHustonDPUrticarial vasculitisClin Rev Allergy Immunol2002520121610.1385/CRIAI:23:2:20112221865, VenzorJLeeWLHustonDPUrticarial vasculitisClin Rev Allergy Immunol2002520121610.1385/CRIAI:23:2:20112221865
M. Church, K. Weller, P. Stock, M. Maurer (2011)
Chronic spontaneous urticaria in children: Itching for insightPediatric Allergy and Immunology, 22
M. Tuchinda, N. Srimaruta, S. Habanananda, J. Vareenil, A. Assatherawatts (1986)
Urticaria in Thai children.Asian Pacific journal of allergy and immunology, 4 1
(CurranMPScottLJPerryCMCetirizine: a review of its use in allergic disordersDrugs200455557)
CurranMPScottLJPerryCMCetirizine: a review of its use in allergic disordersDrugs200455557CurranMPScottLJPerryCMCetirizine: a review of its use in allergic disordersDrugs200455557, CurranMPScottLJPerryCMCetirizine: a review of its use in allergic disordersDrugs200455557
(MortureuxPLéauté-LabrézeCLegrain-LifermannVLamireauTSarlangueJTaiebAAcute urticaria in infancy and early childhood: a prospective studyArch Dermatol1998531932310.1001/archderm.134.3.3199521030)
MortureuxPLéauté-LabrézeCLegrain-LifermannVLamireauTSarlangueJTaiebAAcute urticaria in infancy and early childhood: a prospective studyArch Dermatol1998531932310.1001/archderm.134.3.3199521030MortureuxPLéauté-LabrézeCLegrain-LifermannVLamireauTSarlangueJTaiebAAcute urticaria in infancy and early childhood: a prospective studyArch Dermatol1998531932310.1001/archderm.134.3.3199521030, MortureuxPLéauté-LabrézeCLegrain-LifermannVLamireauTSarlangueJTaiebAAcute urticaria in infancy and early childhood: a prospective studyArch Dermatol1998531932310.1001/archderm.134.3.3199521030
(WanKSEfficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticariaJ Dermatolog Treat2009519419710.1080/0954663080260749519085267)
WanKSEfficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticariaJ Dermatolog Treat2009519419710.1080/0954663080260749519085267WanKSEfficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticariaJ Dermatolog Treat2009519419710.1080/0954663080260749519085267, WanKSEfficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticariaJ Dermatolog Treat2009519419710.1080/0954663080260749519085267
(ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: management of urticariaAllergy200951427144310.1111/j.1398-9995.2009.02178.x19772513)
ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: management of urticariaAllergy200951427144310.1111/j.1398-9995.2009.02178.x19772513ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: management of urticariaAllergy200951427144310.1111/j.1398-9995.2009.02178.x19772513, ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: management of urticariaAllergy200951427144310.1111/j.1398-9995.2009.02178.x19772513
M. Roth (2011)
Pregnancy DermatosesAmerican Journal of Clinical Dermatology, 12
(CloughGFBoutsioukiPChurchMKComparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skinAllergy2001598598810.1034/j.1398-9995.2001.00204.x11576078)
CloughGFBoutsioukiPChurchMKComparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skinAllergy2001598598810.1034/j.1398-9995.2001.00204.x11576078CloughGFBoutsioukiPChurchMKComparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skinAllergy2001598598810.1034/j.1398-9995.2001.00204.x11576078, CloughGFBoutsioukiPChurchMKComparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skinAllergy2001598598810.1034/j.1398-9995.2001.00204.x11576078
(SiebenhaarFDegenerFZuberbierTMartusPMaurerMHigh-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover studyJ Allergy Clin Immunol2009567267910.1016/j.jaci.2008.12.00819201016)
SiebenhaarFDegenerFZuberbierTMartusPMaurerMHigh-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover studyJ Allergy Clin Immunol2009567267910.1016/j.jaci.2008.12.00819201016SiebenhaarFDegenerFZuberbierTMartusPMaurerMHigh-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover studyJ Allergy Clin Immunol2009567267910.1016/j.jaci.2008.12.00819201016, SiebenhaarFDegenerFZuberbierTMartusPMaurerMHigh-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover studyJ Allergy Clin Immunol2009567267910.1016/j.jaci.2008.12.00819201016
(KikuchiYFannTKaplanAAntithyroid antibodies in chronic urticaria and angioedemaJ Allergy Clin Immunol2003521810.1067/mai.2003.160512847508)
KikuchiYFannTKaplanAAntithyroid antibodies in chronic urticaria and angioedemaJ Allergy Clin Immunol2003521810.1067/mai.2003.160512847508KikuchiYFannTKaplanAAntithyroid antibodies in chronic urticaria and angioedemaJ Allergy Clin Immunol2003521810.1067/mai.2003.160512847508, KikuchiYFannTKaplanAAntithyroid antibodies in chronic urticaria and angioedemaJ Allergy Clin Immunol2003521810.1067/mai.2003.160512847508
(LuquinEKaplanAPFerrerMIncreased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuliClin Exp Allergy2005545646010.1111/j.1365-2222.2005.02212.x15836753)
LuquinEKaplanAPFerrerMIncreased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuliClin Exp Allergy2005545646010.1111/j.1365-2222.2005.02212.x15836753LuquinEKaplanAPFerrerMIncreased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuliClin Exp Allergy2005545646010.1111/j.1365-2222.2005.02212.x15836753, LuquinEKaplanAPFerrerMIncreased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuliClin Exp Allergy2005545646010.1111/j.1365-2222.2005.02212.x15836753
(EhlersINiggemanBBindevCZuberbierTRole of non allergic hypersensitivity reactions in children with chronic urticariaAllergy199851074107710.1111/j.1398-9995.1998.tb03817.x9860240)
EhlersINiggemanBBindevCZuberbierTRole of non allergic hypersensitivity reactions in children with chronic urticariaAllergy199851074107710.1111/j.1398-9995.1998.tb03817.x9860240EhlersINiggemanBBindevCZuberbierTRole of non allergic hypersensitivity reactions in children with chronic urticariaAllergy199851074107710.1111/j.1398-9995.1998.tb03817.x9860240, EhlersINiggemanBBindevCZuberbierTRole of non allergic hypersensitivity reactions in children with chronic urticariaAllergy199851074107710.1111/j.1398-9995.1998.tb03817.x9860240
E. Poon, P. Seed, M. Greaves, A. Kobza-Black (1999)
The extent and nature of disability in different urticarial conditionsBritish Journal of Dermatology, 140
L. Gilstrap, R. Christensen, W. Clewell, M. D’Alton, E. Davidson, M. Escobedo, D. Gjerdingen, J. Goddard-finegold, R. Goldenberg, D. Grimes, T. Hansen, R. Kauffman, E. Keeler, W. Oh, E. Susman, M. Vogel, M. Avery, P. Ballard, R. Ballard, P. Crowley, T. Garite, G. Hankins, A. Jobe, J. Koppe, J. Maher, I. Merkatz, S. Shankaran, K. Simpson, J. Sinclair, T. Slotkin, H. Taeusch, L. Wright, D. Alexander, M. Berberich, M. Bracken, L. Cooper, L. Culpepper, J. Elliott, J. Ferguson, F. Frigoletto, D. Gail, W. Hall, M. Jones, B. Medoff‐Cooper, G. Merenstein, J. Whalen, C. Lenfant, A. Hinshaw (1995)
Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesJAMA, 273
(ZurawBLUrticaria, angioedema, and autoimmunityClin Lab Med199755595699316773)
ZurawBLUrticaria, angioedema, and autoimmunityClin Lab Med199755595699316773ZurawBLUrticaria, angioedema, and autoimmunityClin Lab Med199755595699316773, ZurawBLUrticaria, angioedema, and autoimmunityClin Lab Med199755595699316773
(MłynekAMagerlMHannaMLhachimiSBaiardiniIThe German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findingsAllergy2009592793610.1111/j.1398-9995.2008.01920.x19453340)
MłynekAMagerlMHannaMLhachimiSBaiardiniIThe German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findingsAllergy2009592793610.1111/j.1398-9995.2008.01920.x19453340MłynekAMagerlMHannaMLhachimiSBaiardiniIThe German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findingsAllergy2009592793610.1111/j.1398-9995.2008.01920.x19453340, MłynekAMagerlMHannaMLhachimiSBaiardiniIThe German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findingsAllergy2009592793610.1111/j.1398-9995.2008.01920.x19453340
(Epocrates Online. Urticaria and angioedemaAvailable at: https://online.epocrates.com/u/2951844/Urticaria+and+angioedema/FollowUp/Overview. Accessed August 30, 2011)
Epocrates Online. Urticaria and angioedemaAvailable at: https://online.epocrates.com/u/2951844/Urticaria+and+angioedema/FollowUp/Overview. Accessed August 30, 2011Epocrates Online. Urticaria and angioedemaAvailable at: https://online.epocrates.com/u/2951844/Urticaria+and+angioedema/FollowUp/Overview. Accessed August 30, 2011, Epocrates Online. Urticaria and angioedemaAvailable at: https://online.epocrates.com/u/2951844/Urticaria+and+angioedema/FollowUp/Overview. Accessed August 30, 2011
N. Haas, Wiltrud Birkle-Berlinger, B. Henz (2005)
Prognosis of acute urticaria in children.Acta dermato-venereologica, 85 1
M. Kozel, P. Bossuyt, J. Mekkes, J. Bos (2003)
Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review.Journal of the American Academy of Dermatology, 48 3
(KällénBUse of antihistamine drugs in early pregnancy and delivery outcomeJ Matern Fetal Neonatal Med2002514615210.1080/jmf.11.3.146.15212380668)
KällénBUse of antihistamine drugs in early pregnancy and delivery outcomeJ Matern Fetal Neonatal Med2002514615210.1080/jmf.11.3.146.15212380668KällénBUse of antihistamine drugs in early pregnancy and delivery outcomeJ Matern Fetal Neonatal Med2002514615210.1080/jmf.11.3.146.15212380668, KällénBUse of antihistamine drugs in early pregnancy and delivery outcomeJ Matern Fetal Neonatal Med2002514615210.1080/jmf.11.3.146.15212380668
B. Zuraw (1997)
Urticaria, angioedema, and autoimmunity.Clinics in laboratory medicine, 17 3
(PotterPCKappAMaurerMGuilletGJianAMHauptmannPFinlayAYComparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patientsAllergy2009559660410.1111/j.1398-9995.2008.01893.x19053988)
PotterPCKappAMaurerMGuilletGJianAMHauptmannPFinlayAYComparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patientsAllergy2009559660410.1111/j.1398-9995.2008.01893.x19053988PotterPCKappAMaurerMGuilletGJianAMHauptmannPFinlayAYComparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patientsAllergy2009559660410.1111/j.1398-9995.2008.01893.x19053988, PotterPCKappAMaurerMGuilletGJianAMHauptmannPFinlayAYComparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patientsAllergy2009559660410.1111/j.1398-9995.2008.01893.x19053988
(BaiardiniIPasqualiMBraidoFFumagalliFGuerraLA new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaireAllergy200551073107810.1111/j.1398-9995.2005.00833.x15969690)
BaiardiniIPasqualiMBraidoFFumagalliFGuerraLA new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaireAllergy200551073107810.1111/j.1398-9995.2005.00833.x15969690BaiardiniIPasqualiMBraidoFFumagalliFGuerraLA new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaireAllergy200551073107810.1111/j.1398-9995.2005.00833.x15969690, BaiardiniIPasqualiMBraidoFFumagalliFGuerraLA new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaireAllergy200551073107810.1111/j.1398-9995.2005.00833.x15969690
K. Godse (2008)
Omalizumab in severe chronic urticaria.Indian journal of dermatology, venereology and leprology, 74 2
(BoyceJASuccessful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJ Allergy Clin Immunol200651415141810.1016/j.jaci.2006.04.00316751006)
BoyceJASuccessful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJ Allergy Clin Immunol200651415141810.1016/j.jaci.2006.04.00316751006BoyceJASuccessful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJ Allergy Clin Immunol200651415141810.1016/j.jaci.2006.04.00316751006, BoyceJASuccessful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJ Allergy Clin Immunol200651415141810.1016/j.jaci.2006.04.00316751006
(ChuaSLGibbsSChronic urticaria responding to subcutaneous heparin sodiumBr J Dermatol2005521621710.1111/j.1365-2133.2005.06694.x16029359)
ChuaSLGibbsSChronic urticaria responding to subcutaneous heparin sodiumBr J Dermatol2005521621710.1111/j.1365-2133.2005.06694.x16029359ChuaSLGibbsSChronic urticaria responding to subcutaneous heparin sodiumBr J Dermatol2005521621710.1111/j.1365-2133.2005.06694.x16029359, ChuaSLGibbsSChronic urticaria responding to subcutaneous heparin sodiumBr J Dermatol2005521621710.1111/j.1365-2133.2005.06694.x16029359
M. Ozkan, S. Oflaz, N. Kocaman, F. Ozşeker, A. Gelincik, S. Büyüköztürk, S. Ozkan, B. Çolakoğlu (2007)
Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 99 1
(BeckLAMarcotteGVMacGlashanDTogiasASainiSOmalizumabinduced reductions in mast cell Fcepsilon RI expression and functionJ Allergy Clin Immunol2004552753010.1016/j.jaci.2004.06.03215356552)
BeckLAMarcotteGVMacGlashanDTogiasASainiSOmalizumabinduced reductions in mast cell Fcepsilon RI expression and functionJ Allergy Clin Immunol2004552753010.1016/j.jaci.2004.06.03215356552BeckLAMarcotteGVMacGlashanDTogiasASainiSOmalizumabinduced reductions in mast cell Fcepsilon RI expression and functionJ Allergy Clin Immunol2004552753010.1016/j.jaci.2004.06.03215356552, BeckLAMarcotteGVMacGlashanDTogiasASainiSOmalizumabinduced reductions in mast cell Fcepsilon RI expression and functionJ Allergy Clin Immunol2004552753010.1016/j.jaci.2004.06.03215356552
(SabroeRAFiebigerEFrancisDMMaurerDSeedPTGrattanCEClassification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severityJ Allergy Clin Immunol2002549249910.1067/mai.2002.12678212209101)
SabroeRAFiebigerEFrancisDMMaurerDSeedPTGrattanCEClassification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severityJ Allergy Clin Immunol2002549249910.1067/mai.2002.12678212209101SabroeRAFiebigerEFrancisDMMaurerDSeedPTGrattanCEClassification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severityJ Allergy Clin Immunol2002549249910.1067/mai.2002.12678212209101, SabroeRAFiebigerEFrancisDMMaurerDSeedPTGrattanCEClassification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severityJ Allergy Clin Immunol2002549249910.1067/mai.2002.12678212209101
T. Zuberbier, C. Bindslev‐Jensen, W. Canonica, C. Grattan, M. Greaves, B. Henz, A. Kapp, M. Kozel, M. Maurer, H. Merk, T. Schafer, D. Simon, G. Vena, B. Wedi (2006)
EAACI/GA2LEN/EDF guideline: management of urticariaAllergy, 61
Andrew Czeizel, M. Rockenbauer (1997)
Population-based case-control study of teratogenic potential of corticosteroids.Teratology, 56 5
Adriana Pérez, Alison Woods, C. Grattan (2010)
Methotrexate: a useful steroid‐sparing agent in recalcitrant chronic urticariaBritish Journal of Dermatology, 162
(VestergaardCDeleuranMTwo cases of severe refractory chronic idiopathic urticaria treated with omalizumabActa Derm Venereol2010544344410.2340/00015555-088420574627)
VestergaardCDeleuranMTwo cases of severe refractory chronic idiopathic urticaria treated with omalizumabActa Derm Venereol2010544344410.2340/00015555-088420574627VestergaardCDeleuranMTwo cases of severe refractory chronic idiopathic urticaria treated with omalizumabActa Derm Venereol2010544344410.2340/00015555-088420574627, VestergaardCDeleuranMTwo cases of severe refractory chronic idiopathic urticaria treated with omalizumabActa Derm Venereol2010544344410.2340/00015555-088420574627
L. Poulos, A. Waters, P. Correll, R. Loblay, G. Marks (2007)
Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005.The Journal of allergy and clinical immunology, 120 4
L. Beck, G. Marcotte, D. Jr., A. Togias, S. Saini (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and functionThe Journal of Allergy and Clinical Immunology, 114
(BrunettiLFrancarillaRMinelloVLHigh prevalence of autoimmune urticaria in children with chronic urticariaJ Allergy Clin Immunol2004592292710.1016/j.jaci.2004.07.04215480336)
BrunettiLFrancarillaRMinelloVLHigh prevalence of autoimmune urticaria in children with chronic urticariaJ Allergy Clin Immunol2004592292710.1016/j.jaci.2004.07.04215480336BrunettiLFrancarillaRMinelloVLHigh prevalence of autoimmune urticaria in children with chronic urticariaJ Allergy Clin Immunol2004592292710.1016/j.jaci.2004.07.04215480336, BrunettiLFrancarillaRMinelloVLHigh prevalence of autoimmune urticaria in children with chronic urticariaJ Allergy Clin Immunol2004592292710.1016/j.jaci.2004.07.04215480336
M. Pacor, G. Lorenzo, R. Corrocher (2001)
Efficacy of leukotriene receptor antagonist in chronic urticaria. A double‐blind, placebo‐controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acidClinical & Experimental Allergy, 31
(KernFLichtensteinLMDefective histamine release in chronic urticariaJ Clin Invest197651369137710.1172/JCI10840557121)
KernFLichtensteinLMDefective histamine release in chronic urticariaJ Clin Invest197651369137710.1172/JCI10840557121KernFLichtensteinLMDefective histamine release in chronic urticariaJ Clin Invest197651369137710.1172/JCI10840557121, KernFLichtensteinLMDefective histamine release in chronic urticariaJ Clin Invest197651369137710.1172/JCI10840557121
P. Staubach, A. Eckhardt-Henn, M. Dechene, A. Vonend, M. Metz, M. Magerl, P. Breuer, M. Maurer (2006)
Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidityBritish Journal of Dermatology, 154
I. Aronson, Shirley Bond, V. Fiedler, Stephanie Vomvouras, David Gruber, C. Ruiz (1998)
Pruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patients.Journal of the American Academy of Dermatology, 39 6
J. Grant, David Bernstein, C. Buckley, T. Chu, Roger Fox, Ross Rocklin, W. Schoenwetter, Sheldon Spector, Chester Stafford, James Stroh, Kathleen Karpenter (1988)
Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria.The Journal of allergy and clinical immunology, 81 3
(FortsonJSZoneJJHammondMEGroggelGCHypocomplementemic urticarial vasculitis syndrome responsive to dapsoneJ Am Acad Dermatol198651137114210.1016/S0190-9622(86)70282-X3771868)
FortsonJSZoneJJHammondMEGroggelGCHypocomplementemic urticarial vasculitis syndrome responsive to dapsoneJ Am Acad Dermatol198651137114210.1016/S0190-9622(86)70282-X3771868FortsonJSZoneJJHammondMEGroggelGCHypocomplementemic urticarial vasculitis syndrome responsive to dapsoneJ Am Acad Dermatol198651137114210.1016/S0190-9622(86)70282-X3771868, FortsonJSZoneJJHammondMEGroggelGCHypocomplementemic urticarial vasculitis syndrome responsive to dapsoneJ Am Acad Dermatol198651137114210.1016/S0190-9622(86)70282-X3771868
A. Kaplan (2002)
Clinical practice. Chronic urticaria and angioedema.The New England journal of medicine, 346 3
(ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy200951417142610.1111/j.1398-9995.2009.02179.x19772512)
ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy200951417142610.1111/j.1398-9995.2009.02179.x19772512ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy200951417142610.1111/j.1398-9995.2009.02179.x19772512, ZuberbierTAseroRBindslev-JensenCCanonicaGWChurchMKDermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy200951417142610.1111/j.1398-9995.2009.02179.x19772512
J. Boyce (2006)
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.The Journal of allergy and clinical immunology, 117 6
L. Öst, G. Wettrell, I. Björkhem, A. Rane (1985)
Prednisolone excretion in human milk.The Journal of pediatrics, 106 6
(Hamel-TeillacDChronic urticaria in childrenAnn Dermatology Venereol2003515691572)
Hamel-TeillacDChronic urticaria in childrenAnn Dermatology Venereol2003515691572Hamel-TeillacDChronic urticaria in childrenAnn Dermatology Venereol2003515691572, Hamel-TeillacDChronic urticaria in childrenAnn Dermatology Venereol2003515691572
Y. Kikuchi, A. Kaplan (2001)
Mechanisms of autoimmune activation of basophils in chronic urticaria.The Journal of allergy and clinical immunology, 107 6
R. Sabroe, D. Francis, R. Barr, A. Black, M. Greaves (1998)
Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.The Journal of allergy and clinical immunology, 102 4 Pt 1
(SabroeRPoonEOrchardGLaneDFrancisDMCutaneous inflammatory cell infiltration on chronic idiopathic urticaria: comparison of patients with or without anti-Fc episilon RI or anti IgE antibodiesJ Allergy Clin Immunol1999548449310.1016/S0091-6749(99)70475-610069884)
SabroeRPoonEOrchardGLaneDFrancisDMCutaneous inflammatory cell infiltration on chronic idiopathic urticaria: comparison of patients with or without anti-Fc episilon RI or anti IgE antibodiesJ Allergy Clin Immunol1999548449310.1016/S0091-6749(99)70475-610069884SabroeRPoonEOrchardGLaneDFrancisDMCutaneous inflammatory cell infiltration on chronic idiopathic urticaria: comparison of patients with or without anti-Fc episilon RI or anti IgE antibodiesJ Allergy Clin Immunol1999548449310.1016/S0091-6749(99)70475-610069884, SabroeRPoonEOrchardGLaneDFrancisDMCutaneous inflammatory cell infiltration on chronic idiopathic urticaria: comparison of patients with or without anti-Fc episilon RI or anti IgE antibodiesJ Allergy Clin Immunol1999548449310.1016/S0091-6749(99)70475-610069884
C. Gilbert, P. Mazzotta, R. Loebstein, G. Koren (2005)
Fetal Safety of Drugs Used in the Treatment of Allergic RhinitisDrug Safety, 28
S. Bleehen, S. Thomas, M. Greaves, J. Newton, C. Kennedy, F. Hindley, R. Marks, M. Hazell, N. Rowell, G. Fairiss, P. Cartwright, H. Glenny, K. Howland (1987)
Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi‐centre randomized double‐blind studyBritish Journal of Dermatology, 117
A. Banerji, A. Sheffer (2009)
The spectrum of chronic angioedema.Allergy and asthma proceedings, 30 1
(1997)
Clin Lab Med
A. Kessel, E. Bamberger, E. Toubi (2011)
Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study.Journal of the American Academy of Dermatology, 52 1
A. Harris, F. Twarog, R. Geha (1983)
Chronic urticaria in childhood: natural course and etiology.Annals of allergy, 51 2 Pt 1
(WediBRaapUWieczorekDKappAUrticaria and infectionsAnn Asthma Clin Immunol200951010.1186/1710-1492-5-10)
WediBRaapUWieczorekDKappAUrticaria and infectionsAnn Asthma Clin Immunol200951010.1186/1710-1492-5-10WediBRaapUWieczorekDKappAUrticaria and infectionsAnn Asthma Clin Immunol200951010.1186/1710-1492-5-10, WediBRaapUWieczorekDKappAUrticaria and infectionsAnn Asthma Clin Immunol200951010.1186/1710-1492-5-10
Available at: https:// online
(AseroROral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testingClin Exp Dermatol2005558258310.1111/j.1365-2230.2005.01799.x16045700)
AseroROral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testingClin Exp Dermatol2005558258310.1111/j.1365-2230.2005.01799.x16045700AseroROral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testingClin Exp Dermatol2005558258310.1111/j.1365-2230.2005.01799.x16045700, AseroROral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testingClin Exp Dermatol2005558258310.1111/j.1365-2230.2005.01799.x16045700
C. Vestergaard, M. Deleuran (2010)
Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab.Acta dermato-venereologica, 90 4
S. Spector, R. Shikiar, G. Harding, S. Meeves, M. Leahy (2007)
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria.Cutis, 79 2
(EiserARSinghPShaniesHMSustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case reportAngiology199751019102210.1177/0003319797048011149373057)
EiserARSinghPShaniesHMSustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case reportAngiology199751019102210.1177/0003319797048011149373057EiserARSinghPShaniesHMSustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case reportAngiology199751019102210.1177/0003319797048011149373057, EiserARSinghPShaniesHMSustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case reportAngiology199751019102210.1177/0003319797048011149373057
Todor Popov, D. Dumitrascu, A. Bachvarova, C. Bocsan, V. Dimitrov, M. Church (2006)
A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivoInflammation Research, 55
R. Sabroe (2010)
Failure of omalizumab in cholinergic urticariaClinical and Experimental Dermatology, 35
Ikbal Kaygusuz, Ilknur Gumus, Evren Sarifakioglu, Ayla Eser, Bulent Bozkurt, Hasan Kafali (2014)
Autoimmune progesterone dermatitis.Taiwanese journal of obstetrics & gynecology, 53 3
T. Zuberbier, R. Asero, C. Bindslev‐Jensen, G. Canonica, M. Church, A. Giménez‐Arnau, C. Grattan, A. Kapp, M. Maurer, H. Merk, B. Rogala, S. Saini, M. Sánchez-Borges, P. Schmid‐Grendelmeier, H. Schünemann, P. Staubach, G. Vena, B. Wedi (2009)
EAACI/GA²LEN/EDF/WAO guideline: management of urticariaAllergy, 64
(TedeschiAParadoxical exacerbation of chronic urticaria by H1-antihistamines and montelukastEur Ann Allergy Clin Immunol2009518718920128233)
TedeschiAParadoxical exacerbation of chronic urticaria by H1-antihistamines and montelukastEur Ann Allergy Clin Immunol2009518718920128233TedeschiAParadoxical exacerbation of chronic urticaria by H1-antihistamines and montelukastEur Ann Allergy Clin Immunol2009518718920128233, TedeschiAParadoxical exacerbation of chronic urticaria by H1-antihistamines and montelukastEur Ann Allergy Clin Immunol2009518718920128233
(SharpeGRShusterRIn dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists aloneBr J Dermatol1993557557910.1111/j.1365-2133.1993.tb00487.x8251354)
SharpeGRShusterRIn dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists aloneBr J Dermatol1993557557910.1111/j.1365-2133.1993.tb00487.x8251354SharpeGRShusterRIn dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists aloneBr J Dermatol1993557557910.1111/j.1365-2133.1993.tb00487.x8251354, SharpeGRShusterRIn dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists aloneBr J Dermatol1993557557910.1111/j.1365-2133.1993.tb00487.x8251354
(StaubachPEckhardt-HennADecheneMVonendAMetzMQuality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidityBr J Dermatol2006529429810.1111/j.1365-2133.2005.06976.x16433799)
StaubachPEckhardt-HennADecheneMVonendAMetzMQuality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidityBr J Dermatol2006529429810.1111/j.1365-2133.2005.06976.x16433799StaubachPEckhardt-HennADecheneMVonendAMetzMQuality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidityBr J Dermatol2006529429810.1111/j.1365-2133.2005.06976.x16433799, StaubachPEckhardt-HennADecheneMVonendAMetzMQuality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidityBr J Dermatol2006529429810.1111/j.1365-2133.2005.06976.x16433799
(2000)
Methotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reaction
(BriggsGBFreemanRKYaffeSJDrugs in Pregnancy and Lactation20016Hagerstown, MD: Lippincott Williams & Wilkins)
BriggsGBFreemanRKYaffeSJDrugs in Pregnancy and Lactation20016Hagerstown, MD: Lippincott Williams & WilkinsBriggsGBFreemanRKYaffeSJDrugs in Pregnancy and Lactation20016Hagerstown, MD: Lippincott Williams & Wilkins, BriggsGBFreemanRKYaffeSJDrugs in Pregnancy and Lactation20016Hagerstown, MD: Lippincott Williams & Wilkins
A. Tedeschi (2009)
Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast.European annals of allergy and clinical immunology, 41 6
H Wong (2007)
World Allergy Org J
(EliasJBussEKaplanAStudies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T lymphocytes, monocytes, and mast cellsJ Allergy Clin Immunol1986591491810.1016/0091-6749(86)90240-X3491100)
EliasJBussEKaplanAStudies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T lymphocytes, monocytes, and mast cellsJ Allergy Clin Immunol1986591491810.1016/0091-6749(86)90240-X3491100EliasJBussEKaplanAStudies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T lymphocytes, monocytes, and mast cellsJ Allergy Clin Immunol1986591491810.1016/0091-6749(86)90240-X3491100, EliasJBussEKaplanAStudies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T lymphocytes, monocytes, and mast cellsJ Allergy Clin Immunol1986591491810.1016/0091-6749(86)90240-X3491100
(LeeJSLohTHSeowSCTanSHProlonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitisJ Am Acad Dermatol20075994100510.1016/j.jaad.2006.10.96217504716)
LeeJSLohTHSeowSCTanSHProlonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitisJ Am Acad Dermatol20075994100510.1016/j.jaad.2006.10.96217504716LeeJSLohTHSeowSCTanSHProlonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitisJ Am Acad Dermatol20075994100510.1016/j.jaad.2006.10.96217504716, LeeJSLohTHSeowSCTanSHProlonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitisJ Am Acad Dermatol20075994100510.1016/j.jaad.2006.10.96217504716
(O'DonnellBFLawlorFSimpsonJMorganMGreavesMWThe impact of chronic urticaria on the quality of lifeBr J Dermatol1997519720110.1111/j.1365-2133.1997.tb14895.x9068731)
O'DonnellBFLawlorFSimpsonJMorganMGreavesMWThe impact of chronic urticaria on the quality of lifeBr J Dermatol1997519720110.1111/j.1365-2133.1997.tb14895.x9068731O'DonnellBFLawlorFSimpsonJMorganMGreavesMWThe impact of chronic urticaria on the quality of lifeBr J Dermatol1997519720110.1111/j.1365-2133.1997.tb14895.x9068731, O'DonnellBFLawlorFSimpsonJMorganMGreavesMWThe impact of chronic urticaria on the quality of lifeBr J Dermatol1997519720110.1111/j.1365-2133.1997.tb14895.x9068731
(Léauté-LabrézeCMortureuxPTaiebAUrticaria and Serum Sickness2000Oxford, United Kingdom: Blackwell Science)
Léauté-LabrézeCMortureuxPTaiebAUrticaria and Serum Sickness2000Oxford, United Kingdom: Blackwell ScienceLéauté-LabrézeCMortureuxPTaiebAUrticaria and Serum Sickness2000Oxford, United Kingdom: Blackwell Science, Léauté-LabrézeCMortureuxPTaiebAUrticaria and Serum Sickness2000Oxford, United Kingdom: Blackwell Science
S. Spector, R. Tan (2007)
Effect of omalizumab on patients with chronic urticaria.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 99 2
R. Parslew, D. Pryce, J. Ashworth, P. Friedmann (2000)
Warfarin treatment of chronic idiopathic urticaria and angio‐oedemaClinical & Experimental Allergy, 30
(AronsonIKBondSFiedlerVCVomvourasSGruberDRuizCPruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patientsJ Am Acad Dermatol1998593393910.1016/S0190-9622(98)70265-89843004)
AronsonIKBondSFiedlerVCVomvourasSGruberDRuizCPruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patientsJ Am Acad Dermatol1998593393910.1016/S0190-9622(98)70265-89843004AronsonIKBondSFiedlerVCVomvourasSGruberDRuizCPruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patientsJ Am Acad Dermatol1998593393910.1016/S0190-9622(98)70265-89843004, AronsonIKBondSFiedlerVCVomvourasSGruberDRuizCPruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patientsJ Am Acad Dermatol1998593393910.1016/S0190-9622(98)70265-89843004
(FinlayAKhanGKDermatology life quality index (DLQI)--a simple practical measure for routine in clinical useClin Exp Dermatol1994521021610.1111/j.1365-2230.1994.tb01167.x8033378)
FinlayAKhanGKDermatology life quality index (DLQI)--a simple practical measure for routine in clinical useClin Exp Dermatol1994521021610.1111/j.1365-2230.1994.tb01167.x8033378FinlayAKhanGKDermatology life quality index (DLQI)--a simple practical measure for routine in clinical useClin Exp Dermatol1994521021610.1111/j.1365-2230.1994.tb01167.x8033378, FinlayAKhanGKDermatology life quality index (DLQI)--a simple practical measure for routine in clinical useClin Exp Dermatol1994521021610.1111/j.1365-2230.1994.tb01167.x8033378
M. Marmor, R. Carr, M. Easterbrook, A. Farjo, W. Mieler (2002)
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.Ophthalmology, 109 7
A. Tedeschi, R. Asero, A. Marzano, M. Lorini, D. Fanoni, E. Berti, M. Cugno (2009)
Plasma levels and skin‐eosinophil‐expression of vascular endothelial growth factor in patients with chronic urticariaAllergy, 64
C. Grattan (2001)
Basophils in chronic urticaria.The journal of investigative dermatology. Symposium proceedings, 6 2
K. Fujimori, H. Kyozuka (2012)
[Drugs in pregnancy and lactation].Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 6
(JacquesPLavoieABedardPMBrunetCHebertJChronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remissionJ Allergy Clin Immunol199251139114310.1016/0091-6749(92)90297-F1376735)
JacquesPLavoieABedardPMBrunetCHebertJChronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remissionJ Allergy Clin Immunol199251139114310.1016/0091-6749(92)90297-F1376735JacquesPLavoieABedardPMBrunetCHebertJChronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remissionJ Allergy Clin Immunol199251139114310.1016/0091-6749(92)90297-F1376735, JacquesPLavoieABedardPMBrunetCHebertJChronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remissionJ Allergy Clin Immunol199251139114310.1016/0091-6749(92)90297-F1376735
(KaplanAClinical practice. Chronic urticaria and angioedemaN Engl J Med2002517517910.1056/NEJMcp01118611796852)
KaplanAClinical practice. Chronic urticaria and angioedemaN Engl J Med2002517517910.1056/NEJMcp01118611796852KaplanAClinical practice. Chronic urticaria and angioedemaN Engl J Med2002517517910.1056/NEJMcp01118611796852, KaplanAClinical practice. Chronic urticaria and angioedemaN Engl J Med2002517517910.1056/NEJMcp01118611796852
Karsten Weller, S. Altrichter, E. Ardelean, K. Krause, M. Magerl, M. Metz, F. Siebenhaar, Marcus Maurer (2010)
Chronische UrtikariaDer Hautarzt, 61
(EllingSVMcKennaPPowellFCPruritic urticarial papules and plaques of pregnancy in twin and triplet pregnanciesJ Eur Acad Dermatol Venereol2000537838110.1046/j.1468-3083.2000.00026.x11305379)
EllingSVMcKennaPPowellFCPruritic urticarial papules and plaques of pregnancy in twin and triplet pregnanciesJ Eur Acad Dermatol Venereol2000537838110.1046/j.1468-3083.2000.00026.x11305379EllingSVMcKennaPPowellFCPruritic urticarial papules and plaques of pregnancy in twin and triplet pregnanciesJ Eur Acad Dermatol Venereol2000537838110.1046/j.1468-3083.2000.00026.x11305379, EllingSVMcKennaPPowellFCPruritic urticarial papules and plaques of pregnancy in twin and triplet pregnanciesJ Eur Acad Dermatol Venereol2000537838110.1046/j.1468-3083.2000.00026.x11305379
Karin Söderberg, L. Hagmar, J. Schwartzbaum, M. Feychting (2004)
Allergic conditions and risk of hematological malignancies in adults: a cohort studyBMC Public Health, 4
(SagiLSolomonMBaumSLyakhovitskyATrauHBarzilaiAEvidence for methotrexate as a useful treatment for steroid-dependent chronic urticariaActa Derm Venereol2011530330610.2340/00015555-108021479356)
SagiLSolomonMBaumSLyakhovitskyATrauHBarzilaiAEvidence for methotrexate as a useful treatment for steroid-dependent chronic urticariaActa Derm Venereol2011530330610.2340/00015555-108021479356SagiLSolomonMBaumSLyakhovitskyATrauHBarzilaiAEvidence for methotrexate as a useful treatment for steroid-dependent chronic urticariaActa Derm Venereol2011530330610.2340/00015555-108021479356, SagiLSolomonMBaumSLyakhovitskyATrauHBarzilaiAEvidence for methotrexate as a useful treatment for steroid-dependent chronic urticariaActa Derm Venereol2011530330610.2340/00015555-108021479356
K. Lee, Ji Kim, D. Kang, Yoo Choi, Won-Jae Lee, J. Ro (2002)
Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera.The Journal of investigative dermatology, 118 4
(AseroRTedeschiACugnoMHeparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot studyInt Arch Allergy Immunol2010538438910.1159/00029294720203527)
AseroRTedeschiACugnoMHeparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot studyInt Arch Allergy Immunol2010538438910.1159/00029294720203527AseroRTedeschiACugnoMHeparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot studyInt Arch Allergy Immunol2010538438910.1159/00029294720203527, AseroRTedeschiACugnoMHeparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot studyInt Arch Allergy Immunol2010538438910.1159/00029294720203527
M. Church (2011)
Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humansInflammation Research, 60
C Gilbert, P Mazzotta, R Loebstein, G Koren (2005)
Fetal safety of drugs used in the treatment of allergic rhinitis: a critical reviewDrug Saf, 28
I. Baiardini, F. Braido, C. Bindslev-Jensen, P. Bousquet, Z. Brzoza, G. Canonica, Enrico Compalati, Alessandro Fiocchi, W. Fokkens, R. Wijk, A. Gimenez-Arnau, K. Godse, C. Grattan, Jean Grob, S. Grutta, D. Kalogeromitros, E. Kocatürk, Carlo Lombardi, A. Mota-Pinto, E. Ridolo, S. Saini, M. Sánchez-Borges, G. Senna, I. Terreehorst, A. Bom, E. Toubi, J. Bousquet, Jean Bousquet, Torsten Zuberbier, Marcus Maurer (2011)
Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA2LEN taskforce position paperAllergy, 66
Z. Erbagci (2002)
The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.The Journal of allergy and clinical immunology, 110 3
(GruberBBaezaMMarcheseMAgnelloVKaplanAPPrevalence and functional role of anti-IgE autoantibodies in urticarial syndromesJ Invest Dermatol1988521321710.1111/1523-1747.ep124622392448392)
GruberBBaezaMMarcheseMAgnelloVKaplanAPPrevalence and functional role of anti-IgE autoantibodies in urticarial syndromesJ Invest Dermatol1988521321710.1111/1523-1747.ep124622392448392GruberBBaezaMMarcheseMAgnelloVKaplanAPPrevalence and functional role of anti-IgE autoantibodies in urticarial syndromesJ Invest Dermatol1988521321710.1111/1523-1747.ep124622392448392, GruberBBaezaMMarcheseMAgnelloVKaplanAPPrevalence and functional role of anti-IgE autoantibodies in urticarial syndromesJ Invest Dermatol1988521321710.1111/1523-1747.ep124622392448392
F. Bossi, B. Frossi, O. Radillo, M. Cugno, A. Tedeschi, P. Riboldi, R. Asero, Francesco Tedesco, C. Pucillo (2011)
Mast cells are critically involved in serum‐mediated vascular leakage in chronic urticaria beyond high‐affinity IgE receptor stimulationAllergy, 66
(HindmarchIJohnsonSMeadowsRKirkpatrickTShamsiZThe acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flareCurr Med Res Opin2001524125511922397)
HindmarchIJohnsonSMeadowsRKirkpatrickTShamsiZThe acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flareCurr Med Res Opin2001524125511922397HindmarchIJohnsonSMeadowsRKirkpatrickTShamsiZThe acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flareCurr Med Res Opin2001524125511922397, HindmarchIJohnsonSMeadowsRKirkpatrickTShamsiZThe acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flareCurr Med Res Opin2001524125511922397
(BrodellLABeckLASainiSSPathophysiology of chronic urticariaAnn Allergy Asthma Immunol2008529129710.1016/S1081-1206(10)60588-118450112)
BrodellLABeckLASainiSSPathophysiology of chronic urticariaAnn Allergy Asthma Immunol2008529129710.1016/S1081-1206(10)60588-118450112BrodellLABeckLASainiSSPathophysiology of chronic urticariaAnn Allergy Asthma Immunol2008529129710.1016/S1081-1206(10)60588-118450112, BrodellLABeckLASainiSSPathophysiology of chronic urticariaAnn Allergy Asthma Immunol2008529129710.1016/S1081-1206(10)60588-118450112
G. Vena, N. Cassano, D. Colombo, E. Peruzzi, P. Pigatto (2006)
Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.Journal of the American Academy of Dermatology, 55 4
(BanerjiAShefferALThe spectrum of chronic angioedemaAllergy Asthma Proc20095111610.2500/aap.2009.30.318819331715)
BanerjiAShefferALThe spectrum of chronic angioedemaAllergy Asthma Proc20095111610.2500/aap.2009.30.318819331715BanerjiAShefferALThe spectrum of chronic angioedemaAllergy Asthma Proc20095111610.2500/aap.2009.30.318819331715, BanerjiAShefferALThe spectrum of chronic angioedemaAllergy Asthma Proc20095111610.2500/aap.2009.30.318819331715
B. Wedi, A. Kapp (2005)
Chronic urticaria: assessment of current treatmentExpert Review of Clinical Immunology, 1
N. Cassano, V. D'argento, R. Filotico, G. Vena (2005)
Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study.Acta dermato-venereologica, 85 3
S. Castro, E. Koremblit (1951)
[Antihistamines and pregnancy].Prensa medica argentina, 38 44
(PowellRJDu ToitGLSiddiqueNLeechSCDixonTABritish Society for Allergy and Clinical Immunology (BSACI)BSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy2007563165010.1111/j.1365-2222.2007.02678.x17456211)
PowellRJDu ToitGLSiddiqueNLeechSCDixonTABritish Society for Allergy and Clinical Immunology (BSACI)BSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy2007563165010.1111/j.1365-2222.2007.02678.x17456211PowellRJDu ToitGLSiddiqueNLeechSCDixonTABritish Society for Allergy and Clinical Immunology (BSACI)BSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy2007563165010.1111/j.1365-2222.2007.02678.x17456211, PowellRJDu ToitGLSiddiqueNLeechSCDixonTABritish Society for Allergy and Clinical Immunology (BSACI)BSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy2007563165010.1111/j.1365-2222.2007.02678.x17456211
A. Kaplan (2004)
Chronic urticaria: pathogenesis and treatment.The Journal of allergy and clinical immunology, 114 3
(KaplanAPChronic urticaria: pathogenesis and treatmentJ Allergy Clin Immunol2004546547410.1016/j.jaci.2004.02.04915356542)
KaplanAPChronic urticaria: pathogenesis and treatmentJ Allergy Clin Immunol2004546547410.1016/j.jaci.2004.02.04915356542KaplanAPChronic urticaria: pathogenesis and treatmentJ Allergy Clin Immunol2004546547410.1016/j.jaci.2004.02.04915356542, KaplanAPChronic urticaria: pathogenesis and treatmentJ Allergy Clin Immunol2004546547410.1016/j.jaci.2004.02.04915356542
(AseroRChronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed dosesClin Exp Dermatol20075343817042777)
AseroRChronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed dosesClin Exp Dermatol20075343817042777AseroRChronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed dosesClin Exp Dermatol20075343817042777, AseroRChronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed dosesClin Exp Dermatol20075343817042777
(PradatPRobert-GnansiaEDi TannaGLRosarioALisiAMastroiacovoPContibutors to the MADRE DatabaseFirst trimester exposure to corticosteroids and oral cleftsBirth Defects Res A Clin Mol Teratol2003596897010.1002/bdra.1013414745915)
PradatPRobert-GnansiaEDi TannaGLRosarioALisiAMastroiacovoPContibutors to the MADRE DatabaseFirst trimester exposure to corticosteroids and oral cleftsBirth Defects Res A Clin Mol Teratol2003596897010.1002/bdra.1013414745915PradatPRobert-GnansiaEDi TannaGLRosarioALisiAMastroiacovoPContibutors to the MADRE DatabaseFirst trimester exposure to corticosteroids and oral cleftsBirth Defects Res A Clin Mol Teratol2003596897010.1002/bdra.1013414745915, PradatPRobert-GnansiaEDi TannaGLRosarioALisiAMastroiacovoPContibutors to the MADRE DatabaseFirst trimester exposure to corticosteroids and oral cleftsBirth Defects Res A Clin Mol Teratol2003596897010.1002/bdra.1013414745915
Z. Shamsi, I. Hindmarch (2000)
Sedation and antihistamines: a review of inter‐drug differences using proportional impairment ratiosHuman Psychopharmacology: Clinical and Experimental, 15
T. Habif (2013)
Clinical dermatology:Acolor Guide to diagnosis and Therapy
R. Asero, A. Tedeschi (2010)
Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis.Journal of investigational allergology & clinical immunology, 20 5
(ZuberbierTGreavesMWJuhlinLMerkHStinglGHenzBMManagement of urticaria: a consensus reportJ Investig Dermatol Symp Proc2001512813110.1046/j.0022-202x.2001.00023.x11764297)
ZuberbierTGreavesMWJuhlinLMerkHStinglGHenzBMManagement of urticaria: a consensus reportJ Investig Dermatol Symp Proc2001512813110.1046/j.0022-202x.2001.00023.x11764297ZuberbierTGreavesMWJuhlinLMerkHStinglGHenzBMManagement of urticaria: a consensus reportJ Investig Dermatol Symp Proc2001512813110.1046/j.0022-202x.2001.00023.x11764297, ZuberbierTGreavesMWJuhlinLMerkHStinglGHenzBMManagement of urticaria: a consensus reportJ Investig Dermatol Symp Proc2001512813110.1046/j.0022-202x.2001.00023.x11764297
Ernest Charlesworth, A. Kagey-sobotka, Robert Schleimer, Philip Norman, L. Lichtenstein (1991)
Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.Journal of immunology, 146 2
T. Zuberbier, M. Balke, M. Worm, G. Edenharter, M. Maurer (2010)
Epidemiology of urticaria: a representative cross‐sectional population surveyClinical and Experimental Dermatology, 35
D. Doshi, M. Weinberger (2009)
Experience with Cyclosporine in Children with Chronic Idiopathic UrticariaPediatric Dermatology, 26
(GrantJARiethuisenJMMoulaertBDeVosCA double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjectsAnn Allergy Asthma Immunol2002519019710.1016/S1081-1206(10)61995-311868924)
GrantJARiethuisenJMMoulaertBDeVosCA double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjectsAnn Allergy Asthma Immunol2002519019710.1016/S1081-1206(10)61995-311868924GrantJARiethuisenJMMoulaertBDeVosCA double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjectsAnn Allergy Asthma Immunol2002519019710.1016/S1081-1206(10)61995-311868924, GrantJARiethuisenJMMoulaertBDeVosCA double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjectsAnn Allergy Asthma Immunol2002519019710.1016/S1081-1206(10)61995-311868924
M. Yamaguchi, K. Hirai, K. Nakajima, T. Ohtoshi, T. Takaishi, K. Ohta, Y. Morita, K. Ito (1994)
Dexamethasone inhibits basophil migrationAllergy, 49
L. Sagi, M. Solomon, S. Baum, A. Lyakhovitsky, H. Trau, A. Barzilai (2011)
Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria.Acta dermato-venereologica, 91 3
(KikuchiYKaplanAA role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticariaJ Allergy Clin Immunol2002511411810.1067/mai.2002.12095411799375)
KikuchiYKaplanAA role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticariaJ Allergy Clin Immunol2002511411810.1067/mai.2002.12095411799375KikuchiYKaplanAA role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticariaJ Allergy Clin Immunol2002511411810.1067/mai.2002.12095411799375, KikuchiYKaplanAA role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticariaJ Allergy Clin Immunol2002511411810.1067/mai.2002.12095411799375
(ZaidiAKSainiSSMacglashanDWJrRegulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumabJ Allergy Clin Immunol20105902908 e90710.1016/j.jaci.2009.12.99620236696)
ZaidiAKSainiSSMacglashanDWJrRegulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumabJ Allergy Clin Immunol20105902908 e90710.1016/j.jaci.2009.12.99620236696ZaidiAKSainiSSMacglashanDWJrRegulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumabJ Allergy Clin Immunol20105902908 e90710.1016/j.jaci.2009.12.99620236696, ZaidiAKSainiSSMacglashanDWJrRegulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumabJ Allergy Clin Immunol20105902908 e90710.1016/j.jaci.2009.12.99620236696
(CamarasaJMAliagaAFernández-VozmedianoJMFonsecaEIglesiasLTagarroIAzelastine tablets in the treatment of chronic idiopathic urticaria. Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trialSkin Pharmacol Appl Skin Physiol20015778610.1159/00005633711316966)
CamarasaJMAliagaAFernández-VozmedianoJMFonsecaEIglesiasLTagarroIAzelastine tablets in the treatment of chronic idiopathic urticaria. Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trialSkin Pharmacol Appl Skin Physiol20015778610.1159/00005633711316966CamarasaJMAliagaAFernández-VozmedianoJMFonsecaEIglesiasLTagarroIAzelastine tablets in the treatment of chronic idiopathic urticaria. Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trialSkin Pharmacol Appl Skin Physiol20015778610.1159/00005633711316966, CamarasaJMAliagaAFernández-VozmedianoJMFonsecaEIglesiasLTagarroIAzelastine tablets in the treatment of chronic idiopathic urticaria. Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trialSkin Pharmacol Appl Skin Physiol20015778610.1159/00005633711316966
(KozelMMBossuytPMMekkesJRBosJDLaboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic reviewJ Am Acad Dermatol2003540941610.1067/mjd.2003.14212637921)
KozelMMBossuytPMMekkesJRBosJDLaboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic reviewJ Am Acad Dermatol2003540941610.1067/mjd.2003.14212637921KozelMMBossuytPMMekkesJRBosJDLaboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic reviewJ Am Acad Dermatol2003540941610.1067/mjd.2003.14212637921, KozelMMBossuytPMMekkesJRBosJDLaboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic reviewJ Am Acad Dermatol2003540941610.1067/mjd.2003.14212637921
R. Asero (2006)
Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above‐licensed dosesClinical and Experimental Dermatology, 32
Bruce Thiers, Vincent Beltrani (1996)
Urticaria and angioedema.Dermatologic clinics, 14 1
(BaiardiniIGiardiniAPasqualiMDignettiPGuerraLQuality of life and patients' satisfaction in chronic urticaria and respiratory allergyAllergy2003562162310.1034/j.1398-9995.2003.00091.x12823121)
BaiardiniIGiardiniAPasqualiMDignettiPGuerraLQuality of life and patients' satisfaction in chronic urticaria and respiratory allergyAllergy2003562162310.1034/j.1398-9995.2003.00091.x12823121BaiardiniIGiardiniAPasqualiMDignettiPGuerraLQuality of life and patients' satisfaction in chronic urticaria and respiratory allergyAllergy2003562162310.1034/j.1398-9995.2003.00091.x12823121, BaiardiniIGiardiniAPasqualiMDignettiPGuerraLQuality of life and patients' satisfaction in chronic urticaria and respiratory allergyAllergy2003562162310.1034/j.1398-9995.2003.00091.x12823121
(DeLongLKCullerSDSainiSSBeckLAChenSCAnnual direct and indirect health care costs of chronic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patientsArch Dermatol20085353910.1001/archdermatol.2007.518209166)
DeLongLKCullerSDSainiSSBeckLAChenSCAnnual direct and indirect health care costs of chronic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patientsArch Dermatol20085353910.1001/archdermatol.2007.518209166DeLongLKCullerSDSainiSSBeckLAChenSCAnnual direct and indirect health care costs of chronic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patientsArch Dermatol20085353910.1001/archdermatol.2007.518209166, DeLongLKCullerSDSainiSSBeckLAChenSCAnnual direct and indirect health care costs of chronic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patientsArch Dermatol20085353910.1001/archdermatol.2007.518209166
(BoehmIBauerRBieberTUrticaria treated with dapsoneAllergy1999576576610442538)
BoehmIBauerRBieberTUrticaria treated with dapsoneAllergy1999576576610442538BoehmIBauerRBieberTUrticaria treated with dapsoneAllergy1999576576610442538, BoehmIBauerRBieberTUrticaria treated with dapsoneAllergy1999576576610442538
E. Kocatürk, K. Weller, P. Martus, Selin Aktaş, M. Kavala, Sukran Sarigul, I. Baiardini, G. Canonica, Z. Brzoza, D. Kalogeromitros, M. Maurer (2012)
Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.Acta dermato-venereologica, 92 4
D. Patrick, L. Burke, J. Powers, Jane Scott, E. Rock, Sahar Dawisha, R. O'neill, D. Kennedy (2007)
Patient-reported outcomes to support medical product labeling claims: FDA perspective.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 10 Suppl 2
G. Guyatt, A. Oxman, G. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, H. Schünemann (2008)
GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ : British Medical Journal, 336
(PerezAWoodsAGrattanCEMethotrexate: a useful steroid-sparing agent in recalcitrant chronic urticariaBr J Dermatol2010519119410.1111/j.1365-2133.2009.09538.x19903174)
PerezAWoodsAGrattanCEMethotrexate: a useful steroid-sparing agent in recalcitrant chronic urticariaBr J Dermatol2010519119410.1111/j.1365-2133.2009.09538.x19903174PerezAWoodsAGrattanCEMethotrexate: a useful steroid-sparing agent in recalcitrant chronic urticariaBr J Dermatol2010519119410.1111/j.1365-2133.2009.09538.x19903174, PerezAWoodsAGrattanCEMethotrexate: a useful steroid-sparing agent in recalcitrant chronic urticariaBr J Dermatol2010519119410.1111/j.1365-2133.2009.09538.x19903174
(2005)
European Medicines Agency Web site
(LeznoffAJosseRDenburgJDolovichJAssociation of chronic urticaria and angioedema with thyroid autoimmunityArch Dermatol1983563664010.1001/archderm.1983.016503200100076870316)
LeznoffAJosseRDenburgJDolovichJAssociation of chronic urticaria and angioedema with thyroid autoimmunityArch Dermatol1983563664010.1001/archderm.1983.016503200100076870316LeznoffAJosseRDenburgJDolovichJAssociation of chronic urticaria and angioedema with thyroid autoimmunityArch Dermatol1983563664010.1001/archderm.1983.016503200100076870316, LeznoffAJosseRDenburgJDolovichJAssociation of chronic urticaria and angioedema with thyroid autoimmunityArch Dermatol1983563664010.1001/archderm.1983.016503200100076870316
(WongHAcute urticariaWorld Allergy Org J2007S162)
WongHAcute urticariaWorld Allergy Org J2007S162WongHAcute urticariaWorld Allergy Org J2007S162, WongHAcute urticariaWorld Allergy Org J2007S162
A. Zimmerman, E. Berger, S. Elmariah, N. Soter (2012)
The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.Journal of the American Academy of Dermatology, 66 5
(2012)
Prednisone inhibits the appearance of inflammatory Sánchez-Borges et al WAO Journal November 2012
(ReinischJMSimonNGKarowWGGandelmanRPrenatal exposure to prednisone in humans and animals retards intrauterine growthScience1978543643810.1126/science.705336705336)
ReinischJMSimonNGKarowWGGandelmanRPrenatal exposure to prednisone in humans and animals retards intrauterine growthScience1978543643810.1126/science.705336705336ReinischJMSimonNGKarowWGGandelmanRPrenatal exposure to prednisone in humans and animals retards intrauterine growthScience1978543643810.1126/science.705336705336, ReinischJMSimonNGKarowWGGandelmanRPrenatal exposure to prednisone in humans and animals retards intrauterine growthScience1978543643810.1126/science.705336705336
(WellerKAltrichterSArdeleanEKrauseKMagerlMChronic urticaria. Prevalence, course, prognostic factors and impactHautarzt2010575075710.1007/s00105-010-1933-820694454)
WellerKAltrichterSArdeleanEKrauseKMagerlMChronic urticaria. Prevalence, course, prognostic factors and impactHautarzt2010575075710.1007/s00105-010-1933-820694454WellerKAltrichterSArdeleanEKrauseKMagerlMChronic urticaria. Prevalence, course, prognostic factors and impactHautarzt2010575075710.1007/s00105-010-1933-820694454, WellerKAltrichterSArdeleanEKrauseKMagerlMChronic urticaria. Prevalence, course, prognostic factors and impactHautarzt2010575075710.1007/s00105-010-1933-820694454
(MagerlMBorzovaEGimenez-ArnauAGrattanCELawlorFThe definition and diagnostic testing of physical and cholinergic urti-carias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendationsAllergy200951715172110.1111/j.1398-9995.2009.02177.x19793059)
MagerlMBorzovaEGimenez-ArnauAGrattanCELawlorFThe definition and diagnostic testing of physical and cholinergic urti-carias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendationsAllergy200951715172110.1111/j.1398-9995.2009.02177.x19793059MagerlMBorzovaEGimenez-ArnauAGrattanCELawlorFThe definition and diagnostic testing of physical and cholinergic urti-carias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendationsAllergy200951715172110.1111/j.1398-9995.2009.02177.x19793059, MagerlMBorzovaEGimenez-ArnauAGrattanCELawlorFThe definition and diagnostic testing of physical and cholinergic urti-carias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendationsAllergy200951715172110.1111/j.1398-9995.2009.02177.x19793059
Bengt Källén (2002)
Use of antihistamine drugs in early pregnancy and delivery outcomeThe Journal of Maternal-Fetal & Neonatal Medicine, 11
M. Greaves, V. Plummer, P. Mclaughlan, D. Stanworth (1974)
Serum and cell bound IgE in chronic urticariaClinical & Experimental Allergy, 4
(SimonsFEH1 antihistamine treatment in young atopic children: effect on urticariaAnn Allergy Asthma Immunol2007526126610.1016/S1081-1206(10)60662-X17910330)
SimonsFEH1 antihistamine treatment in young atopic children: effect on urticariaAnn Allergy Asthma Immunol2007526126610.1016/S1081-1206(10)60662-X17910330SimonsFEH1 antihistamine treatment in young atopic children: effect on urticariaAnn Allergy Asthma Immunol2007526126610.1016/S1081-1206(10)60662-X17910330, SimonsFEH1 antihistamine treatment in young atopic children: effect on urticariaAnn Allergy Asthma Immunol2007526126610.1016/S1081-1206(10)60662-X17910330
C. Ferreli, A. Pinna, L. Atzori, N. Aste (1999)
Eosinophilic cellulitis (Wells' syndrome): a new case descriptionJournal of the European Academy of Dermatology and Venereology, 13
(KhanDChronic urticaria: diagnosis and managementAllergy Asthma Proc2008543944610.2500/aap.2008.29.315118926051)
KhanDChronic urticaria: diagnosis and managementAllergy Asthma Proc2008543944610.2500/aap.2008.29.315118926051KhanDChronic urticaria: diagnosis and managementAllergy Asthma Proc2008543944610.2500/aap.2008.29.315118926051, KhanDChronic urticaria: diagnosis and managementAllergy Asthma Proc2008543944610.2500/aap.2008.29.315118926051
V. Legrain, A. Taïeb, T. Sage, J. Maleville (1990)
Urticaria in Infants: A Study of Forty PatientsPediatric Dermatology, 7
(SabroeRAGreavesMWChronic idiopathic urticaria with functional autoantibodies: 12 years onBr J Dermatol2006581381910.1111/j.1365-2133.2006.07183.x16634880)
SabroeRAGreavesMWChronic idiopathic urticaria with functional autoantibodies: 12 years onBr J Dermatol2006581381910.1111/j.1365-2133.2006.07183.x16634880SabroeRAGreavesMWChronic idiopathic urticaria with functional autoantibodies: 12 years onBr J Dermatol2006581381910.1111/j.1365-2133.2006.07183.x16634880, SabroeRAGreavesMWChronic idiopathic urticaria with functional autoantibodies: 12 years onBr J Dermatol2006581381910.1111/j.1365-2133.2006.07183.x16634880
McConnell Dj (1976)
Urticaria and angioedema.Cutis, 17 6
(DoshiDRWeinbergerMMExperience with cyclosporine in children with chronic idiopathic urticariaPediatr Dermatol2009540941310.1111/j.1525-1470.2009.00869.x19689515)
DoshiDRWeinbergerMMExperience with cyclosporine in children with chronic idiopathic urticariaPediatr Dermatol2009540941310.1111/j.1525-1470.2009.00869.x19689515DoshiDRWeinbergerMMExperience with cyclosporine in children with chronic idiopathic urticariaPediatr Dermatol2009540941310.1111/j.1525-1470.2009.00869.x19689515, DoshiDRWeinbergerMMExperience with cyclosporine in children with chronic idiopathic urticariaPediatr Dermatol2009540941310.1111/j.1525-1470.2009.00869.x19689515
(KaplanAPWhat the first 10,000 patients with chronic urticaria have taught me. A personal journeyJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615)
KaplanAPWhat the first 10,000 patients with chronic urticaria have taught me. A personal journeyJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615KaplanAPWhat the first 10,000 patients with chronic urticaria have taught me. A personal journeyJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615, KaplanAPWhat the first 10,000 patients with chronic urticaria have taught me. A personal journeyJ Allergy Clin Immunol2009571371710.1016/j.jaci.2008.10.05019081615
(GreavesMChronic urticariaJ Allergy Clin Immunol2000566467210.1067/mai.2000.10570610756214)
GreavesMChronic urticariaJ Allergy Clin Immunol2000566467210.1067/mai.2000.10570610756214GreavesMChronic urticariaJ Allergy Clin Immunol2000566467210.1067/mai.2000.10570610756214, GreavesMChronic urticariaJ Allergy Clin Immunol2000566467210.1067/mai.2000.10570610756214
(van der ValkPGMoretGThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol20035110113)
van der ValkPGMoretGThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol20035110113van der ValkPGMoretGThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol20035110113, van der ValkPGMoretGThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol20035110113
M. Greaves (2002)
Pathophysiology of Chronic UrticariaInternational Archives of Allergy and Immunology, 127
(GodseKVOmalizumab in severe chronic urticariaIndian J Dermatol Venereol Leprol2008515715818388382)
GodseKVOmalizumab in severe chronic urticariaIndian J Dermatol Venereol Leprol2008515715818388382GodseKVOmalizumab in severe chronic urticariaIndian J Dermatol Venereol Leprol2008515715818388382, GodseKVOmalizumab in severe chronic urticariaIndian J Dermatol Venereol Leprol2008515715818388382
(LindelöfBSigurgeirssonBWahlgrenCFEklundGChronic urticaria and cancer: an epidemiological study of 1155 patientsBr J Dermatol199054534562095176)
LindelöfBSigurgeirssonBWahlgrenCFEklundGChronic urticaria and cancer: an epidemiological study of 1155 patientsBr J Dermatol199054534562095176LindelöfBSigurgeirssonBWahlgrenCFEklundGChronic urticaria and cancer: an epidemiological study of 1155 patientsBr J Dermatol199054534562095176, LindelöfBSigurgeirssonBWahlgrenCFEklundGChronic urticaria and cancer: an epidemiological study of 1155 patientsBr J Dermatol199054534562095176
(TuchindaMSrimurutaNAbananandaSVareenilJAssatherawattsAUrticaria in Thai childrenAsian Pac J Allergy Immunol1986541452873823)
TuchindaMSrimurutaNAbananandaSVareenilJAssatherawattsAUrticaria in Thai childrenAsian Pac J Allergy Immunol1986541452873823TuchindaMSrimurutaNAbananandaSVareenilJAssatherawattsAUrticaria in Thai childrenAsian Pac J Allergy Immunol1986541452873823, TuchindaMSrimurutaNAbananandaSVareenilJAssatherawattsAUrticaria in Thai childrenAsian Pac J Allergy Immunol1986541452873823
M. Kowalski, J. Makowska, M. Blanca, S. Bavbek, G. Bochenek, J. Bousquet, P. Bousquet, G. Celik, P. Demoly, E. Gomes, E. Nizankowska-Mogilnicka, A. Romano, M. Sánchez-Borges, M. Sanz, Marta Torres, A. Weck, A. Szczeklik, K. Brockow (2011)
Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA # and GA2LEN/HANNA *Allergy, 66
A. Leznoff, R. Josse, J. Denburg, J. Dolovich (1983)
Association of chronic urticaria and angioedema with thyroid autoimmunity.Archives of dermatology, 119 8
J. Eckman, P. Sterba, D. Kelly, V. Alexander, M. Liu, B. Bochner, D. MacGlashan, S. Saini (2009)
Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.The Journal of allergy and clinical immunology, 125 4
(ArdizzoneSBianchi PorroGComparative tolerability of therapies for ulcerative colitisDrug Saf2002556158210.2165/00002018-200225080-0000312113642)
ArdizzoneSBianchi PorroGComparative tolerability of therapies for ulcerative colitisDrug Saf2002556158210.2165/00002018-200225080-0000312113642ArdizzoneSBianchi PorroGComparative tolerability of therapies for ulcerative colitisDrug Saf2002556158210.2165/00002018-200225080-0000312113642, ArdizzoneSBianchi PorroGComparative tolerability of therapies for ulcerative colitisDrug Saf2002556158210.2165/00002018-200225080-0000312113642
F. Simons (2007)
H1-antihistamine treatment in young atopic children: effect on urticaria.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 99 3
A. Reimers, C. Pichler, A. Helbling, W. Pichler, N. Yawalkar (2002)
Zafirlukast has no beneficial effects in the treatment of chronic urticariaClinical & Experimental Allergy, 32
MK Church (2011)
Inflamm Res
(MarmorMFKellnerULaiTYLyonsJSMielerWFAmerican Academy of OphthalmologyRevised recommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology2011541542210.1016/j.ophtha.2010.11.01721292109)
MarmorMFKellnerULaiTYLyonsJSMielerWFAmerican Academy of OphthalmologyRevised recommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology2011541542210.1016/j.ophtha.2010.11.01721292109MarmorMFKellnerULaiTYLyonsJSMielerWFAmerican Academy of OphthalmologyRevised recommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology2011541542210.1016/j.ophtha.2010.11.01721292109, MarmorMFKellnerULaiTYLyonsJSMielerWFAmerican Academy of OphthalmologyRevised recommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology2011541542210.1016/j.ophtha.2010.11.01721292109
D. Nurse (1968)
Prurigo of PregnancyAustralasian Journal of Dermatology, 9
E. Toubi, A. Kessel, N. Avshovich, E. Bamberger, E. Sabo, D. Nusem, J. Panasoff (2004)
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patientsAllergy, 59
(McGirtLYVasagarKGoberLMSainiSSBeckLASuccessful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazineArch Dermatol200651337134210.1001/archderm.142.10.133717043190)
McGirtLYVasagarKGoberLMSainiSSBeckLASuccessful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazineArch Dermatol200651337134210.1001/archderm.142.10.133717043190McGirtLYVasagarKGoberLMSainiSSBeckLASuccessful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazineArch Dermatol200651337134210.1001/archderm.142.10.133717043190, McGirtLYVasagarKGoberLMSainiSSBeckLASuccessful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazineArch Dermatol200651337134210.1001/archderm.142.10.133717043190
(EnglerRJSquireEBensonPChronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedemaAnn Allergy Asthma Immunol199551551597697475)
EnglerRJSquireEBensonPChronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedemaAnn Allergy Asthma Immunol199551551597697475EnglerRJSquireEBensonPChronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedemaAnn Allergy Asthma Immunol199551551597697475, EnglerRJSquireEBensonPChronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedemaAnn Allergy Asthma Immunol199551551597697475
E. Luquin, A. Kaplan, Marta Ferrer (2005)
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo‐responsiveness to other stimuliClinical & Experimental Allergy, 35
(BagenstoseSELevinLBernsteinJAThe addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test resultsJ Allergy Clin Immunol2004513414010.1016/j.jaci.2003.10.00214713918)
BagenstoseSELevinLBernsteinJAThe addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test resultsJ Allergy Clin Immunol2004513414010.1016/j.jaci.2003.10.00214713918BagenstoseSELevinLBernsteinJAThe addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test resultsJ Allergy Clin Immunol2004513414010.1016/j.jaci.2003.10.00214713918, BagenstoseSELevinLBernsteinJAThe addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test resultsJ Allergy Clin Immunol2004513414010.1016/j.jaci.2003.10.00214713918
F. Simons (2001)
Prevention of acute urticaria in young children with atopic dermatitis.The Journal of allergy and clinical immunology, 107 4
S. Bagenstose, L. Levin, J. Bernstein (2004)
The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.The Journal of allergy and clinical immunology, 113 1
(BleehenSSThomasSEGreavesMWNewtonJKennedyCTCimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind studyBr J Dermatol1987581883307890)
BleehenSSThomasSEGreavesMWNewtonJKennedyCTCimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind studyBr J Dermatol1987581883307890BleehenSSThomasSEGreavesMWNewtonJKennedyCTCimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind studyBr J Dermatol1987581883307890, BleehenSSThomasSEGreavesMWNewtonJKennedyCTCimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind studyBr J Dermatol1987581883307890
(RobertEVollsetSEBottoLMalformation surveillance and maternal drug exposure: the MADRE projectRisk Safety Med1994575)
RobertEVollsetSEBottoLMalformation surveillance and maternal drug exposure: the MADRE projectRisk Safety Med1994575RobertEVollsetSEBottoLMalformation surveillance and maternal drug exposure: the MADRE projectRisk Safety Med1994575, RobertEVollsetSEBottoLMalformation surveillance and maternal drug exposure: the MADRE projectRisk Safety Med1994575
(BaiardiniIBousquetPJBrzozaZCanonicaGWCompalatiERecommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paperAllergy2010529029510.1111/j.1398-9995.2009.02263.x19930232)
BaiardiniIBousquetPJBrzozaZCanonicaGWCompalatiERecommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paperAllergy2010529029510.1111/j.1398-9995.2009.02263.x19930232BaiardiniIBousquetPJBrzozaZCanonicaGWCompalatiERecommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paperAllergy2010529029510.1111/j.1398-9995.2009.02263.x19930232, BaiardiniIBousquetPJBrzozaZCanonicaGWCompalatiERecommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paperAllergy2010529029510.1111/j.1398-9995.2009.02263.x19930232
(GoberLMSterbaPMEckmanJASainiSSEffect of anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patientsJ Allergy Clin Immunol20085supplS147)
GoberLMSterbaPMEckmanJASainiSSEffect of anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patientsJ Allergy Clin Immunol20085supplS147GoberLMSterbaPMEckmanJASainiSSEffect of anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patientsJ Allergy Clin Immunol20085supplS147, GoberLMSterbaPMEckmanJASainiSSEffect of anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patientsJ Allergy Clin Immunol20085supplS147
M. Magerl, E. Borzova, A. Giménez-Arnau, C. Grattan, F. Lawlor, P. Mathelier-Fusade, M. Metz, A. Młynek, M. Maurer (2009)
The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendationsAllergy, 64
A. Giménez-Arnau, R. Pujol, S. Ianoși, A. Kaszuba, A. Malbrán, G. Poop, E. Donado, I. Pérez, I. Izquierdo, E. Arnáiz (2007)
Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre studyAllergy, 62
J. Hilbert, E. Radwanski, M. Affrime, G. Perentesis, S. Symchowicz, N. Zampaglione (1988)
Excretion of Loratadine in Human Breast MilkThe Journal of Clinical Pharmacology, 28
(SainiSSPaternitiMVasagarKGibbonsSPJrSterbaPMCultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2Clin Immunol2009534234810.1016/j.clim.2009.05.00319477690)
SainiSSPaternitiMVasagarKGibbonsSPJrSterbaPMCultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2Clin Immunol2009534234810.1016/j.clim.2009.05.00319477690SainiSSPaternitiMVasagarKGibbonsSPJrSterbaPMCultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2Clin Immunol2009534234810.1016/j.clim.2009.05.00319477690, SainiSSPaternitiMVasagarKGibbonsSPJrSterbaPMCultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2Clin Immunol2009534234810.1016/j.clim.2009.05.00319477690
(BrenemanDLCetirizine versus hydroxyzine and placebo in chronic idiopathic urticariaAnn Pharmacother19965107510798893110)
BrenemanDLCetirizine versus hydroxyzine and placebo in chronic idiopathic urticariaAnn Pharmacother19965107510798893110BrenemanDLCetirizine versus hydroxyzine and placebo in chronic idiopathic urticariaAnn Pharmacother19965107510798893110, BrenemanDLCetirizine versus hydroxyzine and placebo in chronic idiopathic urticariaAnn Pharmacother19965107510798893110
M. Chren, M. Chren, R. Lasek, S. Flocke, S. Zyzanski (1997)
Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.Archives of dermatology, 133 11
(MarmorMFCarrREEasterbrookMFarjoAAMielerWFAmerican Academy of OphthalmologyRecommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of OphthalmologyOphthalmology200251377138210.1016/S0161-6420(02)01168-512093666)
MarmorMFCarrREEasterbrookMFarjoAAMielerWFAmerican Academy of OphthalmologyRecommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of OphthalmologyOphthalmology200251377138210.1016/S0161-6420(02)01168-512093666MarmorMFCarrREEasterbrookMFarjoAAMielerWFAmerican Academy of OphthalmologyRecommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of OphthalmologyOphthalmology200251377138210.1016/S0161-6420(02)01168-512093666, MarmorMFCarrREEasterbrookMFarjoAAMielerWFAmerican Academy of OphthalmologyRecommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of OphthalmologyOphthalmology200251377138210.1016/S0161-6420(02)01168-512093666
(VonakisBMVasagarKGibbonsJGoberSCLSterbaPBasophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticariaJ Allergy Clin Immunol2007544144810.1016/j.jaci.2006.09.03517125820)
VonakisBMVasagarKGibbonsJGoberSCLSterbaPBasophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticariaJ Allergy Clin Immunol2007544144810.1016/j.jaci.2006.09.03517125820VonakisBMVasagarKGibbonsJGoberSCLSterbaPBasophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticariaJ Allergy Clin Immunol2007544144810.1016/j.jaci.2006.09.03517125820, VonakisBMVasagarKGibbonsJGoberSCLSterbaPBasophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticariaJ Allergy Clin Immunol2007544144810.1016/j.jaci.2006.09.03517125820
(HartmannKHaniNHinrichsRHunzelmannNScharffetter-KochanekKSuccessful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticariaActa Derm Venereol200157110.1080/00015550175020834411411930)
HartmannKHaniNHinrichsRHunzelmannNScharffetter-KochanekKSuccessful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticariaActa Derm Venereol200157110.1080/00015550175020834411411930HartmannKHaniNHinrichsRHunzelmannNScharffetter-KochanekKSuccessful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticariaActa Derm Venereol200157110.1080/00015550175020834411411930, HartmannKHaniNHinrichsRHunzelmannNScharffetter-KochanekKSuccessful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticariaActa Derm Venereol200157110.1080/00015550175020834411411930
A. Giannetti, S. Seidenari, M. Mosca, M. Cespa, R. Pericoli, M. Zavatarelli (1984)
[Chronic urticaria. I].Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 119 2
M. Ferrer, P. Gamboa, M. Sanz, M. Goikoetxea, P. Cabrera-Freitag, G. Javaloyes, F. Berroa, A. Kaplan (2011)
Omalizumab is effective in nonautoimmune urticaria.The Journal of allergy and clinical immunology, 127 5
D. Wetter, M. Davis, J. Yiannias, L. Gibson, M. Dahl, R. El-Azhary, A. Bruce, D. Lookingbill, I. Ahmed, A. Schroeter, M. Pittelkow (2005)
Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience.Mayo Clinic proceedings, 80 1
Y. Levy, N. Segal, N. Weintrob, Y. Danon (2003)
Chronic urticaria: association with thyroid autoimmunityArchives of Disease in Childhood, 88
C. Grattan, G. Dawn, S. Gibbs, D. Francis (2003)
Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activityClinical & Experimental Allergy, 33
M. Greaves (2000)
Chronic urticaria in childhoodAllergy, 55
(CriadoRFCriadoPRMartinsJEValenteNYMichalanyNSVasconcellosCUrticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic featuresJ Dermatolog Treat20085929610.1080/0954663070149930918484427)
CriadoRFCriadoPRMartinsJEValenteNYMichalanyNSVasconcellosCUrticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic featuresJ Dermatolog Treat20085929610.1080/0954663070149930918484427CriadoRFCriadoPRMartinsJEValenteNYMichalanyNSVasconcellosCUrticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic featuresJ Dermatolog Treat20085929610.1080/0954663070149930918484427, CriadoRFCriadoPRMartinsJEValenteNYMichalanyNSVasconcellosCUrticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic featuresJ Dermatolog Treat20085929610.1080/0954663070149930918484427
A. Kaplan, J. Garofalo, R. Sigler, T. Hauber (1981)
Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies.The New England journal of medicine, 305 18
(ChakravartyKMcDonaldHPullarTTaggartAChalmersRBSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of DermatologistsRheumatology2008592492510.1093/rheumatology/kel216a16940305)
ChakravartyKMcDonaldHPullarTTaggartAChalmersRBSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of DermatologistsRheumatology2008592492510.1093/rheumatology/kel216a16940305ChakravartyKMcDonaldHPullarTTaggartAChalmersRBSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of DermatologistsRheumatology2008592492510.1093/rheumatology/kel216a16940305, ChakravartyKMcDonaldHPullarTTaggartAChalmersRBSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of DermatologistsRheumatology2008592492510.1093/rheumatology/kel216a16940305
R. Asherson, N. Buchanan, S. Kenwright, C. Fletcher, G. Hughes (1991)
The normocomplementemic urticarial vasculitis syndrome‐report of a case and response to colchicineClinical and Experimental Dermatology, 16
A. Zaidi, S. Saini, D. MacGlashan (2010)
Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.The Journal of allergy and clinical immunology, 125 4
L. Caminiti, G. Passalacqua, G. Magazzù, F. Comisi, D. Vita, G. Barberio, C. Sferlazzas, G. Pajno (2005)
Chronic urticaria and associated coeliac disease in children: A case–control studyPediatric Allergy and Immunology, 16
(SpectorSLTanRAEffect of omalizumab on patients with chronic urticariaAnn Allergy Asthma Immunol2007519019310.1016/S1081-1206(10)60644-817718108)
SpectorSLTanRAEffect of omalizumab on patients with chronic urticariaAnn Allergy Asthma Immunol2007519019310.1016/S1081-1206(10)60644-817718108SpectorSLTanRAEffect of omalizumab on patients with chronic urticariaAnn Allergy Asthma Immunol2007519019310.1016/S1081-1206(10)60644-817718108, SpectorSLTanRAEffect of omalizumab on patients with chronic urticariaAnn Allergy Asthma Immunol2007519019310.1016/S1081-1206(10)60644-817718108
(VasconcelosCXavierPVieiraAPMartinhoMRodriguesJAutoimmune progesterone urticariaGynecol Endocrinol2000524524710.3109/0951359000916768811075293)
VasconcelosCXavierPVieiraAPMartinhoMRodriguesJAutoimmune progesterone urticariaGynecol Endocrinol2000524524710.3109/0951359000916768811075293VasconcelosCXavierPVieiraAPMartinhoMRodriguesJAutoimmune progesterone urticariaGynecol Endocrinol2000524524710.3109/0951359000916768811075293, VasconcelosCXavierPVieiraAPMartinhoMRodriguesJAutoimmune progesterone urticariaGynecol Endocrinol2000524524710.3109/0951359000916768811075293
N. Soter (1991)
Acute and chronic urticaria and angioedema.Journal of the American Academy of Dermatology, 25 1 Pt 2
(MaurerMAltrichterSBieberTBiedermannTBräutigamMEfficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJ Allergy Clin Immunol2011520220910.1016/j.jaci.2011.04.03821636116)
MaurerMAltrichterSBieberTBiedermannTBräutigamMEfficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJ Allergy Clin Immunol2011520220910.1016/j.jaci.2011.04.03821636116MaurerMAltrichterSBieberTBiedermannTBräutigamMEfficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJ Allergy Clin Immunol2011520220910.1016/j.jaci.2011.04.03821636116, MaurerMAltrichterSBieberTBiedermannTBräutigamMEfficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJ Allergy Clin Immunol2011520220910.1016/j.jaci.2011.04.03821636116
(ThompsonAKFinnAFSchoenwetterWFEffect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticariaJ Am Acad Dermatol20005243010.1067/mjd.2000.10468010863219)
ThompsonAKFinnAFSchoenwetterWFEffect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticariaJ Am Acad Dermatol20005243010.1067/mjd.2000.10468010863219ThompsonAKFinnAFSchoenwetterWFEffect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticariaJ Am Acad Dermatol20005243010.1067/mjd.2000.10468010863219, ThompsonAKFinnAFSchoenwetterWFEffect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticariaJ Am Acad Dermatol20005243010.1067/mjd.2000.10468010863219
(Gimenez-ArnauAPujolRMIanosiSMalbranAPoopGRuptatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre studyAllergy2007553954610.1111/j.1398-9995.2007.01330.x17441794)
Gimenez-ArnauAPujolRMIanosiSMalbranAPoopGRuptatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre studyAllergy2007553954610.1111/j.1398-9995.2007.01330.x17441794Gimenez-ArnauAPujolRMIanosiSMalbranAPoopGRuptatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre studyAllergy2007553954610.1111/j.1398-9995.2007.01330.x17441794, Gimenez-ArnauAPujolRMIanosiSMalbranAPoopGRuptatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre studyAllergy2007553954610.1111/j.1398-9995.2007.01330.x17441794
R. Sabroe, D. Francis, R. Barr, A. Black, M. Greaves (1998)
Anti-FcϵRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria☆☆☆★★★♢The Journal of Allergy and Clinical Immunology, 102
(ChrenMMLasekRJFlockeSAZysanskiSJImproved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrumet for patients with skin diseasesArch Dermatol199751433144010.1001/archderm.1997.038904701110189371029)
ChrenMMLasekRJFlockeSAZysanskiSJImproved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrumet for patients with skin diseasesArch Dermatol199751433144010.1001/archderm.1997.038904701110189371029ChrenMMLasekRJFlockeSAZysanskiSJImproved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrumet for patients with skin diseasesArch Dermatol199751433144010.1001/archderm.1997.038904701110189371029, ChrenMMLasekRJFlockeSAZysanskiSJImproved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrumet for patients with skin diseasesArch Dermatol199751433144010.1001/archderm.1997.038904701110189371029
S Varadarajulu (2005)
Urticaria and angioedema. Controlling acute episodes, coping with chronic casesPostgrad Med, 117
(HandaSDograSKumarBComparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticariaJ Dermatolog Treat20045555710.1080/0954663031001345014754652)
HandaSDograSKumarBComparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticariaJ Dermatolog Treat20045555710.1080/0954663031001345014754652HandaSDograSKumarBComparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticariaJ Dermatolog Treat20045555710.1080/0954663031001345014754652, HandaSDograSKumarBComparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticariaJ Dermatolog Treat20045555710.1080/0954663031001345014754652
J. Lee, Teck-Hiong Loh, S. Seow, S. Tan (2007)
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.Journal of the American Academy of Dermatology, 56 6
G. Sharpe, S. Shuster (1993)
In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists aloneBritish Journal of Dermatology, 129
M. Ferrer, E. Luquin, A. Sánchez-Ibarrola, Cristina Moreno, M. Sanz, A. Kaplan (2002)
Secretion of Cytokines, Histamine and Leukotrienes in Chronic UrticariaInternational Archives of Allergy and Immunology, 129
LR Lopez, KC Davis, PF Kohler, AL Shocket (1984)
The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxy-chloroquineJ Allergy CIin Immunol, 73
M. Staevska, Todor Popov, T. Kralimarkova, C. Lazarova, S. Kraeva, D. Popova, D. Church, V. Dimitrov, M. Church (2010)
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.The Journal of allergy and clinical immunology, 125 3
(FradinMSEllisCNGoldfarbMTVoorheesJJOral cyclosporine for severe chronic idiopathic urticaria and angioedemaJ Am Acad Dermatol199151065106710.1016/0190-9622(91)70308-O1810983)
FradinMSEllisCNGoldfarbMTVoorheesJJOral cyclosporine for severe chronic idiopathic urticaria and angioedemaJ Am Acad Dermatol199151065106710.1016/0190-9622(91)70308-O1810983FradinMSEllisCNGoldfarbMTVoorheesJJOral cyclosporine for severe chronic idiopathic urticaria and angioedemaJ Am Acad Dermatol199151065106710.1016/0190-9622(91)70308-O1810983, FradinMSEllisCNGoldfarbMTVoorheesJJOral cyclosporine for severe chronic idiopathic urticaria and angioedemaJ Am Acad Dermatol199151065106710.1016/0190-9622(91)70308-O1810983
B. O'donnell, F. Lawlor, J. Simpson, M. Morgan, M. Greaves (1997)
The impact of chronic urticaria on the quality of lifeBritish Journal of Dermatology, 136
Tomohiro Takeda, Y. Sakurai, S. Takahagi, J. Kato, Koichi Yoshida, A. Yoshioka, M. Hide, M. Shima (2011)
Increase of coagulation potential in chronic spontaneous urticariaAllergy, 66
J. Jolinière, S. Sananes, M. Canis, M. Levardon, Jean-Bernard Dubuisson, Jacques Donnez (1992)
Role of gonadotrophin-releasing hormone agonists in the treatment of external genital endometriosis: review of 77 cases.Clinical therapeutics, 14 Suppl A
(NelsonHSReynoldsRMasonJFexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnn Allergy Asthma Immunol2000551752210.1016/S1081-1206(10)62515-X10831005)
NelsonHSReynoldsRMasonJFexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnn Allergy Asthma Immunol2000551752210.1016/S1081-1206(10)62515-X10831005NelsonHSReynoldsRMasonJFexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnn Allergy Asthma Immunol2000551752210.1016/S1081-1206(10)62515-X10831005, NelsonHSReynoldsRMasonJFexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnn Allergy Asthma Immunol2000551752210.1016/S1081-1206(10)62515-X10831005
S. Wolverton, K. Remlinger (2007)
Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugs.Dermatologic clinics, 25 2
R. Sabroe, M. Greaves (2006)
Chronic idiopathic urticaria with functional autoantibodies: 12 years onBritish Journal of Dermatology, 154
(KesselAToubiECyclosporine-A in severe chronic urticaria: the option for long-term therapyAllergy201051478148210.1111/j.1398-9995.2010.02419.x20626384)
KesselAToubiECyclosporine-A in severe chronic urticaria: the option for long-term therapyAllergy201051478148210.1111/j.1398-9995.2010.02419.x20626384KesselAToubiECyclosporine-A in severe chronic urticaria: the option for long-term therapyAllergy201051478148210.1111/j.1398-9995.2010.02419.x20626384, KesselAToubiECyclosporine-A in severe chronic urticaria: the option for long-term therapyAllergy201051478148210.1111/j.1398-9995.2010.02419.x20626384
M. Kang, Hei Kim, Hyung Kim, Y. Park (2009)
The impact of chronic idiopathic urticaria on quality of life in korean patients.Annals of dermatology, 21 3
K. Chakravarty, H. Mcdonald, T. Pullar, A. Taggart, R. Chalmers, S. Oliver, J. Mooney, M. Somerville, A. Bosworth, T. Kennedy (2008)
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.Rheumatology, 47 6
V Legrain, A Taieb, T Sage, J Maleville (1990)
Urticaria in infants: a study of 40 patientsPaediatric Dermatol, 7
J. Bernstein, Stephen Garramone, Elise Lower (2002)
Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 89 2
A. Leznoff, G. Sussman (1989)
Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients.The Journal of allergy and clinical immunology, 84 1
B. Vonakis, S. Saini (2008)
New concepts in chronic urticaria.Current opinion in immunology, 20 6
R. Asero, A. Tedeschi, R. Coppola, S. Griffini, P. Paparella, P. Riboldi, A. Marzano, D. Fanoni, M. Cugno (2007)
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.The Journal of allergy and clinical immunology, 119 3
(ShamsiZHindmarchISedation and antihistamines: a review of inter-drug differences using proportional impairment ratiosHum Psychopharmacol20005suppl 1S3S3012404608)
ShamsiZHindmarchISedation and antihistamines: a review of inter-drug differences using proportional impairment ratiosHum Psychopharmacol20005suppl 1S3S3012404608ShamsiZHindmarchISedation and antihistamines: a review of inter-drug differences using proportional impairment ratiosHum Psychopharmacol20005suppl 1S3S3012404608, ShamsiZHindmarchISedation and antihistamines: a review of inter-drug differences using proportional impairment ratiosHum Psychopharmacol20005suppl 1S3S3012404608
(KloteMMNelsonMREnglerRJAutoimmune urticaria response to high-dose intravenous immunoglobulinAnn Allergy Asthma Immunol2005530730810.1016/S1081-1206(10)61313-015765750)
KloteMMNelsonMREnglerRJAutoimmune urticaria response to high-dose intravenous immunoglobulinAnn Allergy Asthma Immunol2005530730810.1016/S1081-1206(10)61313-015765750KloteMMNelsonMREnglerRJAutoimmune urticaria response to high-dose intravenous immunoglobulinAnn Allergy Asthma Immunol2005530730810.1016/S1081-1206(10)61313-015765750, KloteMMNelsonMREnglerRJAutoimmune urticaria response to high-dose intravenous immunoglobulinAnn Allergy Asthma Immunol2005530730810.1016/S1081-1206(10)61313-015765750
P Staubach-Renz, E von Stebut, W Bräuninger, M Maurer, K Steinbrink (2007)
[Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]Hautarzt, 58
(GrobJJAuquierPDreyfusIOrtonneJPHow to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of lifeAllergy2009560561210.1111/j.1398-9995.2008.01913.x19133920)
GrobJJAuquierPDreyfusIOrtonneJPHow to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of lifeAllergy2009560561210.1111/j.1398-9995.2008.01913.x19133920GrobJJAuquierPDreyfusIOrtonneJPHow to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of lifeAllergy2009560561210.1111/j.1398-9995.2008.01913.x19133920, GrobJJAuquierPDreyfusIOrtonneJPHow to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of lifeAllergy2009560561210.1111/j.1398-9995.2008.01913.x19133920
O. Diav-Citrin, S. Shechtman, A. Aharonovich, L. Moerman, J. Arnon, R. Wajnberg, A. Ornoy (2003)
Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.The Journal of allergy and clinical immunology, 111 6
(ZuberbierZIfflanderJSemmlerCCzarnetzkiBMAcute urticarial--clinical aspects and therapeutic responsivenessActa Derm Venereol199652952978869688)
ZuberbierZIfflanderJSemmlerCCzarnetzkiBMAcute urticarial--clinical aspects and therapeutic responsivenessActa Derm Venereol199652952978869688ZuberbierZIfflanderJSemmlerCCzarnetzkiBMAcute urticarial--clinical aspects and therapeutic responsivenessActa Derm Venereol199652952978869688, ZuberbierZIfflanderJSemmlerCCzarnetzkiBMAcute urticarial--clinical aspects and therapeutic responsivenessActa Derm Venereol199652952978869688
K. Godse (2008)
AUTOLOGOUS SERUM SKIN TEST IN CHILDRENIndian Journal of Dermatology, 53
(SpectorSLShikiarRHardingGMeevesSLeahyMJThe effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticariaCutis2007515716217388220)
SpectorSLShikiarRHardingGMeevesSLeahyMJThe effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticariaCutis2007515716217388220SpectorSLShikiarRHardingGMeevesSLeahyMJThe effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticariaCutis2007515716217388220, SpectorSLShikiarRHardingGMeevesSLeahyMJThe effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticariaCutis2007515716217388220
Elisabeth Robert, S. Vollset, LorenzoD. Botto, P. Lancaster, Paul Merlob, P. Mastroiacovo, Guido Cocchi, M. Ashizawa, S. Sakamoto, I. Orioli (1994)
Malformation surveillance and maternal drug exposure: the MADRE project.The International journal of risk & safety in medicine, 6 2
(U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research and U.S. Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidanceHealth Qual Life Outcomes200657917034633)
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research and U.S. Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidanceHealth Qual Life Outcomes200657917034633U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research and U.S. Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidanceHealth Qual Life Outcomes200657917034633, U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research and U.S. Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidanceHealth Qual Life Outcomes200657917034633
A. Giménez-Arnau, I. Izquierdo, Marcus Maurer (2009)
The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mgJournal of the European Academy of Dermatology and Venereology, 23
G. Lorenzo, A. D’alcamo, M. Rizzo, M. Leto-Barone, C. Bianco, V. Ditta, D. Politi, F. Castello, I. Pepe, G. Fede, G. Rini (2008)
Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic reviewJournal of Asthma and Allergy, 2
K. Waibel, D. Reese, R. Hamilton, R. Devillez (2010)
Partial improvement of solar urticaria after omalizumab.The Journal of allergy and clinical immunology, 125 2
S. Carmichael, G. Shaw (1999)
Maternal corticosteroid use and risk of selected congenital anomalies.American journal of medical genetics, 86 3
C. Grattan, D. Francis, R. Barlow, M. Greaves, N. Slater (1992)
Plasmapheresis for severe, unremitting, chronic urticariaThe Lancet, 339
(CugnoMMarzanoAVTedeschiAFanoniDVenegoniLAseroRExpression of tissue factor by eosinophils in patients with chronic urticariaInt Arch Allergy Immunol2009517017410.1159/00015574818802362)
CugnoMMarzanoAVTedeschiAFanoniDVenegoniLAseroRExpression of tissue factor by eosinophils in patients with chronic urticariaInt Arch Allergy Immunol2009517017410.1159/00015574818802362CugnoMMarzanoAVTedeschiAFanoniDVenegoniLAseroRExpression of tissue factor by eosinophils in patients with chronic urticariaInt Arch Allergy Immunol2009517017410.1159/00015574818802362, CugnoMMarzanoAVTedeschiAFanoniDVenegoniLAseroRExpression of tissue factor by eosinophils in patients with chronic urticariaInt Arch Allergy Immunol2009517017410.1159/00015574818802362
(TedeschiAAiraghiLLoriniMAseroRChronic urticaria. A role for newer immunomodulatory drugs?Am J Clin Dermatol2003529730510.2165/00128071-200304050-0000112688835)
TedeschiAAiraghiLLoriniMAseroRChronic urticaria. A role for newer immunomodulatory drugs?Am J Clin Dermatol2003529730510.2165/00128071-200304050-0000112688835TedeschiAAiraghiLLoriniMAseroRChronic urticaria. A role for newer immunomodulatory drugs?Am J Clin Dermatol2003529730510.2165/00128071-200304050-0000112688835, TedeschiAAiraghiLLoriniMAseroRChronic urticaria. A role for newer immunomodulatory drugs?Am J Clin Dermatol2003529730510.2165/00128071-200304050-0000112688835
T. Zuberbier, R. Asero, C. Bindslev‐Jensen, G. Canonica, M. Church, A. Giménez-Arnau, C. Grattan, A. Kapp, H. Merk, B. Rogala, S. Saini, M. Sánchez-Borges, P. Schmid‐Grendelmeier, H. Schünemann, P. Staubach, G. Vena, B. Wedi, M. Maurer (2006)
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy, 64
I. Baiardini, A. Giardini, M. Pasquali, P. Dignetti, L. Guerra, C. Specchia, F. Braido, G. Majani, G. Canonica (2003)
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergyAllergy, 58
HF Kjaer, E Eller, A Host, KE Andersen, C Bendslev-Jensen (2008)
The prevalence of allergic diseases in an unselected group of 6 year old children. The DARC birth cohort studyPaed Allergy Immunol, 19
A. Valero, M. Herdman, J. Bartra, M. Ferrer, I. Jáuregui, I. Dávila, A. Cuvillo, J. Montoro, J. Mullol, J. Sastre, G. Canonica, I. Baiardini (2008)
Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).Journal of investigational allergology & clinical immunology, 18 6
(YangKPlacental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoidsRev Reprod1997512913210.1530/ror.0.00201299414475)
YangKPlacental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoidsRev Reprod1997512913210.1530/ror.0.00201299414475YangKPlacental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoidsRev Reprod1997512913210.1530/ror.0.00201299414475, YangKPlacental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoidsRev Reprod1997512913210.1530/ror.0.00201299414475
L. Delong, S. Culler, S. Saini, L. Beck, Suephy Chen (2008)
Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.Archives of dermatology, 144 1
(Rodríguez-PinillaEMartínez-FríasMLCorticosteroids during pregnancy and oral clefts: a case-control studyTeratology199852510.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-49699238)
Rodríguez-PinillaEMartínez-FríasMLCorticosteroids during pregnancy and oral clefts: a case-control studyTeratology199852510.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-49699238Rodríguez-PinillaEMartínez-FríasMLCorticosteroids during pregnancy and oral clefts: a case-control studyTeratology199852510.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-49699238, Rodríguez-PinillaEMartínez-FríasMLCorticosteroids during pregnancy and oral clefts: a case-control studyTeratology199852510.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-49699238
F. Siebenhaar, F. Degener, T. Zuberbier, P. Martus, M. Maurer (2009)
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.The Journal of allergy and clinical immunology, 123 3
P. Pradat, E. Robert‐Gnansia, G. Tanna, A. Rosano, Alessandra Lisi, P. Mastroiacovo (2003)
First trimester exposure to corticosteroids and oral clefts.Birth defects research. Part A, Clinical and molecular teratology, 67 12
S. Handa, S. Dogra, Bhushan Kumar (2004)
Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticariaJournal of Dermatological Treatment, 15
(VaradarajuluSUrticaria and angioedema. Controlling acute episodes, coping with chronic casesPostgrad Med20055253115948365)
VaradarajuluSUrticaria and angioedema. Controlling acute episodes, coping with chronic casesPostgrad Med20055253115948365VaradarajuluSUrticaria and angioedema. Controlling acute episodes, coping with chronic casesPostgrad Med20055253115948365, VaradarajuluSUrticaria and angioedema. Controlling acute episodes, coping with chronic casesPostgrad Med20055253115948365
(KjaerHFEllerEHostAAndersenKEBendslev-JensenCThe prevalence of allergic diseases in an unselected group of 6 year old children. The DARC birth cohort studyPaed Allergy Immunol2008573774510.1111/j.1399-3038.2008.00733.x)
KjaerHFEllerEHostAAndersenKEBendslev-JensenCThe prevalence of allergic diseases in an unselected group of 6 year old children. The DARC birth cohort studyPaed Allergy Immunol2008573774510.1111/j.1399-3038.2008.00733.xKjaerHFEllerEHostAAndersenKEBendslev-JensenCThe prevalence of allergic diseases in an unselected group of 6 year old children. The DARC birth cohort studyPaed Allergy Immunol2008573774510.1111/j.1399-3038.2008.00733.x, KjaerHFEllerEHostAAndersenKEBendslev-JensenCThe prevalence of allergic diseases in an unselected group of 6 year old children. The DARC birth cohort studyPaed Allergy Immunol2008573774510.1111/j.1399-3038.2008.00733.x
Eugene Monroe, David Bernstein, Roger Fox, Grabiec Sv, Honsinger Rw, Kalivas Jt, Katz Hi, F. Cuss, M. Danzig, Garvin Pr (1992)
Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.Arzneimittel-Forschung, 42 9
E. Toubi, A. Blant, A. Kessel, TD Golan (1997)
Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy, 52
(KameyoshiYTanakaTMiharaSTakahagiSNiimiNHideMIncreasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patientsBr J Dermatol2007580380410.1111/j.1365-2133.2007.08060.x17627798)
KameyoshiYTanakaTMiharaSTakahagiSNiimiNHideMIncreasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patientsBr J Dermatol2007580380410.1111/j.1365-2133.2007.08060.x17627798KameyoshiYTanakaTMiharaSTakahagiSNiimiNHideMIncreasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patientsBr J Dermatol2007580380410.1111/j.1365-2133.2007.08060.x17627798, KameyoshiYTanakaTMiharaSTakahagiSNiimiNHideMIncreasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patientsBr J Dermatol2007580380410.1111/j.1365-2133.2007.08060.x17627798
I. Baiardini, P. Bousquet, Z. Brzoza, G. Canonica, E. Compalati, Alessandro Fiocchi, W. Fokkens, R. Wijk, S. Grutta, Carlo Lombardi, Marcus Maurer, A. Pinto, E. Ridolo, G. Senna, Ingrid Terreehorst, A. Bom, J. Bousquet, Torsten Zuberbier, F. Braido (2010)
Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paperAllergy, 65
H. Nelson, R. Reynolds, J. Mason (2000)
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 84 5
(MorettiMECapraraDCoutinhoCJBar-OzBBerkovitchMFetal safety of loratadine use in the first trimester of pregnancy: a multicenter studyJ Allergy Clin Immunol2003547948310.1067/mai.2003.13012642825)
MorettiMECapraraDCoutinhoCJBar-OzBBerkovitchMFetal safety of loratadine use in the first trimester of pregnancy: a multicenter studyJ Allergy Clin Immunol2003547948310.1067/mai.2003.13012642825MorettiMECapraraDCoutinhoCJBar-OzBBerkovitchMFetal safety of loratadine use in the first trimester of pregnancy: a multicenter studyJ Allergy Clin Immunol2003547948310.1067/mai.2003.13012642825, MorettiMECapraraDCoutinhoCJBar-OzBBerkovitchMFetal safety of loratadine use in the first trimester of pregnancy: a multicenter studyJ Allergy Clin Immunol2003547948310.1067/mai.2003.13012642825
(1996)
Dermatol Clin
(ToubiEBlantAKesselAGolanTDLow-dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy1997531231610.1111/j.1398-9995.1997.tb00996.x9140522)
ToubiEBlantAKesselAGolanTDLow-dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy1997531231610.1111/j.1398-9995.1997.tb00996.x9140522ToubiEBlantAKesselAGolanTDLow-dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy1997531231610.1111/j.1398-9995.1997.tb00996.x9140522, ToubiEBlantAKesselAGolanTDLow-dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy1997531231610.1111/j.1398-9995.1997.tb00996.x9140522
(KhakooGSofianou-KatsoulisAPerkinMRLackGClinical features and natural history of physical urticaria in childrenPediatr Allergy Immunol2008536336610.1111/j.1399-3038.2007.00667.x18167159)
KhakooGSofianou-KatsoulisAPerkinMRLackGClinical features and natural history of physical urticaria in childrenPediatr Allergy Immunol2008536336610.1111/j.1399-3038.2007.00667.x18167159KhakooGSofianou-KatsoulisAPerkinMRLackGClinical features and natural history of physical urticaria in childrenPediatr Allergy Immunol2008536336610.1111/j.1399-3038.2007.00667.x18167159, KhakooGSofianou-KatsoulisAPerkinMRLackGClinical features and natural history of physical urticaria in childrenPediatr Allergy Immunol2008536336610.1111/j.1399-3038.2007.00667.x18167159
(AseroRTedeschiARiboldiPCugnoMPlasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serumJ Allergy Clin Immunol200651113111710.1016/j.jaci.2005.12.134316675340)
AseroRTedeschiARiboldiPCugnoMPlasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serumJ Allergy Clin Immunol200651113111710.1016/j.jaci.2005.12.134316675340AseroRTedeschiARiboldiPCugnoMPlasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serumJ Allergy Clin Immunol200651113111710.1016/j.jaci.2005.12.134316675340, AseroRTedeschiARiboldiPCugnoMPlasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serumJ Allergy Clin Immunol200651113111710.1016/j.jaci.2005.12.134316675340
B. Engin, F. Uguz, Ertan Yilmaz, Mustafa Özdemir, I. Mevlitoğlu (2007)
The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJournal of the European Academy of Dermatology and Venereology, 22
(FagioloUKricekFRufCPesericoAAmadoriACancianMEffects of complement inactivation on IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticariaJ Allergy Clin Immunol2000556757210.1067/mai.2000.10891310984379)
FagioloUKricekFRufCPesericoAAmadoriACancianMEffects of complement inactivation on IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticariaJ Allergy Clin Immunol2000556757210.1067/mai.2000.10891310984379FagioloUKricekFRufCPesericoAAmadoriACancianMEffects of complement inactivation on IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticariaJ Allergy Clin Immunol2000556757210.1067/mai.2000.10891310984379, FagioloUKricekFRufCPesericoAAmadoriACancianMEffects of complement inactivation on IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticariaJ Allergy Clin Immunol2000556757210.1067/mai.2000.10891310984379
(Staubach-RenzPvon StebutEBräuningerWMaurerMSteinbrinkK[Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]Hautarzt2007569369710.1007/s00105-007-1301-517453168)
Staubach-RenzPvon StebutEBräuningerWMaurerMSteinbrinkK[Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]Hautarzt2007569369710.1007/s00105-007-1301-517453168Staubach-RenzPvon StebutEBräuningerWMaurerMSteinbrinkK[Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]Hautarzt2007569369710.1007/s00105-007-1301-517453168, Staubach-RenzPvon StebutEBräuningerWMaurerMSteinbrinkK[Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]Hautarzt2007569369710.1007/s00105-007-1301-517453168
(HabifTPUrticaria and angioedemaClinical Dermatology: A Color Guide to Diagnosis and Therapy20044New York, NY: Mosby129161)
HabifTPUrticaria and angioedemaClinical Dermatology: A Color Guide to Diagnosis and Therapy20044New York, NY: Mosby129161HabifTPUrticaria and angioedemaClinical Dermatology: A Color Guide to Diagnosis and Therapy20044New York, NY: Mosby129161, HabifTPUrticaria and angioedemaClinical Dermatology: A Color Guide to Diagnosis and Therapy20044New York, NY: Mosby129161
R. Sabroe, E. Poon, G. Orchard, David Lane, D. Francis, R. Barr, M. Black, A. Black, M. Greaves (1999)
Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.The Journal of allergy and clinical immunology, 103 3 Pt 1
R. Powell, G. Toit, N. Siddique, S. Leech, T. Dixon, A. Clark, R. Mirakian, S. Walker, P. Huber, S. Nasser (2007)
BSACI guidelines for the management of chronic urticaria and angio‐oedemaClinical & Experimental Allergy, 37
L. Gober, P. Sterba, J. Eckman, S. Saini (2008)
Effect of Anti-IgE (Omalizumab) in Chronic Idiopathic Urticaria (CIU) PatientsThe Journal of Allergy and Clinical Immunology, 121
AJ Herzberg, CR Strohmeyer, VA Cirillo-Hyland (1995)
Autoimmune progesterone dermatitisJ Am Acad Dermatol, 32
(GrattanCEO'DonnellBFFrancisDMNiimiNBarlowRJRandomized double-blind study of cyclosporin in chronic 'idiopathic' urticariaBr J Dermatol2000536537210.1046/j.1365-2133.2000.03664.x10951147)
GrattanCEO'DonnellBFFrancisDMNiimiNBarlowRJRandomized double-blind study of cyclosporin in chronic 'idiopathic' urticariaBr J Dermatol2000536537210.1046/j.1365-2133.2000.03664.x10951147GrattanCEO'DonnellBFFrancisDMNiimiNBarlowRJRandomized double-blind study of cyclosporin in chronic 'idiopathic' urticariaBr J Dermatol2000536537210.1046/j.1365-2133.2000.03664.x10951147, GrattanCEO'DonnellBFFrancisDMNiimiNBarlowRJRandomized double-blind study of cyclosporin in chronic 'idiopathic' urticariaBr J Dermatol2000536537210.1046/j.1365-2133.2000.03664.x10951147
M. Maurer, S. Altrichter, T. Bieber, T. Biedermann, M. Bräutigam, S. Seyfried, R. Brehler, J. Grabbe, N. Hunzelmann, T. Jakob, A. Jung, J. Kleine‐Tebbe, M. Mempel, M. Meurer, K. Reich, F. Ruëff, K. Schäkel, K. Sengupta, C. Sieder, J. Simon, B. Wedi, T. Zuberbier, V. Mahler, P. Staubach (2011)
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.The Journal of allergy and clinical immunology, 128 1
(SabroeRAFailure of omalizumab in cholinergic urticariaClin Exp Dermatol2010512712910.1111/j.1365-2230.2009.03748.x)
SabroeRAFailure of omalizumab in cholinergic urticariaClin Exp Dermatol2010512712910.1111/j.1365-2230.2009.03748.xSabroeRAFailure of omalizumab in cholinergic urticariaClin Exp Dermatol2010512712910.1111/j.1365-2230.2009.03748.x, SabroeRAFailure of omalizumab in cholinergic urticariaClin Exp Dermatol2010512712910.1111/j.1365-2230.2009.03748.x
(VenaGACassanoNColomboDPeruzziEPigattoPNeo-I-30 Study GroupCyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trialJ Am Acad Dermatol2006570570910.1016/j.jaad.2006.04.07817010756)
VenaGACassanoNColomboDPeruzziEPigattoPNeo-I-30 Study GroupCyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trialJ Am Acad Dermatol2006570570910.1016/j.jaad.2006.04.07817010756VenaGACassanoNColomboDPeruzziEPigattoPNeo-I-30 Study GroupCyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trialJ Am Acad Dermatol2006570570910.1016/j.jaad.2006.04.07817010756, VenaGACassanoNColomboDPeruzziEPigattoPNeo-I-30 Study GroupCyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trialJ Am Acad Dermatol2006570570910.1016/j.jaad.2006.04.07817010756
P. Staubach‐Renz, E. Stebut, W. Bräuninger, M. Maurer, K. Steinbrink (2007)
Hypokomplementämisches Urtikaria-Vaskulitis-SyndromDer Hautarzt, 58
(NettisEColanardiMCBarraLFerranniniAVaccaATursiALevocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled studyBr J Dermatol2006553353810.1111/j.1365-2133.2005.07049.x16445787)
NettisEColanardiMCBarraLFerranniniAVaccaATursiALevocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled studyBr J Dermatol2006553353810.1111/j.1365-2133.2005.07049.x16445787NettisEColanardiMCBarraLFerranniniAVaccaATursiALevocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled studyBr J Dermatol2006553353810.1111/j.1365-2133.2005.07049.x16445787, NettisEColanardiMCBarraLFerranniniAVaccaATursiALevocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled studyBr J Dermatol2006553353810.1111/j.1365-2133.2005.07049.x16445787
K. Izu, Osamu Yamamoto, Junko Yamaguchi, Tomoko Ohta, Masakazu Asahi (2001)
[A case of autoimmune progesterone dermatitis].Journal of UOEH, 23 4
(ShaharEBergmanRGuttman-YasskyEPollackSTreatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroidsInt J Dermatol200651224122710.1111/j.1365-4632.2006.02655.x17040448)
ShaharEBergmanRGuttman-YasskyEPollackSTreatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroidsInt J Dermatol200651224122710.1111/j.1365-4632.2006.02655.x17040448ShaharEBergmanRGuttman-YasskyEPollackSTreatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroidsInt J Dermatol200651224122710.1111/j.1365-4632.2006.02655.x17040448, ShaharEBergmanRGuttman-YasskyEPollackSTreatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroidsInt J Dermatol200651224122710.1111/j.1365-4632.2006.02655.x17040448
(ToubiEKesselAAvshovichNBambergerESaboENusemDPanasoffJClinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patientsAllergy2004586987310.1111/j.1398-9995.2004.00473.x15230821)
ToubiEKesselAAvshovichNBambergerESaboENusemDPanasoffJClinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patientsAllergy2004586987310.1111/j.1398-9995.2004.00473.x15230821ToubiEKesselAAvshovichNBambergerESaboENusemDPanasoffJClinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patientsAllergy2004586987310.1111/j.1398-9995.2004.00473.x15230821, ToubiEKesselAAvshovichNBambergerESaboENusemDPanasoffJClinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patientsAllergy2004586987310.1111/j.1398-9995.2004.00473.x15230821
O'donnell, Barr, Kobza Black, Francis, Kermani, Niimi, Barlow, Winkelmann, Greaves (1998)
Intravenous immunoglobulin in autoimmune chronic urticariaBritish Journal of Dermatology, 138
J. Tarbox, R. Gutta, C. Radojicic, D. Lang (2011)
Utility of routine laboratory testing in management of chronic urticaria/angioedema.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 107 3
G. Khakoo, Aikaterini Sofianou-Katsoulis, M. Perkin, G. Lack (2008)
Clinical features and natural history of physical urticaria in childrenPediatric Allergy and Immunology, 19
(KikuchiYKaplanAMechanisms of autoimmune activation of basophils in chronic urticariaJ Allergy Clin Immunol200151056106210.1067/mai.2001.11548411398085)
KikuchiYKaplanAMechanisms of autoimmune activation of basophils in chronic urticariaJ Allergy Clin Immunol200151056106210.1067/mai.2001.11548411398085KikuchiYKaplanAMechanisms of autoimmune activation of basophils in chronic urticariaJ Allergy Clin Immunol200151056106210.1067/mai.2001.11548411398085, KikuchiYKaplanAMechanisms of autoimmune activation of basophils in chronic urticariaJ Allergy Clin Immunol200151056106210.1067/mai.2001.11548411398085
(ChurchMKWellerKStockPMauwerMChronic spontaneous urticaria in children: itching for insightPaediatr Allergy Immunol201151810.1111/j.1399-3038.2010.01120.x)
ChurchMKWellerKStockPMauwerMChronic spontaneous urticaria in children: itching for insightPaediatr Allergy Immunol201151810.1111/j.1399-3038.2010.01120.xChurchMKWellerKStockPMauwerMChronic spontaneous urticaria in children: itching for insightPaediatr Allergy Immunol201151810.1111/j.1399-3038.2010.01120.x, ChurchMKWellerKStockPMauwerMChronic spontaneous urticaria in children: itching for insightPaediatr Allergy Immunol201151810.1111/j.1399-3038.2010.01120.x
(MuramatsuCTanabeEUrticarial vasculitis: response to dapsone and colchicineJ Am Acad Dermatol1985510554078096)
MuramatsuCTanabeEUrticarial vasculitis: response to dapsone and colchicineJ Am Acad Dermatol1985510554078096MuramatsuCTanabeEUrticarial vasculitis: response to dapsone and colchicineJ Am Acad Dermatol1985510554078096, MuramatsuCTanabeEUrticarial vasculitis: response to dapsone and colchicineJ Am Acad Dermatol1985510554078096
S. Elling, P. Mckenna, F. Powell (2000)
Pruritic urticarial papules and plaques of pregnancy in twin and triplet pregnanciesJournal of the European Academy of Dermatology and Venereology, 14
K. Hartmann, N. Hani, R. Hinrichs, N. Hunzelmann, K. Scharffetter-Kochanek (2001)
Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria.Acta dermato-venereologica, 81 1
M. Kozel, J. Mekkes, P. Bossuyt, J. Bos (2001)
Natural course of physical and chronic urticaria and angioedema in 220 patients.Journal of the American Academy of Dermatology, 45 3
L. Lopez, Kathleen Davis, P. Kohler, A. Schocket (1984)
The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine.The Journal of allergy and clinical immunology, 73 5 Pt 1
(BanerjiAWellePSheikhJCytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome)Immunol Allergy Clin North Am2006576978110.1016/j.iac.2006.09.00117085290)
BanerjiAWellePSheikhJCytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome)Immunol Allergy Clin North Am2006576978110.1016/j.iac.2006.09.00117085290BanerjiAWellePSheikhJCytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome)Immunol Allergy Clin North Am2006576978110.1016/j.iac.2006.09.00117085290, BanerjiAWellePSheikhJCytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome)Immunol Allergy Clin North Am2006576978110.1016/j.iac.2006.09.00117085290
S. Saini, M. Paterniti, K. Vasagar, S. Gibbons, P. Sterba, B. Vonakis (2009)
Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2.Clinical immunology, 132 3
A. Banerji, P. Weller, J. Sheikh (2006)
Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome).Immunology and allergy clinics of North America, 26 4
E. Nettis, M. Colanardi, L. Barra, A. Ferrannini, A. Vacca, A. Tursi (2006)
Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled studyBritish Journal of Dermatology, 154
L. Gilbert (1988)
A Personal Journey
J. Elias, E. Boss, A. Kaplan (1986)
Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells.The Journal of allergy and clinical immunology, 78 5 Pt 1
T. Tromovitch, W. Heggli (1967)
Autoimmune progesterone urticaria.California medicine, 106 3
(SainiSRosenKEHsiehHJWongDAConnerEA randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H(1)-antihistamine-refractory chronic idiopathic urticariaJ Allergy Clin Immunol2011556757310.1016/j.jaci.2011.06.01021762974)
SainiSRosenKEHsiehHJWongDAConnerEA randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H(1)-antihistamine-refractory chronic idiopathic urticariaJ Allergy Clin Immunol2011556757310.1016/j.jaci.2011.06.01021762974SainiSRosenKEHsiehHJWongDAConnerEA randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H(1)-antihistamine-refractory chronic idiopathic urticariaJ Allergy Clin Immunol2011556757310.1016/j.jaci.2011.06.01021762974, SainiSRosenKEHsiehHJWongDAConnerEA randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H(1)-antihistamine-refractory chronic idiopathic urticariaJ Allergy Clin Immunol2011556757310.1016/j.jaci.2011.06.01021762974
Y. Kikuchi, T. Fann, A. Kaplan (2003)
Antithyroid antibodies in chronic urticaria and angioedema.The Journal of allergy and clinical immunology, 112 1
C. Muramatsu, E. Tanabe (1985)
Urticarial vasculitis: response to dapsone and colchicine.Journal of the American Academy of Dermatology, 13 6
SA Grundmann, S Kiefer, TA Luger, R Brehler (2011)
J Dtsch Dermatol Ges
J. Wiles, R. Hansen, P. Lynch (1985)
Urticarial vasculitis treated with colchicine.Archives of dermatology, 121 6
B. Vonakis, K. Vasagar, S. Gibbons, L. Gober, P. Sterba, Hyeyoun Chang, S. Saini (2007)
Basophil FcɛRI histamine release parallels expression of Src-homology 2–containing inositol phosphatases in chronic idiopathic urticariaThe Journal of Allergy and Clinical Immunology, 119
A. Kaplan, Z. Horáková, S. Katz (1978)
Assessment of tissue fluid histamine levels in patients with urticaria.The Journal of allergy and clinical immunology, 61 6
(PatrickDLBurkeLBPowersJHScottJARockEPPatient-reported outcomes to support medical product labeling claims: FDA perspectiveValue Health20075125137)
PatrickDLBurkeLBPowersJHScottJARockEPPatient-reported outcomes to support medical product labeling claims: FDA perspectiveValue Health20075125137PatrickDLBurkeLBPowersJHScottJARockEPPatient-reported outcomes to support medical product labeling claims: FDA perspectiveValue Health20075125137, PatrickDLBurkeLBPowersJHScottJARockEPPatient-reported outcomes to support medical product labeling claims: FDA perspectiveValue Health20075125137
(SabroeRAFrancisDMBarrRMBlackAKGreavesMWAnti-Fc (episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticariaJ Allergy Clin Immunol1998565165810.1016/S0091-6749(98)70283-09802375)
SabroeRAFrancisDMBarrRMBlackAKGreavesMWAnti-Fc (episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticariaJ Allergy Clin Immunol1998565165810.1016/S0091-6749(98)70283-09802375SabroeRAFrancisDMBarrRMBlackAKGreavesMWAnti-Fc (episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticariaJ Allergy Clin Immunol1998565165810.1016/S0091-6749(98)70283-09802375, SabroeRAFrancisDMBarrRMBlackAKGreavesMWAnti-Fc (episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticariaJ Allergy Clin Immunol1998565165810.1016/S0091-6749(98)70283-09802375
(van der ValkPGMoretGKiemeneyLAThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol2002511011310.1046/j.1365-2133.2002.04582.x11841375)
van der ValkPGMoretGKiemeneyLAThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol2002511011310.1046/j.1365-2133.2002.04582.x11841375van der ValkPGMoretGKiemeneyLAThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol2002511011310.1046/j.1365-2133.2002.04582.x11841375, van der ValkPGMoretGKiemeneyLAThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol2002511011310.1046/j.1365-2133.2002.04582.x11841375
M. Cugno, A. Marzano, A. Tedeschi, D. Fanoni, L. Venegoni, R. Asero (2008)
Expression of Tissue Factor by Eosinophils in Patients with Chronic UrticariaInternational Archives of Allergy and Immunology, 148
J. Reinisch, N. Simon, W. Karow, R. Gandelman (1979)
Prenatal exposure to prednisone in humans and animals retards intrauterine growth.Science, 202 4366
C. Larocca, J. McEvoy, C. Ellis, J. Junkins-Hopkins, T. Kolb, A. Baer, B. Garibaldi (2011)
Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulationClinical Rheumatology, 31
(WaibelKHReeseDAHamiltonRGDevillezRLPartial improvement of solar urticaria after omalizumabJ Allergy Clin Immunol20095490491)
WaibelKHReeseDAHamiltonRGDevillezRLPartial improvement of solar urticaria after omalizumabJ Allergy Clin Immunol20095490491WaibelKHReeseDAHamiltonRGDevillezRLPartial improvement of solar urticaria after omalizumabJ Allergy Clin Immunol20095490491, WaibelKHReeseDAHamiltonRGDevillezRLPartial improvement of solar urticaria after omalizumabJ Allergy Clin Immunol20095490491
(GilbertCMazzottaPLoebsteinRKorenGFetal safety of drugs used in the treatment of allergic rhinitis: a critical reviewDrug Saf2005570771910.2165/00002018-200528080-0000516048356)
GilbertCMazzottaPLoebsteinRKorenGFetal safety of drugs used in the treatment of allergic rhinitis: a critical reviewDrug Saf2005570771910.2165/00002018-200528080-0000516048356GilbertCMazzottaPLoebsteinRKorenGFetal safety of drugs used in the treatment of allergic rhinitis: a critical reviewDrug Saf2005570771910.2165/00002018-200528080-0000516048356, GilbertCMazzottaPLoebsteinRKorenGFetal safety of drugs used in the treatment of allergic rhinitis: a critical reviewDrug Saf2005570771910.2165/00002018-200528080-0000516048356
C Léauté-Labréze (2003)
Presented at: Symposium
K. Krause, E. Ardelean, B. Kessler, M. Magerl, M. Metz, F. Siebenhaar, K. Weller, Margitta Worm, T. Zuberbier, Marcus Maurer (2010)
Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapyAllergy, 65
(SimonsFESussmanGLSimonsKJEffect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H2 antagonists hydroxizine and cetirizine in patients with chronic urticariaJ Allergy Clin Immunol1995568569310.1016/S0091-6749(95)70173-77897151)
SimonsFESussmanGLSimonsKJEffect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H2 antagonists hydroxizine and cetirizine in patients with chronic urticariaJ Allergy Clin Immunol1995568569310.1016/S0091-6749(95)70173-77897151SimonsFESussmanGLSimonsKJEffect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H2 antagonists hydroxizine and cetirizine in patients with chronic urticariaJ Allergy Clin Immunol1995568569310.1016/S0091-6749(95)70173-77897151, SimonsFESussmanGLSimonsKJEffect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H2 antagonists hydroxizine and cetirizine in patients with chronic urticariaJ Allergy Clin Immunol1995568569310.1016/S0091-6749(95)70173-77897151
A. Kessel, R. Bishara, A. Amital, Ellen Bamberger, E. Sabo, G. Grushko, E. Toubi (2005)
Increased plasma levels of matrix metalloproteinase‐9 are associated with the severity of chronic urticariaClinical & Experimental Allergy, 35
U. Research, U. Health (2006)
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 4
M. Curran, L. Scott, C. Perry (2012)
CetirizineDrugs, 64
A. Młynek, A. Zalewska-Janowska, P. Martus, P. Staubach, T. Zuberbier, M. Maurer (2008)
How to assess disease activity in patients with chronic urticaria?Allergy, 63
A. Kessel, E. Toubi (2010)
Cyclosporine‐A in severe chronic urticaria: the option for long‐term therapyAllergy, 65
(KesselABisharaAAmitalEBambergerESaboEGrushkoGToubiEIncreased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticariaClin Exp Allergy2005522122510.1111/j.1365-2222.2005.02168.x15725195)
KesselABisharaAAmitalEBambergerESaboEGrushkoGToubiEIncreased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticariaClin Exp Allergy2005522122510.1111/j.1365-2222.2005.02168.x15725195KesselABisharaAAmitalEBambergerESaboEGrushkoGToubiEIncreased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticariaClin Exp Allergy2005522122510.1111/j.1365-2222.2005.02168.x15725195, KesselABisharaAAmitalEBambergerESaboEGrushkoGToubiEIncreased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticariaClin Exp Allergy2005522122510.1111/j.1365-2222.2005.02168.x15725195
(GrattanCFrancisDSlaterNBarlowRGreavesMPlasmaphoresis for severe, unremitting chronic urticariaLancet199251078108010.1016/0140-6736(92)90666-Q1373787)
GrattanCFrancisDSlaterNBarlowRGreavesMPlasmaphoresis for severe, unremitting chronic urticariaLancet199251078108010.1016/0140-6736(92)90666-Q1373787GrattanCFrancisDSlaterNBarlowRGreavesMPlasmaphoresis for severe, unremitting chronic urticariaLancet199251078108010.1016/0140-6736(92)90666-Q1373787, GrattanCFrancisDSlaterNBarlowRGreavesMPlasmaphoresis for severe, unremitting chronic urticariaLancet199251078108010.1016/0140-6736(92)90666-Q1373787
S. Ying, Y. Kikuchi, Q. Meng, A. Kay, A. Kaplan (2002)
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.The Journal of allergy and clinical immunology, 109 4
(SchweitzerPKMuehlbachMJWalshJKSleepiness and performance during three-day administration of cetirizine or diphenhydramineJ Allergy Clin Immunol1994571672410.1016/0091-6749(94)90179-17930305)
SchweitzerPKMuehlbachMJWalshJKSleepiness and performance during three-day administration of cetirizine or diphenhydramineJ Allergy Clin Immunol1994571672410.1016/0091-6749(94)90179-17930305SchweitzerPKMuehlbachMJWalshJKSleepiness and performance during three-day administration of cetirizine or diphenhydramineJ Allergy Clin Immunol1994571672410.1016/0091-6749(94)90179-17930305, SchweitzerPKMuehlbachMJWalshJKSleepiness and performance during three-day administration of cetirizine or diphenhydramineJ Allergy Clin Immunol1994571672410.1016/0091-6749(94)90179-17930305
(KozelMMNatural course of physical and chronic urticaria and angioedema in 220 patientsJ Am Acad Dermatol2001538739110.1067/mjd.2001.11621711511835)
KozelMMNatural course of physical and chronic urticaria and angioedema in 220 patientsJ Am Acad Dermatol2001538739110.1067/mjd.2001.11621711511835KozelMMNatural course of physical and chronic urticaria and angioedema in 220 patientsJ Am Acad Dermatol2001538739110.1067/mjd.2001.11621711511835, KozelMMNatural course of physical and chronic urticaria and angioedema in 220 patientsJ Am Acad Dermatol2001538739110.1067/mjd.2001.11621711511835
Alexander Kapp, Bettina Wedi (2004)
Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine.Journal of drugs in dermatology : JDD, 3 6
(ReimersAPichlerCHelblingAPichlerWJYawalkarNZafirlukast has no beneficial effects in the treatment of chronic urticariaClin Exp Allergy200251763176810.1046/j.1365-2222.2002.01536.x12653169)
ReimersAPichlerCHelblingAPichlerWJYawalkarNZafirlukast has no beneficial effects in the treatment of chronic urticariaClin Exp Allergy200251763176810.1046/j.1365-2222.2002.01536.x12653169ReimersAPichlerCHelblingAPichlerWJYawalkarNZafirlukast has no beneficial effects in the treatment of chronic urticariaClin Exp Allergy200251763176810.1046/j.1365-2222.2002.01536.x12653169, ReimersAPichlerCHelblingAPichlerWJYawalkarNZafirlukast has no beneficial effects in the treatment of chronic urticariaClin Exp Allergy200251763176810.1046/j.1365-2222.2002.01536.x12653169
(GrattanCWallingtonTWarinRKennedyCBradfieldJA serological mediator in chronic idiopathic urticarial--a clinical, immunological, and histological evaluationBr J Dermatol1986558359010.1111/j.1365-2133.1986.tb04065.x3718848)
GrattanCWallingtonTWarinRKennedyCBradfieldJA serological mediator in chronic idiopathic urticarial--a clinical, immunological, and histological evaluationBr J Dermatol1986558359010.1111/j.1365-2133.1986.tb04065.x3718848GrattanCWallingtonTWarinRKennedyCBradfieldJA serological mediator in chronic idiopathic urticarial--a clinical, immunological, and histological evaluationBr J Dermatol1986558359010.1111/j.1365-2133.1986.tb04065.x3718848, GrattanCWallingtonTWarinRKennedyCBradfieldJA serological mediator in chronic idiopathic urticarial--a clinical, immunological, and histological evaluationBr J Dermatol1986558359010.1111/j.1365-2133.1986.tb04065.x3718848
(LevyYSegalNWeintobNDanonYLChronic urticaria: associated with thyroid auto immunityArch Dis Childhood2003551751910.1136/adc.88.6.51712765919)
LevyYSegalNWeintobNDanonYLChronic urticaria: associated with thyroid auto immunityArch Dis Childhood2003551751910.1136/adc.88.6.51712765919LevyYSegalNWeintobNDanonYLChronic urticaria: associated with thyroid auto immunityArch Dis Childhood2003551751910.1136/adc.88.6.51712765919, LevyYSegalNWeintobNDanonYLChronic urticaria: associated with thyroid auto immunityArch Dis Childhood2003551751910.1136/adc.88.6.51712765919
(HerzbergAJStrohmeyerCRCirillo-HylandVAAutoimmune progesterone dermatitisJ Am Acad Dermatol1995533333810.1016/0190-9622(95)90398-47829735)
HerzbergAJStrohmeyerCRCirillo-HylandVAAutoimmune progesterone dermatitisJ Am Acad Dermatol1995533333810.1016/0190-9622(95)90398-47829735HerzbergAJStrohmeyerCRCirillo-HylandVAAutoimmune progesterone dermatitisJ Am Acad Dermatol1995533333810.1016/0190-9622(95)90398-47829735, HerzbergAJStrohmeyerCRCirillo-HylandVAAutoimmune progesterone dermatitisJ Am Acad Dermatol1995533333810.1016/0190-9622(95)90398-47829735
Bettina Wedi, Ulrike Raap, Dorothea Wieczorek, Alexander Kapp (2009)
Urticaria and infectionsAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 5
(AshersonRABuchananNKenwrightSFletcherCMHughesGRThe normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicineClin Exp Dermatol1991542442710.1111/j.1365-2230.1991.tb01227.x1806316)
AshersonRABuchananNKenwrightSFletcherCMHughesGRThe normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicineClin Exp Dermatol1991542442710.1111/j.1365-2230.1991.tb01227.x1806316AshersonRABuchananNKenwrightSFletcherCMHughesGRThe normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicineClin Exp Dermatol1991542442710.1111/j.1365-2230.1991.tb01227.x1806316, AshersonRABuchananNKenwrightSFletcherCMHughesGRThe normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicineClin Exp Dermatol1991542442710.1111/j.1365-2230.1991.tb01227.x1806316
(ZuberbierTOantaABogackaEMedinaIWeselFComparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled studyAllergy2010551652810.1111/j.1398-9995.2009.02217.x19860762)
ZuberbierTOantaABogackaEMedinaIWeselFComparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled studyAllergy2010551652810.1111/j.1398-9995.2009.02217.x19860762ZuberbierTOantaABogackaEMedinaIWeselFComparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled studyAllergy2010551652810.1111/j.1398-9995.2009.02217.x19860762, ZuberbierTOantaABogackaEMedinaIWeselFComparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled studyAllergy2010551652810.1111/j.1398-9995.2009.02217.x19860762
(Puech-PlottovaIMichelJLRouchouseBPerrotJLDzvigaCCambazardFSolar urticaria: one case treated by intravenous immunoglobulinAnn Dermatol Venereol2000583183511060387)
Puech-PlottovaIMichelJLRouchouseBPerrotJLDzvigaCCambazardFSolar urticaria: one case treated by intravenous immunoglobulinAnn Dermatol Venereol2000583183511060387Puech-PlottovaIMichelJLRouchouseBPerrotJLDzvigaCCambazardFSolar urticaria: one case treated by intravenous immunoglobulinAnn Dermatol Venereol2000583183511060387, Puech-PlottovaIMichelJLRouchouseBPerrotJLDzvigaCCambazardFSolar urticaria: one case treated by intravenous immunoglobulinAnn Dermatol Venereol2000583183511060387
I. Puech-Plottova, J. Michel, B. Rouchouse, J. Perrot, C. Dzviga, F. Cambazard (2000)
[Solar urticaria: one case treated by intravenous immunoglobulin].Annales de dermatologie et de venereologie, 127 10
(SoterNAAcute and chronic urticaria and angioedemaJ Am Acad Dermatol199151 pt 21461541869689)
SoterNAAcute and chronic urticaria and angioedemaJ Am Acad Dermatol199151 pt 21461541869689SoterNAAcute and chronic urticaria and angioedemaJ Am Acad Dermatol199151 pt 21461541869689, SoterNAAcute and chronic urticaria and angioedemaJ Am Acad Dermatol199151 pt 21461541869689
P. Gonzalez, V. Soriano, T. Caballero, E. Niveiro (2005)
Idiopatic angioedema treated with dapsone.Allergologia et immunopathologia, 33 1
Z. Brzoza, K. Badura-Brzoza, A. Młynek, Markus Magerl, I. Baiardini, G. Canonica, Karsten Weller, E. Kocatürk, D. Kalogeromitros, D. Kalogeromitros, A. Zalewska-Janowska, Torsten Zuberbier, Marcus Maurer (2011)
Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL).Journal of dermatological science, 62 1
(GreavesMWPlummerVMMcLaughlanPStanworthDRSerum and cell bound IgE in chronic urticariaClin Allergy1974526527110.1111/j.1365-2222.1974.tb01384.x4473279)
GreavesMWPlummerVMMcLaughlanPStanworthDRSerum and cell bound IgE in chronic urticariaClin Allergy1974526527110.1111/j.1365-2222.1974.tb01384.x4473279GreavesMWPlummerVMMcLaughlanPStanworthDRSerum and cell bound IgE in chronic urticariaClin Allergy1974526527110.1111/j.1365-2222.1974.tb01384.x4473279, GreavesMWPlummerVMMcLaughlanPStanworthDRSerum and cell bound IgE in chronic urticariaClin Allergy1974526527110.1111/j.1365-2222.1974.tb01384.x4473279
F. Kern, L. Lichtenstein (1976)
Defective histamine release in chronic urticaria.The Journal of clinical investigation, 57 5
D. Dreyfus (2008)
Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 100 6
R. Criado, P. Criado, J. Martins, N. Valente, N. Michalany, C. Vasconcellos (2008)
Urticaria unresponsive to antihistaminic treatment: An open study of therapeutic options based on histopathologic featuresJournal of Dermatological Treatment, 19
Laura McGirt, K. Vasagar, L. Gober, S. Saini, L. Beck (2006)
Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.Archives of dermatology, 142 10
D. Hamel-Teillac (2003)
[Chronic urticaria in children].Annales de dermatologie et de venereologie, 130 Spec No 1
E. Paul, R. Bödeker (1986)
Treatment of chronic urticaria with terfenadine and ranitidineEuropean Journal of Clinical Pharmacology, 31
(GonzálezPSorianoVCaballeroTNiveiroEIdiopathic angioedema treated with dapsoneAllergol Immunopathol (Madr)20055545546)
GonzálezPSorianoVCaballeroTNiveiroEIdiopathic angioedema treated with dapsoneAllergol Immunopathol (Madr)20055545546GonzálezPSorianoVCaballeroTNiveiroEIdiopathic angioedema treated with dapsoneAllergol Immunopathol (Madr)20055545546, GonzálezPSorianoVCaballeroTNiveiroEIdiopathic angioedema treated with dapsoneAllergol Immunopathol (Madr)20055545546
J. Camarasa, A. Aliaga, J. Fernández‐Vozmediano, E. Fonseca, L. Iglesias, I. Tagarro (2001)
Azelastine Tablets in the Treatment of Chronic Idiopathic UrticariaSkin Pharmacology and Physiology, 14
R. Asero (2000)
Are IVIG for chronic unremitting urticaria effective?Allergy, 55
M. Sands, Jessica Blume, S. Schwartz (2007)
Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab.The Journal of allergy and clinical immunology, 120 4
A. Kaplan, K. Joseph, R. Maykut, G. Geba, R. Zeldin (2008)
Treatment of chronic autoimmune urticaria with omalizumab.The Journal of allergy and clinical immunology, 122 3
G. Lorenzo, M. Pacor, P. Mansueto, M. Pellitteri, C. Bianco, V. Ditta, N. Martinelli, G. Rini (2004)
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.The Journal of allergy and clinical immunology, 114 3
(NettisEColanardiMCParadisoMTFerranniniADesloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled studyClin Exp Allergy200451401140710.1111/j.1365-2222.2004.02019.x15347373)
NettisEColanardiMCParadisoMTFerranniniADesloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled studyClin Exp Allergy200451401140710.1111/j.1365-2222.2004.02019.x15347373NettisEColanardiMCParadisoMTFerranniniADesloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled studyClin Exp Allergy200451401140710.1111/j.1365-2222.2004.02019.x15347373, NettisEColanardiMCParadisoMTFerranniniADesloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled studyClin Exp Allergy200451401140710.1111/j.1365-2222.2004.02019.x15347373
MP Curran, LJ Scott, CM Perry (2004)
Cetirizine: a review of its use in allergic disordersDrugs, 15
(TedeschiAAseroRMarzanoAVLoriniMFanoniDBertiECugnoMPlasma levels and skin eosinophils expression of vascular endothelial growth factor in patients with chronic urticariaAllergy200951616162210.1111/j.1398-9995.2009.02069.x19485983)
TedeschiAAseroRMarzanoAVLoriniMFanoniDBertiECugnoMPlasma levels and skin eosinophils expression of vascular endothelial growth factor in patients with chronic urticariaAllergy200951616162210.1111/j.1398-9995.2009.02069.x19485983TedeschiAAseroRMarzanoAVLoriniMFanoniDBertiECugnoMPlasma levels and skin eosinophils expression of vascular endothelial growth factor in patients with chronic urticariaAllergy200951616162210.1111/j.1398-9995.2009.02069.x19485983, TedeschiAAseroRMarzanoAVLoriniMFanoniDBertiECugnoMPlasma levels and skin eosinophils expression of vascular endothelial growth factor in patients with chronic urticariaAllergy200951616162210.1111/j.1398-9995.2009.02069.x19485983
(KowalskiMLMakowskaJSBlancaMBavbekSBochenekGHypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNAAllergy2011581882910.1111/j.1398-9995.2011.02557.x21631520)
KowalskiMLMakowskaJSBlancaMBavbekSBochenekGHypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNAAllergy2011581882910.1111/j.1398-9995.2011.02557.x21631520KowalskiMLMakowskaJSBlancaMBavbekSBochenekGHypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNAAllergy2011581882910.1111/j.1398-9995.2011.02557.x21631520, KowalskiMLMakowskaJSBlancaMBavbekSBochenekGHypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNAAllergy2011581882910.1111/j.1398-9995.2011.02557.x21631520
P. valk, G. Moret, L. Kiemeney (2002)
The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBritish Journal of Dermatology, 146
P. Mortureux, C. Léauté-Labrèze, V. Legrain-Lifermann, T. Lamireau, J. Sarlangue, A. Taïeb (1998)
Acute urticaria in infancy and early childhood: a prospective study.Archives of dermatology, 134 3
(CharlesworthENKagey-SobotkaASchleimerRPNormanPSLichtensteinLMPrednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergenJ Immunol199156716761702812)
CharlesworthENKagey-SobotkaASchleimerRPNormanPSLichtensteinLMPrednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergenJ Immunol199156716761702812CharlesworthENKagey-SobotkaASchleimerRPNormanPSLichtensteinLMPrednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergenJ Immunol199156716761702812, CharlesworthENKagey-SobotkaASchleimerRPNormanPSLichtensteinLMPrednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergenJ Immunol199156716761702812
(KesselABambergerEToubiETacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective studyJ Am Acad Dermatol2005514514810.1016/j.jaad.2004.09.02315627098)
KesselABambergerEToubiETacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective studyJ Am Acad Dermatol2005514514810.1016/j.jaad.2004.09.02315627098KesselABambergerEToubiETacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective studyJ Am Acad Dermatol2005514514810.1016/j.jaad.2004.09.02315627098, KesselABambergerEToubiETacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective studyJ Am Acad Dermatol2005514514810.1016/j.jaad.2004.09.02315627098
G. Dawn, M. Urcelay, A. Ah-Weng, S. O'neill, W. Douglas (2003)
Effect of high‐dose intravenous immunoglobulin in delayed pressure urticariaBritish Journal of Dermatology, 149
(HaasNBirkle-BerlingerWHenzBMPrognosis of acute urticaria in childrenActa Derm Venereol20055747510.1080/0001555041002354515849000)
HaasNBirkle-BerlingerWHenzBMPrognosis of acute urticaria in childrenActa Derm Venereol20055747510.1080/0001555041002354515849000HaasNBirkle-BerlingerWHenzBMPrognosis of acute urticaria in childrenActa Derm Venereol20055747510.1080/0001555041002354515849000, HaasNBirkle-BerlingerWHenzBMPrognosis of acute urticaria in childrenActa Derm Venereol20055747510.1080/0001555041002354515849000
(EngstromJNeherJWhat is the prognosis for patients with chronic urticaria?J Fam Pract20115168a168b21369561)
EngstromJNeherJWhat is the prognosis for patients with chronic urticaria?J Fam Pract20115168a168b21369561EngstromJNeherJWhat is the prognosis for patients with chronic urticaria?J Fam Pract20115168a168b21369561, EngstromJNeherJWhat is the prognosis for patients with chronic urticaria?J Fam Pract20115168a168b21369561
(GrobJJAuquierPDreyfusIOrtonneJPQuality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled studyJ Eur Acad Dermatol Venereol20085879318181978)
GrobJJAuquierPDreyfusIOrtonneJPQuality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled studyJ Eur Acad Dermatol Venereol20085879318181978GrobJJAuquierPDreyfusIOrtonneJPQuality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled studyJ Eur Acad Dermatol Venereol20085879318181978, GrobJJAuquierPDreyfusIOrtonneJPQuality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled studyJ Eur Acad Dermatol Venereol20085879318181978
P. Potter, A. Kapp, M. Maurer, G. Guillet, A. Jian, P. Hauptmann, A. Finlay (2009)
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patientsAllergy, 64
C. Grattan (2004)
The urticaria spectrum: recognition of clinical patterns can help managementClinical and Experimental Dermatology, 29
(StaevskaMPopovTAKralimarkovaTLazarovaCKraevaSThe effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticariaJ Allergy Clin Immunol2010567668210.1016/j.jaci.2009.11.04720226302)
StaevskaMPopovTAKralimarkovaTLazarovaCKraevaSThe effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticariaJ Allergy Clin Immunol2010567668210.1016/j.jaci.2009.11.04720226302StaevskaMPopovTAKralimarkovaTLazarovaCKraevaSThe effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticariaJ Allergy Clin Immunol2010567668210.1016/j.jaci.2009.11.04720226302, StaevskaMPopovTAKralimarkovaTLazarovaCKraevaSThe effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticariaJ Allergy Clin Immunol2010567668210.1016/j.jaci.2009.11.04720226302
Y. Kameyoshi, Toshihiko Tanaka, S. Mihara, S. Takahagi, N. Niimi, M. Hide (2007)
Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patientsBritish Journal of Dermatology, 157
(FerrerMLuguinESanchez-IbarrolaAMorenoCSanzMKaplanASecretion of cytokines, histamine, and leukotrienes in chronic urticariaInt Arch Allergy Immunol2002525426010.1159/00006677212444324)
FerrerMLuguinESanchez-IbarrolaAMorenoCSanzMKaplanASecretion of cytokines, histamine, and leukotrienes in chronic urticariaInt Arch Allergy Immunol2002525426010.1159/00006677212444324FerrerMLuguinESanchez-IbarrolaAMorenoCSanzMKaplanASecretion of cytokines, histamine, and leukotrienes in chronic urticariaInt Arch Allergy Immunol2002525426010.1159/00006677212444324, FerrerMLuguinESanchez-IbarrolaAMorenoCSanzMKaplanASecretion of cytokines, histamine, and leukotrienes in chronic urticariaInt Arch Allergy Immunol2002525426010.1159/00006677212444324
(DawnGUrcelayMAh-WengAO'NeillSMDouglasWSEffect of high-dose intravenous immunoglobulin in delayed pressure urticariaBr J Dermatol2003583684010.1046/j.1365-2133.2003.05486.x14616377)
DawnGUrcelayMAh-WengAO'NeillSMDouglasWSEffect of high-dose intravenous immunoglobulin in delayed pressure urticariaBr J Dermatol2003583684010.1046/j.1365-2133.2003.05486.x14616377DawnGUrcelayMAh-WengAO'NeillSMDouglasWSEffect of high-dose intravenous immunoglobulin in delayed pressure urticariaBr J Dermatol2003583684010.1046/j.1365-2133.2003.05486.x14616377, DawnGUrcelayMAh-WengAO'NeillSMDouglasWSEffect of high-dose intravenous immunoglobulin in delayed pressure urticariaBr J Dermatol2003583684010.1046/j.1365-2133.2003.05486.x14616377
(Di LorenzoGPacorMLMansuetoPEsposito PellateriMLo BiancoCRandomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticariaJ Allergy Clin Immunol2004561962510.1016/j.jaci.2004.06.01815356567)
Di LorenzoGPacorMLMansuetoPEsposito PellateriMLo BiancoCRandomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticariaJ Allergy Clin Immunol2004561962510.1016/j.jaci.2004.06.01815356567Di LorenzoGPacorMLMansuetoPEsposito PellateriMLo BiancoCRandomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticariaJ Allergy Clin Immunol2004561962510.1016/j.jaci.2004.06.01815356567, Di LorenzoGPacorMLMansuetoPEsposito PellateriMLo BiancoCRandomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticariaJ Allergy Clin Immunol2004561962510.1016/j.jaci.2004.06.01815356567
D. Breneman (1996)
Cetirizine versus Hydroxyzine and Placebo in Chronic Idiopathic UrticariaAnnals of Pharmacotherapy, 30
R. Engler, E. Squire, P. Benson (1995)
Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 74 2
(Léauté-LabrézeCChildhood versus adult urticaria. Dermatology from young to oldPresented at: Symposium2003Rotterdam: Isala)
Léauté-LabrézeCChildhood versus adult urticaria. Dermatology from young to oldPresented at: Symposium2003Rotterdam: IsalaLéauté-LabrézeCChildhood versus adult urticaria. Dermatology from young to oldPresented at: Symposium2003Rotterdam: Isala, Léauté-LabrézeCChildhood versus adult urticaria. Dermatology from young to oldPresented at: Symposium2003Rotterdam: Isala
A. Jaffer (1991)
Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria.The Journal of allergy and clinical immunology, 88 6
Andrew Grant, Jean-Michel Riethuisen, B. Moulaert, C. Devos (2002)
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 88 2
(2003)
Childhood versus adult urticaria. Dermatology from young to old
Urticaria and angioedema are common clinical conditions representing a major concern for physicians and patients alike. The World Allergy Organization (WAO), recognizing the importance of these diseases, has contributed to previous guidelines for the diagnosis and management of urticaria. The Scientific and Clinical Issues Council of WAO proposed the development of this global Position Paper to further enhance the clinical management of these disorders through the participation of renowned experts from all WAO regions of the world. Sections on definition and classification, prevalence, etiology and pathogenesis, diagnosis, treatment, and prognosis are based on the best scientific evidence presently available. Additional sections devoted to urticaria and angioedema in children and pregnant women, quality of life and patient-reported outcomes, and physical urticarias have been incorporated into this document. It is expected that this article will supplement recent international guidelines with the contribution of an expert panel designated by the WAO, increasing awareness of the importance of urticaria and angioedema in medical practice and will become a useful source of information for optimum patient management worldwide.
World Allergy Organization Journal – Springer Journals
Published: Nov 15, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.